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Summary 
 
The irreversible loss of spinal cord parenchyma including astroglia, 
oligodendroglia and neurons is one of the key factors responsible for the 
severe functional impairment in individuals suffering from spinal cord injury 
Therefore, adequate cell replacement strategies might be one means to 
promote structural and functional recovery. Neural stem/ progenitor cells 
(NPC), which have been identified in the adult mammalian nervous system 
including the spinal cord, represent one promising source to replace scaffold 
forming astrocytes, remyelinating oligodendrocytes and neurons within the 
injured spinal cord. Intrinsic neural stem/progenitor cells at and around the 
lesion site can be stimulated by the application of appropriate molecules to 
replace lost spinal cord tissue intrinsically (stimulation of endogenous cell 
replacement). Alternatively, neural stem cells can be isolated from small 
brain/spinal cord biopsies, propagated in vitro and ultimately transplanted into 
the injured spinal cord (neural stem cell transplantation).  
Recently it has been published that mesenchymal stem cells (MSC) secrete a 
yet unidentified factor, which strongly promotes oligodendroglial differentiation 
of hippocampus derived adult neural progenitor cells in vitro under co-culture 
conditions, whereas the astrogenic commitment of NPC is inhibited.  
Based on these findings, I investigated whether the region of isolation (origin) 
of NPC will influence the expression pattern of specific differentiation markers 
after incubation with MSC-conditioned media (MSC-CM). I could show that 
MSC-derived soluble factors induce the expression of oligodendrocyte 
markers in NPC in vitro regardless of the origin of the NPC. Furthermore, 
incubation of NPC with conditioned media derived from fibroblasts resulted in 
an even higher number of cells expressing the oligodendroglial marker MBP 
at the expense of cells expressing the astroglial marker GFAP. These data 
and the fact that MSC and fibroblasts share the same mesenchymal origin 
suggest that MSC-derived soluble factors and fibroblasts-derived soluble 
factors act via the same signaling pathway. 
In the next step, NPC or NPC pre-differentiated towards an oligodendroglial 
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lineage were co-seeded with MSC onto hippocampal slice cultures. Under 
CNS-organotypic conditions MSC still promoted an oligodendroglial fate of 
seeded NPC. While the survival of the seeded NPC was good, the survival of 
oligodendroglial pre-differentiated NPC was very limited after seeding onto 
hippocampal slices. 
To see if the pro-oligodendrogenic activity of MSC is maintained in vivo, NPC 
or pre-differentiated NPC were co-transplanted with MSC into the intact spinal 
cord of adult rats. Although the survival of pre-differentiated NPC was very 
low, a significantly increased oligodendroglial differentiation was observed 
when compared to NPC co-grafted with MSC. 
In subsequent experiments, NPC were co-grafted with MSC or fibroblast into 
the injured spinal cord. Histological analysis demonstrated that fibroblast as 
well as MSC containing grafts filled the cystic lesion after SCI and provided a 
supporting scaffold to sustain adult NPC within the lesion cavity. Interestingly, 
fibroblasts but not MSC increased the oligodendroglial differentiation of co-
grafted NPC in the injured spinal cord. In vitro data demonstrated that BMP2 
and BMP4 (bone morphogenic protein 2 and 4), which are strongly up-
regulated after spinal cord injury completely counteracted effects of MSC, on 
oligodendroglial differentiation of NPC. Thus, neutralization of BMPs or BMP 
signaling might be necessary to enhance oligodendroglial differentiation by 
MSC in vivo.  
Moreover, my studies revealed that the transplantation of MSC into the injured 
spinal cord does not alter the proliferation or survival of endogenous NPC. 
Rather MSC influence the differentiation of endogenous oligodendroglial 
progeny as early as three days after SCI and shift the differentiation pattern of 
NPC towards an oligodendroglial phenotype four weeks after SCI at the 
expense of astroglial differentiation. 
In summary, these studies demonstrate that MSC provide a pro-
oligodendrogenic microenvironment for NPC seeded onto hippocampal slices 
or transplanted into the intact spinal cord. In contrast, MSC do not influence 
the differentiation of co-transplanted NPC in the acutely injured spinal cord, 
but profoundly affect the differentiation of endogenous NPC.  
For any cell-based therapy to be translated into the clinic appropriate 
monitoring tools need to be established to visualize morphological changes 
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caused by cell transplantation into the injured spinal cord. Magnetic 
resonance imaging (MRI) represents the gold-standard to non-invasively 
visualize the spinal cord parenchyma. As a first step to validate cell-therapy 
induced morphological changes, I performed analysis using a routine clinical 
3T MRI-scanner. The referring study demonstrated that a routine clinical 3T 
MRI-scanner can be used for small animal imaging to noninvasively visualize 
pathological changes occurring after rat spinal cord injury. Changes in 3T MRI 
signals correlate with histological, structural and behavioral (locomotor) 
outcomes after SCI. 
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Zusammenfassung 
 
Der irreversible Verlust von Rückenmarksgewebe insbesondere Astroglia, 
Oligodendroglia und Neuronen ist eine der Hauptursachen für schwer-
wiegende funktionellen Beeinträchtigungen in Individuen, die eine Rücken-
marksverletzung erleiden. Daher werden adäquate Zellersatz-Strategien 
benötigt, die eine umfangreiche strukturelle und funktionelle Regeneration 
fördern. Neurale Stamm-/Vorläuferzellen (NPC), welche im adulten Nerven-
system von Säugetieren einschließlich des Rückenmarks identifiziert wurden, 
stellen eine vielversprechende Quelle dar, um gerüst-bildende Astrozyten, re-
myelinisierende Oligodendrozyten sowie Neurone innerhalb des verletzten 
Rückenmarks zu ersetzen. Neurale Stamm-/Vorläuferzellen können entweder 
in oder um die Läsionsstelle herum durch die Gabe von geeigneten Molekülen 
stimuliert werden, mit dem Ziel verlorenes Rückenmarksgewebe intrinsisch 
(Stimulation des endogenen Zellersatzes) zu ersetzen. Alternativ können 
neurale Stammzellen aus kleinen Gehirn-/Rückenmarks-Biopsien isoliert, in 
vitro expandiert und schließlich in das verletzte Rückenmark transplantiert 
werden (Neurale Stammzell-Transplantation). 
In einer kürzlich veröffentlichten Studie konnte gezeigt werden, dass 
mesenchymale Stammzellen (MSC) einen bisher noch nicht identifizierten 
Faktor sezernieren, welcher die oligodendrogliale Differenzierung von adulten 
hippocampalen Vorläuferzellen unter Ko-Kultur Bedingungen in vitro fördert 
und gleichzeitig die astrogliale Differenzierung der NPC inhibiert. 
Basierend auf diesen Ergebnissen habe ich den Einfluss des Herkunftsortes 
der NPC in Bezug auf das Expressionsmuster spezifischer Differenzierungs-
marker nach Inkubation mit konditioniertem Medium der MSC (MSC-CM) 
charakterisiert. Ich konnte zeigen, dass lösliche Faktoren der MSC die 
Expression von oligodendrozytären Markern in NPC unter in vitro Beding-
ungen induzieren, unabhängig von deren anatomischer Herkunft. Darüber 
hinaus führte die Inkubation von NPC mit konditioniertem Medium von Fibro-
blasten sogar zu einer noch höheren Expression des oligodendroglialen 
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Markers MBP und darüber hinaus zu einer signifikant niedrigeren Expression 
des astroglialen Markers GFAP. Diese Daten und die Tatsache, dass MSC 
und Fibroblasten beide mesenchymalen Ursprungs sind, deutet darauf hin, 
dass lösliche Faktoren sowohl der MSC als auch der Fibroblasten über den 
gleichen Signalweg wirken. 
Im nächsten Schritt wurden NPC oder oligodendroglial vordifferenzierte NPC 
zusammen mit MSC auf hippocampale Schnittkulturen ausgesät. Hierbei 
zeigte sich, dass MSC auch in einer ZNS-organotypischen Umgebung die 
oligodendrogliale Differenzierung der transplantierten NPC fördern. Während 
das Überleben der ausgesäten NPC auf hippocampalen Schnitten gut war, 
war das Überleben der oligodendroglial-vordifferenzierten NPC sehr limitiert.  
Anschließend habe ich NPC oder oligodendroglial vordifferenzierte NPC 
zusammen mit MSC in das intakte Rückenmark adulter Ratten transplantiert, 
um zu testen, ob die pro-oligodendrogene Aktivität der MSC auch in vivo 
aufrecht erhalten bleibt. Obwohl das Überleben der vordifferenzierten NPC 
sehr niedrig war, konnte eine signifikante Erhöhung der oligodendroglialen 
Differenzierung dieser Zellen im Vergleich zu NPC, die mit MSC ko-
transplantiert wurden, festgestellt werden.  
In weiterführenden Experimenten konnte durch die Ko-Transplantation von 
NPC mit MSC bzw. Fibroblasten ins läsionierte Rückenmark gezeigt werden, 
dass sowohl MSC- als auch Fibroblasten-enthaltende Transplantate, in der 
Lage waren den zystischen Läsionsdefekt, wie er charakteristischerweise 
nach einer Rückenmarksverletzung auftritt, zu ersetzen und ein 
unterstützendes zelluläres Gerüst zu bilden, um adulte NPC innerhalb der 
Läsion zu halten. Interessanterweise führte die Ko-Transplantation von NPC 
mit Fibroblasten zu einer erhöhten oligodendroglialen Differenzierung der ko-
transplantierten NPC, wohingegen dieser Effekt bei einer MSC-NPC Ko-
Transplantation nicht nachgewiesen werden konnte. In vitro Daten 
demonstrierten, dass BMP2 und BMP4 (Bone Morphogenic Protein 2 und 4), 
die nach einer Rückenmarksverletzung stark hoch regulierten werden, 
komplett dem MSC bedingten Effekt auf die oligodenrogliale Differenzierung 
der NPC, entgegenwirken. Demzufolge könnte die Neutralisation von BMPs 
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oder deren Signalkaskade, nötig sein, um die oligodendroglial Differenzierung 
durch MSC in vivo zu erhöhen. 
Zusätzlich demonstriert diese Studie, dass die Transplantation von MSC ins 
läsionierte Rückenmark weder die Proliferation noch das Überleben von 
endogenen NPC beeinflusst. Allerdings führt die Transplantation von MSC 
schon innerhalb von drei Tagen nach einer Rückenmarksverletzung zu einer 
erhöhten Expression von oligodendroglialen Markern und nach einem Monat 
zu einer Verlagerung des Differenzierungsmusters der endogenen NPC in 
Richtung Oligodendroglia auf Kosten der astroglialen Differenzierung. 
Zusammenfassend konnte in dieser Studie gezeigt werden, das MSC eine 
pro-oligodendrogene Umgebung für NPC bereitstellen, welche auf 
hippocampale Schnitte bzw. ins intakte Rückenmark transplantiert wurden. Im 
Gegensatz dazu konnten diese Beobachtungen nach einer 
Rückenmarksläsion nicht mit ko-transplantierten NPC, sondern lediglich mit 
endogenen NPC rekapituliert werden.  
Für jede zell-basierte Therapie, die in die Klinik transferiert werden soll, 
müssen geeignete bildgebende Verfahren etabliert werden, um 
morphologische Veränderungen darstellen zu können, die durch 
Zelltransplantationen ins verletze Rückenmark hervorgerufen werden. Die 
Magnetresonanztomographie (MRT) stellt den Goldstandard dar, um das 
Rückenmarksparenchym nicht-invasiv zu visualisieren. Um die durch 
Zelltherapie induzierte morphologische Veränderungen zu validieren, habe ich 
Untersuchungen mittels eines klinischen Routine-3T MRT Scanner 
durchgeführt. In dieser Arbeit konnte gezeigt werden, dass es möglich ist, 
einen klinischen Routine-3T Kerspintomgraphen für die Bildgebung von 
Tieren zu nutzen, um nicht-invasiv pathologische Veränderungen, die nach 
einer Rückenmarksverletzung in der Ratte auftreten zu visualisieren und 
diese mit histologischen, strukturellen und Verhaltensveränderungen zu 
korrelieren. 
  
 
1. Introduction 
1.1. Neural stem cells and neurogenesis 
1.1.1. History 
In the last century the dogma existed that the adult central nervous system 
(CNS) is incapable of neurogenesis. In 1897 Schaper described the existence 
of “indifferent-cells” in the CNS. He suggested that these cells might exist 
lifelong and serve as material for regeneration processes after artificial or 
pathological substance deprivation in the CNS. But as far as he knew at this 
time, only a regeneration of neuroglia to recover the substance deprivation 
took place. It was Ramón y Cajal who first established the neuron doctrine 
(1913) by using the Golgi’s method. The neuron doctrine reveals that the 
nervous system consists of structural and functional units, the neurons. The 
neurons are individual cells, which have an axon and several dendrites and 
are not connected in a network. By using the newly invented 3H-Tymidine 
autoradiography method, Altman found in 1963 evidence of neuogenesies in 
the hippocampus (Altman 1963) and olfactory bulb (Altman 1965) of adult 
rats. Through this method dividing cells are labeled in the S-phase of the cell 
cycle by incorporating 3H-Tymidine into the DNA. But only the invention of the 
light microscopy as well as the usage of the thymidine analog 5-bromo-2’-
deoxyuridine (BrdU) provided structural evidence of neurogenesis in the adult 
mammalian brain (Nicholas B. Hastings 2000). But only when Kaplan and 
Hinds showed the existence of neurogenesis in the adult rat in 1977 by 
electron microscopy (Kaplan and Hinds 1977), the dogma of the “static brain” 
became outdated. They detected with 3H-Tymidine labeled neurons in the 
granular layers of dentate gyrus and olfactory bulb. And in 1984 Kaplan and 
Bell identified “mitotic neuroblasts with synapses” and axons on their cell 
bodies in the postnatal dentate gyrus (Kaplan and Bell 1984). But it was not 
until 1992, when Reynolds and Weiss published that “cells of the adult mouse 
striatum have the capacity to divide and differentiate into neurons and 
astrocytes, “ when the studies on adult stem cells and their potential to 
regenerate became a center of interest (Reynolds and Weiss 1992). A few 
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years later Weiss (Weiss et al. 1996) and Shihabuddin (Shihabuddin, Ray and 
Gage 1997) published that it is possible to isolate neural stem/progenitor 
(NPC) cells from the adult spinal cord, proliferate and expand them in the 
presence of epidermal growth factor (EGF) and basic fibroblast growth factor 
(bFGF)  and differentiate them into neurons, astrocytes and oligodendroctes 
in vivo. Martens further found that NPC in the spinal cord lie next to the 
central canal (Martens, Seaberg and van der Kooy 2002). In 1998 Erikisson 
then published, the occurrence of “neurogenesis in the adult human 
hippocampus” and, that “the human brain retains the potential for self-renewal 
throughout life” (Eriksson et al. 1998). 
1.1.2. Adult neural stem cells 
Over the past decades, convincing evidence emerged that neurogenesis in 
the adult CNS is a continuous physiological process. Neurogenesis occurs in 
two regions: the subventricular zone (SVZ) of the lateral ventricles, were 
olfactory bulb neurons origin from, and the subgranular zone of the dentate 
gyrus of the hippocampus, which is a region important for learning and 
memory (Altman 1965, Kaplan and Hinds 1977, Kuhn, Dickinson-Anson and 
Gage 1996) (Fig.1.1).  
 
 
Figure 1.1. Sites of adult neurogenesis in the adult human and rat brain 
Neurogenesis takes place in the subventricular zone (SVZ) of the lateral ventricles and in the 
dentate gyrus of the hippocampus in the adult brain. In the rat brain, neural progenitor cells 
from the SVZ migrate along the rostral migratory stream to the olfactory bulb, where they 
differentiate into neurons and integrate (Figure extracted from (Crews and Nixon 2003). 
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Additionally, recent studies indicated also the existence of NPC in other 
regions of the CNS, i.e. the striatum, neocortex and spinal cord (Palmer et al. 
1999, Palmer, Ray and Gage 1995, Yamamoto et al. 2001, Weiss et al. 
1996). New cells risen from the adult SVZ migrate along the rostral migratory 
stream to the olfactory bulb, where they differentiate into new interneurons 
(Kuhn and Svendsen 1999, Thomas, Gates and Steindler 1996, Lois and 
Alvarez-Buylla 1994, Doetsch and Alvarez-Buylla 1996). In the hippocampal 
neurogenesis, progenitor cells divide along the border of the hilus and the 
granule cell layer, whereas the daughter cells differentiate into granule and 
periglomerular neurons (van Praag et al. 2002, Kuhn and Svendsen 1999, 
Cameron et al. 1993, Cameron and McKay 2001, Lois and Alvarez-Buylla 
1994). Adult NPC are multipotent in vivo as well as in vitro and characterized 
by their capacity to self-renew and divide indefinitely. They occur in the 
embryonic as well in the adult brain and have the potential to differentiate into 
the three major CNS lineages, neurons, astroglia and oligodendroglia (Gage 
2000, Gotz and Huttner 2005, Kuhn et al. 1996) (Fig.1.2).  
 
                                      
Figure 1.2. Potential of adult neural stem/progenitor cells 
Adult NPC are multipotent and have the potential to self-renew. They can generate lineage 
restricted precursors cells, which further differentiate into the three major cell types of the 
CNS: neurons, astrocytes and oligodendrocytes. (Figure extracted from: www.helmholtz-
muenchen.de/neu/Aktuelles/.../033_038_idg_akt.pdf).  
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Adult NPC cells are continuously generated and persist throughout the life 
span of mammals including humans (Kuhn et al. 1996, Eriksson et al. 1998, 
Kukekov et al. 1999). It is important to note that neurogenesis occurs either in 
a physiological mode or is exogenously modulated by external signals or 
pathophysiological processes. It is known, that external stimulants such as 
enriched environment and physical activity (van Praag, Kempermann and 
Gage 1999b, Kempermann, van Praag and Gage 2000, Gage 2000, van 
Praag et al. 1999a) or application of defined molecules such as bFGF (Kuhn 
et al. 1997), EGF (Palmer et al. 1995, Reynolds and Weiss 1992), vascular 
endothelial growth factor (VEGF) (Schanzer et al. 2004, Jin et al. 2002) or 
brain-derived neurotrophic factor (BDNF) (Chmielnicki et al. 2004, Gustafsson 
et al. 2003) and erythropoietin (Shingo et al. 2001) enhance neurogenesis, 
whereas stress acting through associated corticosteroid stress hormones 
(Tanapat et al. 2001, Gould et al. 1997, Cameron and Gould 1994, Duman, 
Malberg and Nakagawa 2001) or TGF-beta1 (Wachs et al. 2006) down-
regulate neurogenesis. Although neurogenesis persists in the aged brain, its 
rate declines with age in rats (Kuhn et al. 1996), mice (Kempermann, Kuhn 
and Gage 1998), monkeys (Gould et al. 1999) and humans (Cameron and 
McKay 1999, Kukekov et al. 1999). Finally, CNS disease conditions such as 
seizures, stroke/hypoxia and traumatic brain injury represented by respective 
animal models induce neurogenesis (Kokaia and Lindvall 2003, Bengzon et 
al. 1997, Parent, Valentin and Lowenstein 2002, Jin et al. 2001, Ming and 
Song 2005, Parent 2003).  
 
1.1.3. Culturing Methods - Adult neural stem cells in vitro 
NPC of the of the adult CNS can be isolated from neurogenic regions like the 
subventricular zone (SVZ) or the hippocampus (Gage, Ray and Fisher 1995b, 
Reynolds and Weiss 1992) as well as from non-neurogenic regions like e.g. 
the spinal cord striatum and neocortex (Palmer et al. 1999, Palmer et al. 
1995, Weiss et al. 1996). These cells can be isolated and propagated in vitro 
either as adherent monolayers on coated surfaces or as floating aggregates 
of NSC, the so-called neurospheres. Neurospheres are non-adherent, 
heterogeneous spherical structures, which are organized three-dimensional 
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fashion whereas they show a core of differentiated GFAP or βIII-tubulin 
positive cells, which is surrounded by undifferentiated, proliferating cells 
(Campos 2004). By the usage of certain growth factors, it is further possible to 
augment and proliferate these cells in neurosphere cultures (Reynolds, 
Tetzlaff and Weiss 1992, Reynolds and Weiss 1992, Weiss et al. 1996). To 
maintain undifferentiated NSC in vitro it is necessary to culture them in the 
presence of EGF and/or bFGF (Roy et al. 2000, Wachs et al. 2003, Gritti et al. 
1996). Recently, cell culture conditions were optimized/standardized to 
propagate neural stem cells at high expansion rates without losing 
multipotency and without promoting tumorgenicity (Wachs et al. 2003). The 
most common method to differentiate NSC is the withdrawal of the mitogens 
and/or adding different factors that induce some of the cells to develop into 
different lineages (e.g. serum) (Arsenijevic et al. 2001, Gage et al. 1995a, 
Johansson et al. 1999, Reynolds et al. 1992, Reynolds and Weiss 1992). The 
stem cells will efficiently differentiate in culture dishes into neurons, 
oligodendrocytes (the cells that insulate the electrical signals passing down 
axons in the nervous system) and astrocytes (another type of non-neuronal 
cell in the CNS) (Arsenijevic et al. 2001, Wachs et al. 2003, Kukekov et al. 
1999, Roy et al. 2000). The isolation and proliferation of adult neural stem 
cells from the adult rodent CNS were replicated with adult CNS tissue derived 
from human subjects. Adult human neural stem cells were capable of 
generating astro-/oligodendroglial cells as well as neurons, thus confirming 
their multipotency (Arsenijevic et al. 2001, Johansson et al. 1999). 
 
1.2. Spinal Cord Injury 
Spinal cord injury in humans is in most instances caused by a blunt trauma 
that causes fracturation of the vertrebral column with dislocation of bone 
fragments and consecutive contusion/compression of the spinal cord, which 
leads to the irreversible loss of function since the spinal cord has only limited 
capacity to self-renew. Motor control and sensory input is lost below the level 
of the lesion (Barnabe-Heider and Frisen 2008). Much of the prognosis and 
recovery depends on the location and severity of the injury. Some patients 
recover well and others may be paralyzed for life. Generally, patients 
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experience more paralysis when the injury is higher in the spinal column. 
Although spontaneous regeneration of lesioned fibres is absent in the adult 
CNS, many patients suffering from incomplete spinal cord injuries show 
significant functional recovery. This recovery process can go on for months, 
sometimes even years after the injury and probably depends on the 
reorganization of circuits (plasticity) that have been spared by the lesion 
(Raineteau and Schwab 2001). 
 
1.2.1 Epidemiology of spinal cord injury 
It is estimated that the annual incidence of spinal cord injury (SCI) in 
developed countries varies between 20 to 55 cases per million inhabitants, 
whereas motor vehicle accidents (42,1%), falls (26,7%), interpersonal 
violence (15,1%) and sports activities (7,6%) are main causes for SCI 
(Wyndaele and Wyndaele 2006, van den Berg et al. 2010) (Fig.1.3).  
            
Figure 1.3. Etiology of spinal cord injury 
(Figure adopted from: Spinal Cord Injury Statistics Updated June, 2009 (National Spinal Cord 
Injury Statistical Center (NSCISC), http://www.fscip.org/facts.htm).  
 
Interestingly, the incidence rate in developing countries is much lower 
compared to that in developed countries (Chiu et al. 2010). Prevalence in 
acute SCI is defined as all persons with an SCI in a specified population at a 
particular point (Sekhon and Fehlings 2001). In the United States the 
prevalence of SCI is about 259,000 people. Since there are various studies 
where the investigators applied different methods concerning epidemiology of 
SCI, the evaluation of the existing studies is difficult. However in recent years 
the average age at injury did increase from around 30 to 40-50 years over the 
last years. In general males are more often affected by SCI then females, with 
a male-female ratio varying from 1.3:1 in Australia to up to 7.5:1 in Pakistan 
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(Chiu et al. 2010, van den Berg et al. 2010). Currently 80% of the SCI 
reported to the NSCISC the have occurred among males. 
Spinal cord injury can be classified into 5 main categories based on the 
American Spinal Injury Association (ASIA) Impairment Scale (Fig.1.4). In a 
complete injury (ASIA A), the motor and sensory function is lost below the 
level of injury, whereas in an incomplete injury more or less sensation 
and/or movement below the level of the injury is retained (ASIA B through E). 
About 50 years ago, approximately two thirds of SCI were complete. Latest 
estimates show a shift towards incomplete injuries (55%). The majority of SCI 
affect the cervical segments, varying from 32 to 75% off the injuries resulting 
in tetraplegia and between 19 and 68% in paraplegia (van den Berg et al. 
2010). Persons with tetraplegia have suffered injury to one of the eight 
cervical segments (C1-8) of the spinal cord with paralysis of both arms and 
legs. Those with paraplegia have lesions in the thoracic, lumbar, or sacral 
regions of the spinal cord, so that the function is lost only in the lower part of 
the body. Injuries can also be classified as traumatic or non-traumatic. 
Traumatic injuries are sudden causing immediate spinal cord damage and 
consecutive functional deficits. Non-traumatic injuries tend to develop 
more slowly from disorders compressing the spinal cord (cancer, hemorrhage, 
vertebral disk prolaps) and other diseases directly harming the spinal cord 
such as infections or ischemia. Nevertheless, even after a neurologically 
complete traumatic SCI, a variable rim of white matter closest to the surface 
of the spinal cord is usually spared (Kakulas 1999). Furthermore, functional 
recovery can be seen in many of the patients (Burns et al. 1997, Waters et al. 
1995), as well as in animal models of incomplete SCI (Blight 1993, Little et al. 
1999, Raineteau and Schwab 2001). 
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Figure 1.4. Classification of spinal cord injury severity using the American Spinal Injury 
Association (ASIA) Impairment Scale 
SCI results in the disruption of motor control and sensory input below the level of the lesion 
(Figure extracted from (Thuret, Moon and Gage 2006)). 
 
1.2.2. Pathomorphology of spinal cord injury 
Spinal cord injury can be classified into four general types: 1) cord 
maceration, in which the morphology of the cord is severely distorted; 2) cord 
lacerations (gun shot or knife wounds), which results in a clear-cut disruption 
of the surface anatomy; 3) contusion injury, which leads to a central 
hematomyelia that may evolve to syringomyelia; and 4) solid cord injury, in 
which there is no central focus of necrosis as in contusion injury (Hulsebosch 
2002, Bunge et al. 1993, Bunge, Puckett and Hiester 1997, Norenberg, Smith 
and Marcillo 2004). 
There are three phases of the pathological response to SCI (Bunge et al. 
1993, Bunge et al. 1997, Tator 1995, Tator 1996, Tator 1998). The acute 
injury phase, which starts at the moment of injury and may continue for 
hours or even days, depending on the severity of the injury. The initial force of 
the traumatic insult, evoked by compression, laceration, contusion, or stretch 
A (complete injury):    No motor or sensory function is preserved in  
                                   the sacral segments S4–S5. 
B (incomplete injury): Sensory but not motor function is preserved 
                                   below the neurological level and includes  
                                   the sacral segments S4–S5. 
C (incomplete injury): Motor function is preserved below the  
                                   neurological level, and more than a half of  
                                   key muscles below the neurological level  
                                   have a muscle grade of less than 3, which  
                                   indicates active movement with full range of  
                                   motion against gravity 
D (incomplete injury): Motor function is preserved below the 
                                   neurological level, and at least a half of key 
                                   muscles below the neurological level have   
                                   a muscle grade of 3 or more.  
E (normal):                 Motor and sensory functions are normal. 
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injury of the cord (Anthes, Theriault and Tator 1996, Anthes, Theriault and 
Tator 1995), causes an immediate mechanical damage, affecting the neurons, 
axons and blood vessels of the spinal cord. This acute injury triggers a 
number of pathophysiological events. A shift of electrolytes in the cells at the 
lesion center is occurring, increasing the intracellular Na+-concentration. The 
increase of K+ into the extracellular space results from an injury-induced block 
of axonal conduction (Eidelberg, Sullivan and Brigham 1975), which 
contributes to the state known as spinal shock. Spinal shock usually recovers 
within 24 hours. It represents a generalized failure of circuitry in the spinal 
neural network characterized by the temporary loss of spinal activity 
(Hulsebosch 2002).  
Another common pathological feature of acute SCI is an early hemorrhage 
with localized edema, loss of microcirculation, axonal and neuronal necrosis 
and demyelination (Hulsebosch 2002, Tator and Fehlings 1991).  
In the secondary injury or recovery phase, refers to a period during 
which function returns, starting within hours and extending for months or even 
years after the initial injury. The pathophysiological alterations (ischemic 
cellular death, electrolytic shifts, and edema) initiated in the acute injury phase 
persist leading to a progressive loss of axons and neurons. Additionally, 
apoptosis occurs, involving reactive gliosis. As a result, the size of the initial 
lesion grows to a notably larger cystic lesion defect (Hulsebosch 2002, Collins 
1983). 
Finally, the chronic injury phase occurs over a period of days to years and 
refers to a time when functional recovery has reached a plateau and the 
spinal cord anatomy has been irreversibly changed (Collins 1983). Necrosis 
as well as the continuing apoptosis at the lesion center has leads to massive 
tissue degeneration and the development of a cystic lesion cavity (Kao and 
Chang 1977). These effects induce the activation of microglia and the 
invasion of macrophages and fibroblasts, causing in the replacement of white 
and grey matter by the glial scar tissue. Demyelination is caused by apoptosis 
of oligodendrocytes and results in rearrangements of ion channels, which 
further leads to conduction deficits of axons that have survived the initial 
trauma, (Hulsebosch 2002, Shuman, Bresnahan and Beattie 1997, Barnabe-
Heider and Frisen 2008). In some cases, the initial lesion cyst is enlarged due 
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to the flow cerebrospinal fluid (CSF) into the resulting cavity, a condition 
called syringomyelia (Potter and Saifuddin 2003). In many cell types, 
permanent hyperexcitability develops, which results in chronic pain 
syndromes (Christensen et al. 1996, Christensen and Hulsebosch 1997). It is 
now generally accepted that the mechanisms which occur after an acute 
spinal cord injury is a two-step process involving the primary and secondary 
injury mechanism, even though it is difficult to separate them temporarily 
(Tator and Fehlings 1991).  
 
1.2.2.1. Primary injury mechanisms 
The mechanisms of the primary injury are caused by the acute compression 
or laceration of the spinal cord, due to the initial mechanical force of the 
traumatic insult. This mechanical impact can involve the displacement of bony 
fragments or disc material into the spinal cord during burst fracture or fracture 
dislocation of the spine (Tator 1995, Tator and Fehlings 1991). A less frequent 
occurring injury type is the direct transection of the spinal cord which often 
occur after knife wounds or gun shots (Sekhon and Fehlings 2001). Several 
injury mechanisms occur, including the damage cell membranes, mechanical 
damage of the spinal cord axon pathways and damage to the vasculature of 
the cord. 
 
1.2.2.2. Secondary injury mechanisms 
The secondary injury is initiated by damage to the cell membrane, resulting in 
ionic derangement, which leads to the progressive destruction of the spinal 
cord (Borgens 2003). Progressive loss of axons and neurons take place in 
massive additional damaging processes after the impact to the cord, initiated 
by the primary injury (Collins 1983, Sandler and Tator 1976a, Sandler and 
Tator 1976b). These secondary injury mechanisms are autocatalytic and can 
occur over many days, even weeks. They involve numerous biological 
processes, cellular responses and vasuclar events that develop over minutes 
to hours after the primary injury and lead to demyelination and scar formation 
(Borgens 2003). 
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1.2.2.2.1. Vascular events 
Acute SCI causes within minutes after the primary injury numerous vasular 
changes. The normal autoregulation in the spinal cord is lost due to systemic 
hypotension, a state, which is called neurogenic shock (Senter and Venes 
1979, Tator and Fehlings 1991, Young, DeCrescito and Tomasula 1982). The 
impairment of the spinal autoregulation additionally leads to a reduction of 
blood flow in the spinal cord, resulting not only in vasospasm and thrombosis 
but also in the reduction of microcirculation and lack of perfusion (Tator 1991, 
Senter and Venes 1979). These vascular disruptions are associated with post 
traumatic ischemia especially in areas adjacent to hemorrhage and lead to 
infarction and necrosis, which is more severe in grey than in white matter 
tissue (Sandler and Tator 1976a, Tator 1991, Tator and Fehlings 1991, 
Nelson et al. 1977). Moreover, ultrastructural alterations of the blood-brain 
barrier consist of 
endothelial changes leading to edema formation and glial swelling (Goodman, 
Bingham and Hunt 1976). 
 
1.2.2.2.2. Biochemical changes 
The release of excitatory amino acids contributes to secondary tissue damage 
after traumatic spinal cord injury. It has been described that the excitatory 
amino acid neurotransmitter glutamate has an exitotoxic effect following SCI 
(Demediuk, Daly and Faden 1989, Westerberg et al. 1987). The increased 
extracellular glutamate concentration (Benveniste et al. 1984) leads to the 
subsequent activation of the glutamate receptor N-methyl-D-aspartate 
(NMDA) in the neuronal cell membrane, which has been shown to open the 
receptor dependent NMDA channels resulting in the massive influx Ca2+ into 
the cell (Choi 1988, Tator 1995, Tator and Fehlings 1991). In addition, 
increase of intracellular Na+ initiates the release of Ca2+ from intracellular 
stores such as the endoplamatic reticulum or mitochondria, through the 
reversed action of Na+/Ca2+ exchanger by pumping out Ca2+ from intracellular 
stores into the cytoplasm in reverse of Na+ (Stys, Waxman and Ransom 
1991a, Stys, Waxman and Ransom 1991b, Borgens 2003). Increased 
intracellular Ca2+ in turn activates calcium-dependent proteases, leading to 
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the degradation of myelin proteins and cytoskeletal components including 
neurofilaments (Banik et al. 1982, Banik et al. 1984). The cell membrane is 
destabilized, which causes impaired axoplasmatic transport (Schlaepfer and 
Bunge 1973). Furthermore, the mitochondrial function is also impaired, by 
what Na+ streams into the mitochondria, which in turn reduces the ATP 
production, resulting not only in a reduced Na+/K+-ATPase activity, but also in 
the release of cytochrome C, which induces apoptotic cell death by caspase 3 
activation (Narita et al. 1998). In addition, elevated Ca2+ levels activate the 
calcium-dependent enzymes phospholipase C and kinase C, which induce 
cell lysis and necrosis (Tator 1995, Tator and Fehlings 1991, Muller et al. 
1999, Hulsebosch 2002).  
The collapse of oxygen metabolism within the cell, coupled with specific 
enzymatic catalysis, leads to the production of highly reactive oxygen 
metabolites such as superoxide anions, hydrogen peroxide and hydroxyl 
radicals (Dykens 1994). These so called free radicals are cytodestructive and 
promote lipid peroxidation, which contributes to the breakdown of ionic 
membrane gradients as well as to the disruption of the cell membranes 
(Yamamoto et al. 1983). 
 
1.2.2.2.3. Cellular events 
Following CNS injury, a pronounced cellular inflammatory reaction occurs 
which is characterized by the activation of resident and recruited immune 
cells. In regions rostral or caudal to the epicenter, prolonged activation of 
inflammatory cells occurs preferentially in white matter and primarily consists 
of activated microglia and astrocytes (Dusart and Schwab 1994, Popovich, 
Wei and Stokes 1997). 
Within 6hours after the primary injury, a significant neutrophil infiltration in the 
lesion site appears and after 24h they reach their highest cell density. The 
following days are characterized by a gradual replacement of neutrophils by 
macrophages. Proliferation and recruitment of macrophages and microglial 
cells become predominant 2 days after injury. At day 4 to 7, macrophage-like 
cells remove tissue debris by phagocytosis. This process, together with a 
reaction of the surrounding astrocytes, finally leads to the formation of 
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cavities, which are surrounded by the glial scar. Besides the restoration of 
tissue homeostasis, neutrophils are able to release oxygen radicals as well as 
a variety of enzymes and contribute therefore to secondary extension of the 
lesion (Dusart and Schwab 1994). Already one hour after the lesion, microglial 
cells and astrocytes become activated. Some activated microglia convert to a 
macrophage phenotype that is referred as „brain-macrophage“ and remove 
axon and myelin debris by phagocytosis (Popovich et al. 1997). Furthermore, 
activated microglia function as antigen presenting cells to mediate the T-cell 
response (Schmitt et al. 2000). It has been shown, that macrophages and 
lymphocytes infiltrate the injured spinal cord tissue several days after the 
initial injury (Popovich et al. 1997). This infiltration together with the persisting 
immune cell activation has both beneficial and destructive effects on the 
functional outcome after SCI. The removal of axon and myelin debris has 
positive effects, since it is known that adult CNS myelin contains axon growth 
inhibitors (Hauben et al. 2000) On the other hand, SCI induces the expression 
of pro-inflammatory cytokines like the tumor necrosis factor-alpha (TNF-alpha) 
(Bethea et al. 1999) as well as the production of nitric oxide (NO) by neuronal 
nitric oxide synthase which in turn are involved in the secondary damage to 
neuronal tissue (Wada et al. 1998).  
Reactive astrocytes are also present in the acute lesion but more prominent at 
7-28 days after the injury. These cells are observed only in the surrounding 
outer ring of spared white matter at the lesion site and in tissue adjacent to 
the lesion but are mainly absent in the lesion site (Popovich et al. 1997, Eng, 
Reier and Houle 1987). Reactive astrocytes can be identified by their 
increased immunoreactivity for the intermediate filament protein GFAP and 
vimentin (Eng et al. 1987, Miller et al. 1986). An important property of reactive 
astrocytes is that they surround the lesion cavity by forming a wall of scar 
tissue in response to injury in the CNS - a process called reactive gliosis 
(Miller et al. 1986). Unlike fibroblasts, which form scars in nonneural tissues 
by secreting large amounts of collagenous extracellular matrix, astrocytes 
form scars by producing numerous extracellular matrix proteins, including the 
axonal growth inhibiting chondroitin sulfate proteoglycan (CSPG) proteins like 
versican, phosphocan, NG2, and neurocan (McKerracher et al. 1994, Bignami 
et al. 1972, Miller et al. 1986, Hulsebosch 2002). But meningal fibroblasts can 
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also invade the lesion, forming basement membranes, probably in 
collaboration with astrocytes (Bernstein et al. 1985, Feringa, Vahlsing and 
Woodward 1984, Schwab and Bartholdi 1996). It is known that astrocytes are 
a heterogenous class of cells (Miller and Raff 1984, Raff et al. 1983), whereby 
the type-1 astrocytes, together with activated microglia/macrophages, are 
responsible to form the glial scar tissue in the white matter surrounding the 
lesion site (Miller et al. 1986, Dusart and Schwab 1994). The presence of 
growth-inhibitory proteins like CSPGs leads to the formation of the glial scar, 
which represents a barrier to axonal growth (Liuzzi and Lasek 1987, Rudge 
and Silver 1990, Hulsebosch 2002). Nevertheless, reactive astrocytes also 
play an important role in the repair of the blood-brain barrier and are essential 
for wound healing (Faulkner et al. 2004). Moreover, reactive astrocytes exhibit 
important protective functions for neurons and oligodendrocytes by producing 
numerous growth factors and cytokines. They also preserve motor functions 
and play fundamental roles in regulation leukocyte infiltration after mild or 
moderate SCI (Faulkner et al. 2004, Bush et al. 1999). Therefore, reactive 
astrocytes play a bivalent role after injuries to the CNS. On the one hand, they 
stabilize the injured tissue during the secondary injury phase, but inhibit 
axonal regeneration on the other hand. 
After an injury to the spinal cord, axonal loss takes place in the ascending 
fiber tracts above the lesion and in descending fiber tracts below the lesion. 
The distal segment of a nerve fiber (the part no longer connected to the 
neuronal cell body) retracts from postsynaptic neurons and undergoes 
secondary or Wallerian degeneration, and although the proximal segment 
typically survives, it is unable to successfully regenerate (Bradbury and 
McMahon 2006, Franklin and Ffrench-Constant 2008). Wallerian 
degeneration happens in both the central and the peripheral (PNS) nervous 
system and is characterized by segmentation of the myelin and results in 
atrophy and destruction of the axon (Basiri and Doucette 2010). Although 
there are some similarities in the molecular and cellular pattern of Wallerian 
degeneration in the PNS and CNS, like the degeneration of myelin sheats, 
(Franson and Ronnevi 1984, George and Griffin 1994), the removal of axonal 
and myelin debris by microglia and astrocytes is greatly delayed in the CNS 
and occurs over a much longer time frame than seen in a peripheral nerve 
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(Griffin et al. 1992, Basiri and Doucette 2010, George and Griffin 1994, 
Vargas and Barres 2007). The poor efficiency in removing axonal and myelin 
debris arising as a result of Wallerian degeneration in the CNS vs. the PNS is 
likely due to differences in the microglial and macrophage responses (George 
and Griffin 1994, Vargas and Barres 2007). Following transection of axons, 
the continuing axoplamic flow leads to the formation of terminal clubs in both 
proximal and distal stumps of the lesioned axons (Kao, Chang and 
Bloodworth 1977a, Kao, Chang and Bloodworth 1977b). The dissolution of the 
terminal clubs results in autolysis of spinal cord tissue and the subsequent 
cavitation of the cord due to the release of hydrolytic lysosomal enzymes (Kao 
et al. 1977a, Kao et al. 1977b).  
The characterized cellular and vasuclar events as well the mentioned 
biological processes are part of the secondary injury phase and also affect 
cells of the spinal cord, which at first survived the initial injury. Secondary cell 
death occurs, whereas most apoptotic cells are present in the area of the 
lesion epicenter (Yong et al. 1998, Tator 1991). Apoptosis of oligodendrocytes 
adjacent to spares axons causes chronic demyelination, which often 
represents the morphological correlate for the delayed loss of function after 
spinal cord injury (Blight 1994, Totoiu and Keirstead 2005, Blight 1985). 
1.2.3.1. Extrinsic Inhibitors and Barriers of Regeneration 
1.2.3.1.1. Cavity formation 
After the initial injury and following necrosis as well as apoptosis, a fluid filled  
cavity develops, resulting in the loss of grey and white matter (Kao and Chang 
1977). The initial cyst can be enlarged and expanded to additional spinal cord 
segments causing additional cell death and increased loss of function (Potter 
and Saifuddin 2003, Greitz 2006). The formation of the cystic cavity displays a 
physical barrier to spontaneous regeneration (Willerth and Sakiyama-Elbert 
2008). Cell therapies have shown beneficial effects, by providing trophic 
support for cell migration or by secreting factors that promote axon 
regeneration into the cavity. The infusion of e.g. mesenchymal stromal cells 
(MSC) into the cerebrospinal fluid (CSF) of the spinal cord resulted in a 
smaller lesion cavity and the improvement of behavioral function compared to 
controls (Ohta et al. 2004, Wu et al. 2003). 
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Table 1.1. Secondary injury mechanisms involved in the  
                  Pathophysiology following acute spinal cord injury 
Vasular events 
 Mechanical disrupture of capillaries and venules 
Disruption of blood brain barrier  
Loss of autoregulation 
Hemorrhage (especially in grey matter) 
Loss of microcirculation / Reduction of spinal cord blood flow (thrombosis,   
vasospasm) 
Post traumatic ischemia 
 Edema 
Biochemial changes 
 Uncontrolled excitatory amino acid release  Excitotoxicity (glutamate) 
 Ca2+ influx into cells  
 Na+ influx into mitochondria 
 Collapse of oxidative metabolism and decreased ATP production 
 Cytochrome C release 
 Free radical overproduction 
 Lipid peroxidation 
Cellular events 
 Invasion of immune cells (neutrophils)  
 Microglia activation 
 Reactive Astrogliosis 
 Wallerian degeneration 
 Rupture of terminal clubs resulting in hydrolytic enzyme release 
 Apoptosis of glial cells 
 Invasion of fibroblasts 
 
1.2.3.1.2. Glial scar formation 
One of the most potent obstacles for axonal recovery after SCI represents the 
glial scar formation. Many different types of cells such as microglia, 
macrophages, oligodendrocyte precursors, and meningeal cells are recruited 
to the injury site at different time points, but the glial scar consists 
predominately of reactive astrocytes with additional contributions of 
extracellular matrix (ECM) molecules, especially CSPGs and during the scar 
formation, inflammatory cells (Fawcett and Asher 1999, Schwab and Bartholdi 
1996, Gallo, Bertolotto and Levi 1987, Katoh-Semba et al. 1995). The scar is 
comprised of two main zones, the lesion core, where meningeal fibroblasts, 
vascular endothelial cells, and frequently oligodendrocyte precursors (OPC) 
can be found, and the surrounding area consisting of reactive astrocytes, 
OPC, and microglia. Additionally, debris from the damaged tissue, axons, and 
degenerating myelin is present in the scar. The lesion core represents usually 
an utterly barrier for axon regeneration (Fawcett 2006, Reier and Houle 1988). 
When re-growing axons enter the environment of the glial scar they form so 
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called dystrophic endbulbs (Silver and Miller 2004, Liuzzi and Lasek 1987, 
Rudge and Silver 1990). Furthermore, the astrocytes are tightly packed and 
attached to one another by gap and tight junctions surrounded by ECM, so 
that they separate the injured tissue from its surrounding (Fawcett and Asher 
1999, Reier and Houle 1988, Eng et al. 1987). After an injury, many 
astrocytes become hypotrophic (Dusart and Schwab 1994, Bunge et al. 1994) 
and start to up-regulate glial fibrillary protein (GFAP), vimentin and nestin as 
well as inhibitory molecules (Fawcett and Asher 1999, Silver and Miller 2004). 
The most important inhibitory molecules produced by reactive astrocytes are 
CSPGs (McKeon, Jurynec and Buck 1999, Willerth and Sakiyama-Elbert 
2008, Rolls, Shechter and Schwartz 2009). They form a relatively large family, 
which includes aggrecan, brevican, neurocan, NG2, phosphacan and 
versican, all of which have chondroitin sulphate side chains. CSPGs 
furthermore consist of a core protein and one or more covalently attached 
glycosaminoglycan chains (GAGs) and are secreted by almost all cell types at 
the injury site (especially astrocytes) (Katoh-Semba et al. 1995, Tang, Davies 
and Davies 2003, Asher et al. 2000, Asher et al. 2002, Davies et al. 2004). 
The sulphated GAGs play an important role in the inhibitory effects on axonal 
growth of CSPGs, because it has been demonstrated in many studies that the 
removal of the GAG chains, e.g. by treatment with the enzyme 
chrondroitinase ABC (ChABC), promotes axon growth (McKeon, Hoke and 
Silver 1995, Smith-Thomas et al. 1995, Smith-Thomas et al. 1994, Curinga et 
al. 2007, Silver and Miller 2004). 
Besides proteoglycans, several other axon growth inhibitors have been 
identified in the glial scar tissue. The secreted protein semaphorin 3 (Sema 3), 
is expressed in invading fibroblasts and acts as a chemoprepellant through its 
high-affinity receptor neurophilin (De Winter et al. 2002, Pasterkamp et al. 
1999, Silver and Miller 2004). In addition, Sema 5A, can bind both to CSPG 
GAG chains, resulting in changes of the semaphorin from an axon growth 
permissive configuration to a growth inhibitory one (Kantor et al. 2004, 
Fawcett 2006). It also has been demonstrated that members of the eph/ephrin 
family of tyrosine kinases and their ligands are up-regulated after injury. The 
ephrin-B2 expression is increased in astrocytes whereas the expression of the 
receptor EPHB2 is increased in meningeal fibroblasts, which invade the 
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injured spinal cord. The binding of ephrin-B2 with its receptor leads to the 
formation of the so called glial/mesenchymal scar and inhibits axon 
regeneration (Bundesen et al. 2003, Silver and Miller 2004, Fawcett 2006, 
Feringa et al. 1984). Moreover, the secreted Slit proteins together with their 
high-affinity receptor glypican-1, a heparan sulfate proteoglycan, are up-
regulated in reactive astrocytes and show repulsive effects for axon 
elongation (Hagino et al. 2003, Silver and Miller 2004). 
After the disruption of the blood-brain barrier (BBB) as a result of SCI, the 
formation of the glial scar occurs, which is induced by the invasion of 
activated microglia and the influx of normally absent molecules in the 
damaged spinal cord tissue (Preston, Webster and Small 2001). Potential 
triggers for the induction of reactive gliosis are the transforming growth factor-
β (TGFβ) and interleukin-1, which are secreted by astrocytes and 
macrophages. They have shown to play an important role in the 
transformation of normal astrocytes into reactive astrocytes (Moon and 
Fawcett 2001, Silver and Miller 2004, Rolls et al. 2009). Furthermore, the 
interaction between the inflammatory cytokine interferon-γ and the basic 
fibroblast growth factor 2 (FGF2) take place in the induction of the glial scar 
(Yong et al. 1991, Silver and Miller 2004).  
In addition to preventing recovery, the glial scar also provides several 
beneficial functions. It takes place in stabilizing the spinal cord parenchyma 
after injury, by creating a scaffold (Silver and Miller 2004, Rolls et al. 2009). 
Some populations of astrocytes even support axon re-growth and protect 
neurons directly from nitric oxide toxicity (Yiu and He 2006, Faulkner et al. 
2004, Rolls et al. 2009, Chen et al. 2001). By producing and secreting CSPGs 
in the lesion area, activated astrocytes isolated the injury site by building a 
barrier for potentially harmful molecules in order to minimize the area of 
cellular degradation and balance the inflammatory response (Chen et al. 
2001, Yiu and He 2006, Rolls et al. 2009, Roitbak and Sykova 1999). 
Furthermore, astrocytes provide trophic support at the injury site (do Carmo 
Cunha et al. 2007, White, Yin and Jakeman 2008). Therefore, the balance 
between inhibitory and beneficial effects of the glial scar fundamentally 
influences the ability of axons to regenerate. 
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1.2.3.1.3. Myelin based inhibitors  
Several axon growth inhibitors, which are released by damaged 
oligodendrocytes, including Nogo, Myelin-Associated Glycoprotein (MAG), 
Oligodendrocyte Myelin glycoprotein (OMgp) and tenascin-R, have been 
identified in the CNS myelin (Willerth and Sakiyama-Elbert 2008, Busch and 
Silver 2007, McGee and Strittmatter 2003, Kottis et al. 2002, Salzer, Holmes 
and Colman 1987, McKerracher et al. 1994). Nogo exists in three isoforms, 
Nogo-A, Nogo-B and Nogo-C, but the predominant isoform expressed in the 
CNS is Nogo-A, which consists of two inhibitory domains, that are primarily 
associated with the endoplasmatic reticulum of oligodendrocytes (GrandPre et 
al. 2000). The extracellular domain, also referred to as Nogo-66, contains 66 
amino acids and is located at the C-terminus and the Amino-Nogo-A domain 
is located at the N-terminus (GrandPre et al. 2000, Willerth and Sakiyama-
Elbert 2008, Wang et al. 2002, Schwab, Tuli and Failli 2006b, Oertle et al. 
2003).  
The myelin-associated transmembrane glycoprotein MAG was the first 
characterized inhibitor from myelin in vitro (McKerracher et al. 1994, 
Mukhopadhyay et al. 1994). MAG is a member of the sialic acid-binding 
subgroup of the Ig superfamily and selectively localized in periaxonal 
Schwann cell and oligodendroglial membranes of myelin sheaths, suggesting 
that it functions in glia–axon interactions in both the PNS and CNS (Quarles 
2007, McKerracher et al. 1994, Salzer et al. 1987). In vivo, however, loss of 
MAG function fails to promote extensive regeneration (Bartsch et al. 1995, Li 
et al. 1996).  
The OMgp is a glycosylphosphatidylinositol-anchored protein expressed by 
neurons and oligodendrocytes in the CNS. It is a member of leucine-rich 
repeats protein family and involved in growth cone collapse and inhibition of 
neurite outgrowth (Wang et al. 2002, Vourc'h and Andres 2004).  
The three proteins (Nogo-A, OMgp, and MAG) all bind to the Nogo receptor 
NgR, a glycosylphosphatidyl-anchored (GPI-anchored) protein (Fournier, 
GrandPre and Strittmatter 2001). A receptor complex, comprised of the NgR, 
the 75 receptor and LINGO-1, transduces the signals from all these inhibitors 
in vitro. Downstream of these inhibitors, the activation of small GTPase RhoA 
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and its effector Rho-kinase has been shown to mediate the inhibition of 
neurite outgrowth (Willerth and Sakiyama-Elbert 2008, Niederost et al. 2002, 
Liu et al. 2002, Fournier et al. 2001, Oertle et al. 2003). 
The role of these proteins as potent inhibitors of neurite outgrowth and growth 
cone collapse has been identified in various culture experiments 
(McKerracher et al. 1994, Chen et al. 2000, GrandPre et al. 2000, Prinjha et 
al. 2000), but the exact role in vivo remains unclear. These proteins can be 
neutralized to improve functional outcome after SCI through the application of 
Nogo specific antibodies such as the monoclonal antibody IN-1 (Thallmair et 
al. 1998, Z'Graggen et al. 1998, Chen et al. 2000, Bregman et al. 1995, 
Caroni and Schwab 1988), agonists such as Nogo-66 (McGee and 
Strittmatter 2003), using enzymatic removal of the receptor (Liu et al. 2002) or 
by knocking down expression of the Nogo receptor that binds these proteins 
(Willerth and Sakiyama-Elbert 2008, Li et al. 2005). The inhibition of NgR 
signaling after SCI through the delivery of antibodies against Nogo leads to 
log-distance re-growth of only a small proportion of corticospinal axons. 
Nevertheless, axon regeneration and anatomical plasticity can be stimulated 
in corticospinal pathways in order to enhance functional recovery in animal 
models of SCI (Brosamle et al. 2000, Bregman et al. 1995, Li and Strittmatter 
2003, Thallmair et al. 1998, Schnell and Schwab 1990). Even though the 
axons of Nogo-A/B deficient mice showed enhanced neurite outgrowth in 
vitro, the knockout of either specific or all three Nogo variants did not or at 
best result in a very limited enhanced regeneration of corticospinal tract (CST) 
axons following a dorsal column lesion (Lee et al. 2009, Zheng et al. 2003, 
Kim et al. 2003, Simonen et al. 2003), suggesting that Nogo alone is not 
sufficient to induce extensive axon regeneration. 
Tenascin-R is an extracellular matrix glycoprotein present in the CNS, 
particularly in white matter. It is produced by oligodendrocytes, and up-
regulated after injury to the CNS (Milev et al. 1998). It has been demonstrated 
that tenacin-R can inhibit axon growth and restrict motor neuron innervations 
(Apostolova, Irintchev and Schachner 2006, Becker et al. 1999, Willerth and 
Sakiyama-Elbert 2008, Fawcett and Asher 1999). In addition to its direct 
effects on axon growth, tenascin has binding sites for most of the inhibitory 
CSPGs (Rauch et al. 1997, Fawcett and Asher 1999). Tenascin-R deficient 
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mice showed improved functional recovery after SCI compared to wild type 
mice, suggesting that knocking down its expression could be used as a 
therapeutic intervention (Willerth and Sakiyama-Elbert 2008, Apostolova et al. 
2006). 
 
1.2.3.2. Intrinsic factors limiting regeneration 
1.2.3.2.1. Genes associated with regeneration 
The different intrinsic abilities of lesioned CNS neurons contribute significantly 
to the poor regenerative capacity of the CNS. Various molecular and 
biochemical changes take place in neuronal cells in response to axotomy. The 
up-regulation of neurite growth and regeneration associated genes (RAGs) 
such as GAP-43 (growth associated protein-43) (Bomze et al. 2001, Ramer, 
Priestley and McMahon 2000, Ramer et al. 2002), CAP-23 and SPRR1A 
(small proline-rich repeat protein 1A) (Bonilla, Tanabe and Strittmatter 2002) 
as well as the up-regulation of cell surface adhesion molecules, in particular 
those of the L1 family and NCAM, seems to be important for an effective 
axonal regeneration (Maier and Schwab 2006, Kwon et al. 2007, Bulsara et 
al. 2002). In contrast to PNS injuries, SCI and other CNS lesions activate 
RAGs in only in some injured neurons, which may be one reason for the 
failure of most axons of the CNS to regenerate (Broude et al. 1997, Jung, 
Petrausch and Stuermer 1997, Bulsara et al. 2002, Schaden, Stuermer and 
Bahr 1994, Schreyer and Skene 1993). It has been demonstrated that 
overexpression of RAGs can induce axonal regeneration (Bomze et al. 2001, 
Ramer et al. 2002, Ramer et al. 2000). This indicates that a successful 
regeneration of axotomized CNS neurons is correlated with the expression 
levels of RAGs (Bulsara et al. 2002, Becker et al. 1998, Kwon et al. 2007).  
1.2.3.2.2. Trophic support 
Neurotrophic factors such as nerve growth factor (NGF), BDNF, neurotrophin-
3 (NT-3) and neurotrophin-4/5 (NT-4/5) have been shown to play key roles in 
neuronal survival and differentiation during the development of the CNS and 
PNS. In addition, they are involved in the maintenance of a neuronal 
phenotype and influence synaptic functions (Lindsay et al. 1994, Kobayashi et 
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al. 1997, Schnell et al. 1994, Davies 1994, Lewin and Barde 1996). In contrast 
to PNS neurons, CNS neurons lack sufficient expression of neurotrophins, 
which can result in axotomy-induced atrophy of rubrospinal and corticospinal 
neurons (Kobayashi et al. 1997, Giehl and Tetzlaff 1996). On the other hand, 
the application of neurotrophins at the cell body of the red nucleus prevented 
atrophy of rubrospinal neurons (Bretzner et al. 2008, Kobayashi et al. 1997). 
Moreover, it has been demonstrated in several studies that local 
administration of neurotrophins can enhance sprouting of CNS axons 
(Oudega and Hagg 1999, Schnell et al. 1994, Tuszynski et al. 1994, Xu et al. 
1995a, Ye and Houle 1997). Furthermore, the administration of BDNF and 
NT-4/5 has shown to augment the poor intrinsic regenerative capabilities of 
CNS neurons by reversing neuronal atrophy and stimulating the expression of 
GAP-43 in order to promote functional and structural recovery. Taylor et al. 
showed that the delivery of an NT-3 gradient rostral to the injured spinal cord 
promoted short-distance axonal regeneration (Taylor et al. 2006), whereas the 
application of a BDNF gradient induced long, directional axonal growth 
(Bonner et al. 2010). These studies imply that the administration of 
neurotrophic factors represents a potential strategy to induce axonal recovery. 
 
1.2.3.3. Demyelination 
Demyelination due to the loss of oligodendrocytes and the resulting 
conduction deficits in surviving axons, also contributes significantly to 
functional deficits after SCI (Gledhill, Harrison and McDonald 1973, 
Hulsebosch 2002). Since the CNS exhibits only a very limited capacity for 
remyelination, and the terminal differentiation from endogenous NPC into 
mature oligodendrocytes is often not sufficient, cell replacement strategies are 
a promising strategy in order to promote remyelination. 
Possible candidates are cells forming PNS type myelin such as Schwann cells 
and olfactory ensheathing cells (OEC), which have been shown to form 
functionally relevant myelin with improvement of saltatory nerve conduction 
after transplantation into various CNS sites (Weidner et al. 1999a, Blakemore 
and Crang 1985, Honmou et al. 1996, Sasaki et al. 2004, Akiyama et al. 
2004). OPC/oligodendrocytes responsible for myelination in the CNS, also 
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promoted remyelination and functional improvement after transplantation 
(Windrem et al. 2004, Archer et al. 1997, Brustle et al. 1999). Another 
approach to improve functional outcome after SCI would be to protect the 
remaining endogenous oligodendrocytes or to stimulate endogenous NPC to 
differentiate into mature oligodendrocytes. 
 
1.2.4. Strategies to induce recovery after spinal cord injury 
The ultimate goal would be to achieve both, functional and structural recovery 
after injuries to the spinal cord. In order to measure functional recovery, 
behavioral as well as electrophysiological test need to be performed. To 
determine structural recovery, like tissue repair, axonal growth, remyelination 
or synapse formation, descriptive tests to identify the integrity of the injured 
tissue can be performed. The application of several strategies to improve the 
outcome after SCI, are described in the following sections.  
 
1.2.4.1. Neuroprotection – Reduction of secondary damage 
Traumatic injury to the spinal cord leads to the loss of grey matter and white 
matter (WM) tissue. The functional deficits produced by SCI are mainly 
caused by the loss of white matter, particularly by disrupting the long tracts of 
descending and ascending axon pathways (Blight and Decrescito 1986, Noble 
and Wrathall 1989). 
Interestingly, the sparing of WM is highly correlated to the recovery of 
hindlimb locomotion after SCI (Blight 1991, Basso, Beattie and Bresnahan 
1996). The pathophysiological changes emerging during the secondary injury 
phase are involved in the increased white matter loss over time after the initial 
injury (Tator 1995, Rosenberg and Wrathall 1997). Therefore, it would be 
important to apply therapeutic interventions before the secondary injury phase 
starts. 
Improved functional outcome after SCI may be elicited by neuroprotective 
approaches that limit secondary tissue loss and thus the loss of function. 
Removing or blocking inhibitory molecules such as Nogo-A, MAG, OMgp, 
CSPGs, collagen, semaphorins or ephrins, in the spinal cord lesion area has 
been shown to induce tissue sparing and functional recovery after SCI (Liu, 
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Chen and Tao 2008, Fawcett 2006, Schwab et al. 2006a). Moreover, the 
reduction of the release of glutamate, cytochrome C, Ca2+, Na+, or free 
radicals also have beneficial effects on functional and structural outcome 
(Schwab et al. 2006a, Teng et al. 2004, Teng and Wrathall 1997). Apart from 
cyclooxygenase inhibitors (Hurley, Olschowka and O'Banion 2002, Schwab et 
al. 2004), which have an anti-inflammatory effect and reduce the formation of 
free radicals, recently erythropoetin (EPO) has been discovered as a glia- and 
neuroprotective drug (Goldman and Nedergaard 2002, Gorio et al. 2002). 
Beside its anti-inflammatory role (Agnello et al. 2002), EPO can normalize the 
autoregulation of the vessel tone and suppresses expression of the inducible 
nitric oxide synthase (iNOS) (Schwab et al. 2006a). In order to reduce or 
prevent secondary damage to the spinal cord effectively, the above 
mentioned approaches should be applied before or at least immediately after 
the initial injury, which of course is difficult to realize in a clinical stetting. 
Therefore, the research to attenuate sequelae of secondary injury 
mechanisms will be very important in future. 
 
1.2.4.2. Promoting plasticity 
More than 50% of spinal injuries are neurological incomplete with increasing 
tendency. Almost all of these patients suffering from SCI still reveal spared 
rims of white matter at the injury site with spared axons passing through the 
injury to the distal part of the cord (Kakulas 1999). The promotion of the injury-
induced plasticity of spared axons to form collateral sproutings in order to 
create new functional circuitries may be a promising strategy to improve 
functional outcome after SCI (Bradbury and McMahon 2006). Because it has 
been shown that the spinal cord is quite plastic and that this ability for 
plasticity declines at around 5 of age in humans, it would be favorable to 
achieve the same level of plasticity that is seen in children in the adult spinal 
cord (Fawcett 2006, Raineteau and Schwab 2001). Several studies 
demonstrated that neurotrophic factors can promote spinal cord plasticity and 
sprouting after injury (Jones et al. 2001). The combination of the neurotrophin 
NT-3 together with an anti Nogo-A antibody has been shown to result in even 
stronger sprouting and functional recovery in the partially damaged spinal 
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cord then the blocking of Nogo-A itself (Schnell et al. 1994, Raineteau et al. 
2001, Blochlinger et al. 2001, Z'Graggen et al. 1998). Furthermore, inhibitory 
molecules like CSPGs and tenascin-R in the extracellular matrix seem to be 
involved in the poor plasticity in adults, since the digestion of the CSPGs by 
ChABC enhances axonal sprouting and improves functional recovery 
(Pizzorusso et al. 2002, Bruckner et al. 1993, Bradbury et al. 2002, Fawcett 
2006). Hence, promoting plasticity, meaning to change the structure, function 
and organization of spared neurons e.g. by axonal sprouting in response to an 
injury, would also be a therapeutic option to improve functional outcome after 
SCI. 
 
1.2.4.3. Promoting axonal regeneration 
Axon regeneration is a product of the balance between the regenerative ability 
of the axon and the permissiveness of the environment. Altering either of 
these factors will affect the success or failure of regeneration (Fawcett and 
Asher 1999). In order to achieve an effective axonal regeneration, a combined 
therapy that both stimulates axonal growth and neutralizes inhibitors would be 
needed. 
Different types of neuronal growth can contribute to a restoration of input to 
neurons that lose their normal connections. The most common type is the 
reactive synaptogenesis. Reactive synaptogenesis refers to the process by 
which the local growth of afferents terminates near sites of partial denervation. 
This process also involves the synaptic reinnervation of the partially 
denervated nerve cell by newly formed (collateral) axonal branches of 
persisting afferent or local fibres, resulting in the formation of new synaptic 
contacts. Another type of neuronal growth is termed regenerative sprouting 
and refers to the process of axonal growth as a response to axonal 
amputation. In contrast, axonal regeneration occurs as a response of 
denervation, which leads to the reinnervation of lesioned neurons through the 
in-growth of new axons and the formation of new connections (Hamori 1990, 
Matthews, Cotman and Lynch 1976, Steward 1989).  
Several intrinsic factors affect the regenerative capacity of axon. As already 
mentioned above, the axonal regenerative ability declines with age (Chen, 
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Jhaveri and Schneider 1995, Li, Field and Raisman 1995, Chuckowree, 
Dickson and Vickers 2004, Nicholls and Saunders 1996) and in addition, 
some types of axons regenerate better than others (Li et al. 1995). Another 
important issue is that CNS axons show a greater regenerative response if 
they are lesioned more proximate (closer to the cell body) compared to distal 
lesioned axons (Fawcett 2006, Tetzlaff et al. 1994). Furthermore, absent 
protein synthesis due to the lack of ribosomes in adult CNS axons is probably 
one reason for the their lack of sprouting responses and growth cone 
regeneration after SCI (Verma et al. 2005) since it has been shown that PNS 
axons, embryonic axons as well as developing CNS axons contain ribosomes 
and are capable of protein synthesis (Zheng et al. 2001, Bunge, Bunge and 
Pappas 1962). The numerous inhibitory molecules present in the environment 
after a spinal cord lesion also represent important factors that limit effective 
axonal regeneration. To overcome this hurdles by removing cells that produce 
inhibitory molecules, preventing or reducing their synthesis, blocking or even 
degrading inhibitory molecules, would be possible approaches. Moreover, the 
enhancement of axon growth associated molecules like GAP-43, CAP-23 or 
L1 could also be a possibility (Becker et al. 2004, Mason, Lieberman and 
Anderson 2003, Bomze et al. 2001, Buffo et al. 1997).  
To regain complete axonal function would be the ultimate intent in SCI 
research. Whereas it will be difficult to distinguish between functional 
improvement due to axonal regeneration and functional improvement due to 
plasticity effects within spared axons, since most SCI models represent 
incomplete injuries and elicit some spontaneous regain of function by 
compensation of spared connections.  
 
1.2.4.4 Promoting remyelination 
Remyelination of the CNS involves the synthesis of new myelin sheats by 
oligodendrocytes to ensheat „naked“ axons in order to regain proper nerve 
conduction. The promotion of remyelination represents therefore another 
important strategy to induce recovery after SCI. So far, several strategies 
have shown to be beneficial.  
For example, the inhibition of BMP (bone morphogenetic protein) activity. 
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BMPs are not only important regulators during CNS development and but they 
are also up-regulated after injuries to the CNS (Fuller et al. 2007, Setoguchi et 
al. 2001). Moreover, BMPs promote the astroglial differentiation, while 
inhibiting the oligodendroglial differentiation of NPC (Bonaguidi et al. 2005, 
Gross et al. 1996, Nakashima et al. 2001, Samanta and Kessler 2004, Wang 
et al. 2001). The overexpression of the BMP antagonist Noggin in a SCI-
model showed a shift from astrogenic to oligodendrogenic differentiation 
(Setoguchi et al. 2004). Therefore, blocking the BMP signaling seems to be 
an attractive therapeutic strategy in order increase remyelination. 
The suppression of p57kip2 would be another approach. p57kip2 is a novel 
intrinsic inhibitor of oligodendroglial differentiation. The protein is, among 
other cellular processes, involved in cell cycle control (Besson, Dowdy and 
Roberts 2008). The down-regulation of p57/kip2 has shown to accelerate 
morphological maturation as well as myelin expression of oligodendrocytes in 
vitro, which makes this a promising approach in order to promote 
remyelination (Rivera et al. 2010). Another inhibitor of oligodendrogenesis and 
myelination is LINGO-1 (Leucine rich repeat and Ig domain containing 1) (Mi, 
Sandrock and Miller 2008). Antagonizing LINGO-1 activity has shown to 
promote remyelination in demyelination models (Mi et al. 2007, Mi et al. 
2009). Thyroid hormone (TH) on the other hand has shown to promote 
remyelination. It induces the proliferation of OPC and drives their 
differentiation and maturation towards an oligodendroglial cell type (Ahlgren et 
al. 1997, Billon et al. 2001, Rodriguez-Pena 1999). Furthermore, TH has been 
shown to enhance remyelination in an EAE model (Calza et al. 2002, Calza et 
al. 2005).  
As an alternative to targeting single molecules of the oligodendrogenic 
program, in order to achieve remyelination, an attractive approach might be 
the use of cells that produce myelinating cells or provide a local 
microenvironment favoring oligodendrocyte generation. Two strategies might 
be possible: 1.) the stimulation of endogenous NPC and OPC to produce 
oligodendrocytes and 2.) the transplantation of cells with the potential to 
myelinate axons. 
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1.2.4.5. Cell replacement therapies 
The irreversible loss of spinal cord parenchyma including astroglia, 
oligodendroglia and neurons is one of the key factors responsible for the 
severe functional impairment of individuals suffering from SCI. Since the adult 
CNS is not able to intrinsically replace lost spinal cord parenchyma 
sufficiently, adequate cell replacement strategies are needed in order to 
promote substantial and structural recovery.  
Many cell populations originating from tissues/organs other than the CNS, 
have been investigated in regard to their regenerative capacity after 
transplantation into the injured spinal cord. Possible candidates are cells 
forming PNS type myelin such as Schwann cells and olfactory ensheathing 
cells (OEC), which have been shown to promote partial structural repair after 
transplantation into various CNS sites (Weidner et al. 1999a, Blakemore and 
Crang 1985, Honmou et al. 1996, Sasaki et al. 2004, Akiyama et al. 2004, Lu 
and Ashwell 2002). OPC/oligodendrocytes also promoted remyelination and 
functional improvement after transplantation (Windrem et al. 2004, Archer et 
al. 1997, Brustle et al. 1999). Stem cells represent another cell population, 
which is quite promising. Depending on the type of stem cell, they are capable 
of differentiating into relevant glial and neuronal lineages. In general, one has 
to distinguish between embryonic and somatic stem cells.  
Embryonic stem cells, which are derived from the inner cells mass of the 
blastocyst, are still totipotent until the eight-cell stage, this means that from 
each of these cells a viable organism can still develop (McDonald et al. 1999). 
Pluripotent, neuronal stem cells can be isolated from both the embryonic and 
the adult mammalian CNS of different types of species (Brustle et al. 1999, 
Gage 2000, McKay 1997, Zompa et al. 1997). Transplanted stem cells are 
able to specifically adapt to the local CNS environment and to differentiate 
into the corresponding neuronal or glial subpopulations (Gaiano and Fishell 
1998). In contrast, somatic stem cells can be obtained from individual ion 
organs as soon as organogenesis has occurred, which means from the fetal 
state through adulthood. Somatic stem cells are usually more restricted in 
their ability to differentiate into various cell lineages. Therefore, they are 
considered just to be multipotent. Quite a few somatic stem cells from organs 
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other than the CNS have been investigated in respect to their capacity to 
transdifferentiate into neural tissue. In the last few years it turned out that 
transdifferentiation of somatic stem cells into neural cells is a rare if not non-
existing biological phenomenon. Rather, cells of e.g. blood origin, which have 
been identified to express neural phenotypes after transplantation, underwent 
cell fusion (Sandner and Weidner 2007).  
NPC cells, which have been identified in the adult mammalian nervous 
system including the spinal cord, represent a promising source to replace 
scaffold forming astrocytes, remyelinating oligodendrocytes and neurons 
within the injured spinal cord (Cao, Benton and Whittemore 2002a). NPC at 
and around the lesion site can be stimulated by the application of appropriate 
molecules to replace lost spinal cord tissue intrinsically (stimulation of 
neurogenesis) (Kulbatski et al. 2005, Obermair, Schroter and Thallmair 2008, 
Thuret et al. 2006). Alternatively, NPC can be isolated from small brain/spinal 
cord biopsies, propagated in vitro and ultimately transplanted into the injured 
spinal cord (neural stem cell transplantation). Both approaches have been 
tested on the preclinical level promoting variable degrees of spinal cord 
regeneration (Fig.1.5.). A major advantage of adult NPC is that they can be 
obtained from the patient’s own CNS tissue, thus avoiding graft-rejection and 
ethical concerns as they apply to embryonic stem cells and somatic fetal 
derived stem cells.  
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Figure 1.5. Concept of extrinsic (transplantation) and intrinsic (stimulation of 
endogenous neural cells) replacement strategy 
NPC either can be stimulated by the application of appropriate molecules (intrinsic strategy) 
or they can be isolated from small brain/spinal cord biopsies, propagated in vitro and 
transplanted into the injured spinal cord (extrinsic strategy). 
 
 
In the majority of transplantation studies adult NPC were grafted several days 
to 2 weeks after the actual spinal cord injury. This approach regularly yielded 
high numbers (about 37%) of surviving neural stem cells (Cao et al. 2001, 
Enzmann et al. 2005, Hofstetter et al. 2005, Karimi-Abdolrezaee et al. 2006). 
Nonetheless, transplantation immediately after injury yielded a rather high 
number of surviving neural stem cells (Vroemen et al. 2003). If transplantation 
is delayed up to 8 weeks after the injury, the cell survival decreases 
significantly (Karimi-Abdolrezaee et al. 2006). Not only grafting into the host 
parenchyma surrounding the spinal cord injury site, but also neural stem cells 
grafted directly into the lesion cavity/center survived well (Cao et al. 2001, 
Vroemen et al. 2003). Despite good survival, cystic lesion defects were not 
replaced by grafted neural stem cells (Vroemen et al. 2003).  
Subsequent studies showed that only the combination of neural stem cells 
with platform providing fibroblasts allowed to maintain neural stem cells within 
cystic lesion defects (Pfeifer et al. 2004). Following co-grafting of adult neural 
stem cells with fibroblasts around 43% of the grafted cells took on an 
astroglial phenotype, whereas roughly 18% differentiated into 
oligodendrocytes (Pfeifer et al. 2004). Recently, the infusion of various growth 
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factors including EGF, FGF2 and PDGF-AA at the same time induced a shift 
of neural stem cells, grafted into the contused rat spinal cord towards, 
oligodendroglial differentiation (Karimi-Abdolrezaee et al. 2006). Roughly 50% 
of the grafted neural stem cells differentiated along an oligodendroglial 
lineage. Further analysis revealed that at least a proportion of grafted cells 
appeared to remyelinate axons. Remyelination was determined the 
measurement of the myelination index by electronmicroscopy or by detecting 
grafted cells, which were MBP-immunoreactive and formed myelin. None of 
the existing studies investigating the transplantation of undifferentiated adult 
neural stem cells into the spinal cord observed neuronal differentiation. Only 
the interference with the differentiation of neural stem cells through growth 
factor application (Karimi-Abdolrezaee et al. 2006) or transduction with 
neurogenin-2, which belongs to a group of transcription factors inhibiting 
gliogenesis (Hofstetter et al. 2005), promoted oligodendroglial differentiation 
and as a consequence induced enhanced remyelination. Both studies 
reported functional improvement in various behavioral tasks, however, none 
of these results can be directly related to the observed remyelination. 
The local administration of numerous growth factors has been shown to 
enhance axonal regrowth and even functional recovery after spinal cord 
injury. Ideally cells are genetically modified before transplantation to 
overexpress a given growth factor. Several cell populations, such as 
fibroblasts and Schwann cells, have been successfully transduced to stably 
overexpress neurotrophic factors (Weidner et al. 1999a, Grill et al. 1997, Lu, 
Jones and Tuszynski 2005, Jones et al. 2001). Transplantation of genetically 
engineered fibroblasts that overexpress neurotrophins are able to stimulate 
axonal regeneration and to induced locomotor improvement (Grill et al. 1997, 
Blesch and Tuszynski 2003). Therefore it is desirable to augment the 
regenerative capacity of adult neural stem cells by transducing them to 
overexpress growth promoting factors. 
Mesenchymal stromal cells (MSC) represents another promising cell type in 
order to achieve remyelination after SCI. Recently, it has been demonstrated 
in vitro that soluble factors present in the conditioned medium of MSC (MSC-
CM) strongly activate and promote the oligodendrogenic fate decision in NPC 
(Rivera et al. 2006, Rivera et al. 2008), even though the underlying 
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mechanism and the molecules of this pro-oligodendrogenic effect are still 
unknown. This differentiation towards the oligodendroglial lineage was 
demonstared by a strong increase of of cells expressing the oligodendroglial 
markers GalC and MBP, which was at the expense of astrogenesis, since the 
number of GFAP-expressing cells was dramatically reduced. Moreover, it has 
been shown, that the expression of the pro-oligodendrogenic transcription 
factors Olig1/2 were increased, while the expression of the inhibitor of 
differentiation Id2 was reduced. These observations indicate that MSC-CM 
not only promotes oligodendrocyte differentiation and maturation, but also 
oligodendrocyte fate decision. Furthermore, it has been demonstrated, that 
transplanted MSC integrate into the host tissue, enhance axonal regeneration 
and improve functional outcome (Ankeny, McTigue and Jakeman 2004, 
Hofstetter et al. 2002, Neuhuber et al. 2005, Zurita and Vaquero 2006). MSC 
further promote oligodendroglial differentiation and remyelination in animal 
models of stroke and MS (Bai et al. 2007, Lu et al. 2009, Zhang et al. 2009), 
which make MSC also a promising cell type for cell transplantation 
approaches in animal models of SC. Several studies demonstrated that 
grafted MSC (Liu et al. 2008) provide a regenerative host microenvironment 
by secreting different growth factors, cytokines or bioactive factors that not 
only regulate proliferation, differentiation and migration, decrease apoptosis or 
enhance angiogenensis of endogenous stem or progenitor cells, but also 
inhibit glial scar formation (Caplan 2007, Hung et al. 2007, Munoz et al. 2005, 
Prockop 2007). Moreover, MSC secret anti-inflammatory molecules and show 
immunoregulatory effects by inhibiting T-cell recognition and proliferation 
(Caplan 2007, Uccelli, Moretta and Pistoia 2008, Uccelli, Pistoia and Moretta 
2007, Uccelli et al. 2006). Another advatage of MSC is that they can be easily 
isolated and rapidly expanded in vitro and transplanted back into patients as 
autografts, avoiding grafts-rejection and ethical concerns, which makes them 
feasible for the clinical use (Keating 2006, Wright et al. 2008). 
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1.2.5. Magnetic resonance (MR) imaging for studying spinal cord 
injury 
MR imaging represents the gold standard to visualize the spinal cord in the 
clinical routine diagnostic setting as well as in clinical research (Weber et al. 
2006, Sicard et al. 2006, Thorsen et al. 2003, Guzman et al. 2000, Brandt et 
al. 2008). MR imaging can be employed to non-invasively analyze 
pathomorphologic changes in the injured human spinal cord parenchyma, 
such as hemorrhage, edema and secondary degenerative changes including 
cystic degeneration and glial scar formation (Sandner et al. 2009, Hadley and 
Teasdale 1988, Manelfe 1991, Weber et al. 2006). Moreover, MR imaging 
might provides the facility to predict motor recovery after spinal cord injury 
(Flanders et al. 1996). 
Not only in humans, but also in small animals such as rats or mice MR 
imaging technology is of high interest for monitoring structural changes in the 
injured rat spinal cord for several reasons: With MR imaging, structural 
changes can be assessed over time within identical animals, which not only 
gives more precise information than correlative histology based studies, but 
also helps to substantially reduce the numbers of experimental animals. 
Animal studies allow correlation of MR imaging findings with histology based 
analysis, a prerequisite to later on plan and interpret MR imaging findings in 
humans after injury and regenerative therapeutic interventions (e.g. cell-
transplantation, biomaterial implantation). In addition, markers (e.g. iron oxide 
nanoparticles or gadolinium based probes) to identify the location and survival 
of cell grafts can be validated. Numerous studies in rodents described MR 
findings in vivo with dedicated experimental imaging systems up to 17.6T field 
strength combined with surface or implanted coils, which achieve high spatial 
resolution of morphological changes in the injured spinal cord (Bilgen et al. 
2000, Ford et al. 1994, Fraidakis et al. 1998, Fukuoka et al. 1998a, Guizar-
Sahagun et al. 1994, Metz et al. 2000, Narayana et al. 2004, Ohta et al. 1999, 
Weber et al. 2006). However, their usefulness is clearly impaired by their 
limited availability, rodent size restrictions and potentially higher mortality rate. 
But various studies of small animal imaging studies have been performed on 
standard clinical 1.5T and 3T scanners, which are broadly available and 
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therefore represent a powerful tool to monitor the effects of experimental 
therapeutic interventions in small animals (Guzman et al. 2000, Linn et al. 
2007, Chen et al. 2004a, Fehm et al. 2005). 
In animal models, regenerative strategies have been performed in order to 
promote structural and functional recovery after spinal cord injury. In 
particular, cell-based therapies have shown promising effects for the 
treatment of neurological diseases and stroke (Hoehn et al. 2002, Bulte et al. 
1999) and in regenerating the injured spinal cord (Grill et al. 1997, Xu et al. 
1995b, Pfeifer et al. 2004, Li, Field and Raisman 1997). For the clinical 
application of these therapeutic approaches, noninvasive imaging techniques 
that monitor the migration, differentiation processes and the regenerative 
potential of these cells after grafting, are mandatory.  
 
1.2.6. Introduction to the used animal models of spinal cord injury 
1.2.6.1. Cervical dorsal column transection using a Tungsten wire 
knife device 
This lesion model for SCI in rats comprises the bilateral transection of the 
cervical dorsal columns at the C3 level using a Tungsten wire knife device. 
The stereotactic guidance of the wire knife device results in highly 
reproducible lesions, allowing the characterization of local responses and 
structural alterations after injury. In addition, there is almost no damage to the 
spinal cord grey matter, and importantly the dura remains intact allowing the 
injection of cell-suspensions into the lesion with almost no leaking out of the 
cells. The wire knife lesions cause a rather blunt transection, disrupting the 
dorsal corticospinal tract (CST), the fasciculus gracilis and the fasciculus 
cuneatus, with minimal disruption of the vasculature and the surrounding 
spinal cord cytoarchitecture. Because of this minimal disruption, the infiltration 
of meningeal fibroblasts is mainly avoided. Over time, the lesion transforms 
into a cystic cavity, which is restricts to the lesion site (Weidner, Grill and 
Tuszynski 1999b) (Fig.1.6.). 
The wire knife transection model interrupts the crossed component in the 
ventralmost part of the dorsal funiculus of the CST, which contains 95% of the 
descending axons and an ipsilateral ventral component containing less than 
5% of all CST axons. A large proportion of the overlying dorsal funicular 
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dorsal sensory ascending projection are also lesioned by this procedure 
(Weidner et al. 2001). Beyond, the CST also exists of two other minor 
components, the lateral and dorsolateral components, together constituting 
less than 2% of CST axons (Vahlsing and Feringa 1980, Joosten et al. 1992, 
Brosamle and Schwab 1997). The fibers of the CST originate in layer V of the 
primary motor and sensory cortex (Miller 1987) and control different types of 
movements through its terminations in the intermediate grey and ventral horn 
which include direct terminations on motorneurons (Liang et al. 1991). 
However, the CST is not essential for the control of skilled limb movements 
such as reaching for and grasping food (Whishaw, Gorny and Sarna 1998), 
since it has been demonstrated that only combined lesions of both dorsal and 
ventral CST components eliminated sprouting and impaired function in fine 
motor tasks such as grasping (Weidner et al. 2001). This specific lesion of the 
dorsal CST does not result in obvious long-term behavioral deficit. Therefore 
the described lesion model is suitable to assess morphological changes, in 
particular the regeneration CST axons, can be examined (Weidner et al. 
2001). 
 
 
Figure 1.6. Schematic representation of the Cervical dorsal column transection model 
The crossed dorsal components of CST axons of rats contain about 95% of the descending 
axons, whereas an ipsilateral ventral component contains less than 5% of all CST axons. (A) 
In this SCI model, a dura incision is made and the wire knife device is stereotactically lowered 
into the spinal cord parenchyma. At the correct depth, the tungsten wire is extruded, forming a 
wire arch below the dorsal component of the corticospinal projections (yellow). (B) Afterwards, 
the wire knife device is rised up until the tip of the wire is visible, transecting the dorsal 
columns bilaterally and interrupting the dorsal component of the corticospinal projections and 
a portion of the rostrally projecting proprioceptive dorsal sensory pathway. The wire arc was 
then retracted back into the wire knife device, and the instrument was removed from the cord, 
thereby leaving the dura intact (C) Directly following the lesion, cell-grafts can be injected 
under stereotactic guidance into the lesioned area through a pulled glass micropipette. 
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1.2.6.2. Contusive spinal cord injury using the Infinitive Horizon 
Impactor device 
Blunt spinal cord injuries were performed at thoracical level in adult rats using 
the Infinite Horizon (IH) spinal cord injury device (Precision Systems & 
Instrumentation, Lexington, KY, USA). This computer-controlled device 
creates a highly reproducible, well-defined contusion injury by rapidly applying 
a controlled impact defined in terms of force to the exposed spinal cord. The 
reproducibility of the injuries is achieved by the application of a force-feedback 
impounder that mesaures the employed force to the animal (Scheff et al. 
2003). This severe thoracical contusion lesion induces, in contrast to the wire-
knife lesion model, lasting behavioural deficits which can be assessed by 
various behavioral test like the Basso, Beattie, and Bresnahan locomotive 
rating scale (Basso, Beattie and Bresnahan 1995). In addition, this animal 
model represents a more clinical related approach and thus allows the 
pathomorphological comparison between animal model and injured patient.
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2. Aim of the Thesis 
 
In incomplete and even complete spinal cord injury a more or less extensive 
rim of spared descending and ascending axon projections is preserved, which 
becomes demyelinated and thus fails to mediate neurological function. Based 
on the recent studies (Rivera et al. 2006, Rivera et al. 2008) showing that 
MSC derived soluble factors induce oligodendroglial differentiation in vitro, the 
main aim of this study was to determine, whether MSC derived soluble factors 
will also promote in vivo following transplantation into the intact and injured rat 
spinal cord oligodendroglial differentiation and ultimately remyelination as the 
structural basis for functional recovery.  
 
Detailed aims of the study were: 
1. Determine the potential of MSC-CM to promote oligodendroglial 
differentiation in SVZ derived NPC in vitro. 
2. Determine oligodendroglial differentiation in NPC co-seeded with MSC onto 
hippocampal slice cultures. 
3. Determine oligodendroglial differentiation in SVZ derived NPC co-grafted 
with MSC into the intact spinal cord. 
4. Determine oligodendroglial differentiation in pre-differentiated NPC co-
grafted with MSC into the intact spinal cord. 
5. Determine oligodendroglial differentiation in NPC co-grafted with MSC into 
the injured rat spinal cord. 
6. Determine oligodendroglial differentiation in endogenous NPC after grafting 
with MSC into injured rat spinal cord. 
7. Determine molecular factors underlying the differentiation pattern of NPC 
grafts in vivo. 
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8. In parallel, as a step towards clinical translation, a routine 3.0T MRI was 
evaluated regarding its capacity to visualize morphological changes in the 
contused rat spinal cord as a prerequisite to validate this diagnostic tool for 
monitoring of structural changes in cell-based therapies in the clinical setting. 
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3. Material and Methods 
3.1. Material 
All chemicals were purchased from Merck (Darmstadt, Germany), if not noted 
elsewise. 
3.1.1. Chemicals 
3.1.1.1. Cell culture 
 
3.1.1.2. Immunodetection 
Chemical Source 
4’6-diamidino-2-phenylindole (DAPI) Sigma-Aldrich, Taufkirchen, Germany 
DAB Peroxidase Substrate Kit Biozol, Eching, Germany 
Donkey serum PAN, Germany 
Gelatin from cold water fish skin Sigma-Aldrich, Taufkirchen, Germany 
Prolong Antifade Invitrogen GmbH, Germany 
Triton X-100 Sigma-Aldrich, Taufkirchen, Germany 
Nuclear Fast Red solution  Linaris, Wertheim, Germany 
Chemical Source 
Alpha MEM Gibco BRL, Germany 
Accutase PAA, Pasching, Austria 
B27 supplement Gibco BRL, Germany 
Bromodesoxyuridine (BrdU) Sigma-Aldrich, Taufkirchen, Germany 
Dispase II Boehringer, Germany 
DMEM/F12 Gibco BRL, Germany 
DMSO Sigma-Aldrich, Taufkirchen, Germany 
DNase I Worthington Biochemicals, England 
Dulbecco’s phosphate buffered saline Sigma-Aldrich, Taufkirchen, Germany 
Epidermal growth factor (EGF) R&D Systems 
Fetal bovine serum (FBS) PAN, Germany 
Fibroblast growth factor (FGF) R&D Systems 
Glucose Merck, Germany 
Hank’s Balanced Salt Solution PAN, Germany 
Heparin Sigma-Aldrich, Taufkirchen, Germany 
Laminin Sigma-Aldrich, Taufkirchen, Germany 
L-glutamine PAN, Germany 
Neurobasal Medium (NB) Gibco BRL, Germany 
Papain Worthington Biochemicals, England 
Penicillin/streptomycin PAN, Germany 
Poly-L-ornithine Sigma-Aldrich, Taufkirchen, Germany 
Trypan Blue Sigma-Aldrich, Taufkirchen, Germany 
Trypsin PAN, Germany 
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3.1.1.3. Other Chemicals + Kits 
Chemical Company 
Ethanol Baker, Unterschleißheim, 
Germany Isoflurane Baxter 
2-Mercaptoethanol Sigma-Aldrich, Germany 
2-Methybutane (Isopentane) Fluka 
Paraformaldehyde Sigma-Aldrich, Germany 
SYBRGreen JumpStartTM Taq Ready 
MixTM  
Sigma-Aldrich, Germany 
RNase-free DNase-Set  Qiagen, Hilden, Germany 
RNeasy Mini Kit  Qiagen, Hilden, Germany 
Reverse Transscription System Promega, Mannheim, Germany 
 
3.1.2 Antibodies 
 
Primary antibody Experimental 
application 
Dil. Source 
ms α APC                      
(mouse anti- Adenomatous 
polyposis coli) 
mature 
oligodendrocytes 
1:500 Calbiochem, 
Darmstadt, 
Germany 
rt α BrdU 
(Bromodesoxyuridine) 
base analog 
(proliferation marker) 
1:500 AbDSerotec, 
UK 
rb α GalC 
(Galactocerebroside) 
mature 
oligodendrocyte 
1:250 Chemicon, 
Temecula, CA 
rb α GFAP                         
(glial fibrillary acidic protein) 
astrocytes 1:1000 Dako, A/S, 
Glostrup, DK 
gt α GFP                      
(green fluorescent protein) 
 1:500 Rockland, 
Gilbertsville, 
USA ms α (Map2ab)             
microtuble associated 
protein 2ab 
mature neurons 1:200 Sigma-Aldrich, 
Taufkirchen, 
Germany 
ms α MPB (= SMI-94) 
(myelin basic protein) 
mature neurons 1:750 HiSS Diag. 
Germany 
 
 
Secondary antibody Dil. Source 
dk α ms IgG Alexa Fluor 488 1:1000 Molecular Probes, Germany 
dk α gt IgG Alexa Fluor 488 1:1000 Molecular Probes, Germany 
dk α rb IgG Alexa Fluor 488 1:1000 Molecular Probes, Germany 
dk α ms-RHOX (rhodamine X) 1:1000 Dianova, Hamburg, Germany 
dk α rb-RHOX  1:1000 Dianova, Hamburg, Germany 
dk α rt-RHOX  1:1000 Dianova, Hamburg, Germany 
dk α rb-CY5 1:1000 Dianova, Hamburg, Germany 
dk α rt-Biotin 1:1000 Dianova, Hamburg, Germany 
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3.1.3. Buffer and solutions 
Reagent  Application  Source  
Borate Buffer (0.1M)     
pH 8.5 
- 3.08g boric acid                        
- 450 ml H2O                              
- 5N NaOH to pH 8.5                  
- fill up to 500ml 
Sigma-Aldrich, 
Germany        
Sigma-Aldrich, 
Germany 
Cyro Protect Solution 
(CPS)  
 
- 250 ml Glycerine                       
- 500 ml 0,1 M PO4 buffer          
- 250 ml ethylene glycol  
 
Donkey serum 
blocking buffer 
- 960 µl TBS                              
- 30 µl donkey serum                  
- 10 µl Triton X-100 
Merck, Germany 
PAN, Germany 
Sigma, Germany 
Fish Skin Gelatin 
Buffer (FSGB) 
- 1000 ml TBS                           
- 10g BSA                                   
- 2 ml v Fish Skin Gelatine 
optional: 1 ml Triton X-100 
 
Sigma, Germany 
Phosphate Buffer         
(PO4: 0.2M) 
- 6,35g NaH2PO4 x H2O             
- 41,35g Na2HPO4 x 7 H2O           
-  fill up with ddH2O to 1L 
Sigma-Aldrich, 
Taufkirchen, 
Germany 
4% 
Paraformaldehyde 
(PFA) 
- 40g paraformaldehyde            
- add 500ml H2O, heat to 70°C     
- dissolve while stirring               
- add 1ml 10M NaOH                 
- filter solution and add 500ml    
0.2M PO4 
Sigma-Aldrich, 
Taufkirchen, 
Germany 
PBS (0.1M) - 500ml 0.2M Phosphate Buffer 
- 500ml dH2O                             
- 9g Natriumchloride 
 
PPD (100ml) - 0.01% Papain                           
- 0.1% Dispase II                            
- 0.01% Dnase                              
- 149 mg MgSO4*7H2O                    
- in HBSS w/o Ca2+/Mg2+ 
Worthington, USA 
Boehringer 
Mannheim 
Worthington, USA 
PAN, Germany 
30% Sucrose - 300g Sucrose                                
- 400ml 0.2M PO4                      
- 400 ml ddH2O 
Sigma-Aldrich, 
Taufkirchen, 
Germany 
20 x SSC: - NaCl 175.3 g                                
- NaCitrat x 2 H20 88.2 g                     
- H2Odest ad 1000 ml             - 
Adjust pH 7.0 with 1 N HCl  
10 x TBS - Trizma Base 30 g                        
- KCl 2 g                                       
- NaCl 80 g                                        
- Fill up to 1000ml with H2Odest  
- Adjust pH 7.4 with 1 N HCl 
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3.1.4. RT-PCR primers 
All primers were purchased from Invitrogen (Karlsruhe, Germany).  
 
 
 
 
 
PCR-Program:  
The following temperature profile was used for all the genes analyzed:  
 
  1 cycle:       10 min    95°C            activation of polymerase 
40 cycles:     30 sec    95°C            denaturation 
 1 min    56°C            annealing 
 1 min    72°C            elongation 
  1 cycle:    1 min    95°C 
            30 sec   55°C 
            30 sec   95°C 
 
The quality of the products was controlled by a Melt curve. An example of 
RNA quantification is shown in the Results section. 
 
 
 
 
Name 
 
Sequence 
forward    5’ - 
3’ 
Sequence 
reverse  5’ – 
3’ 
Tem
p. 
Size 
Olig1 
(Oligodendrocyte 
transcription factor 1) 
GCCCCACCAAGTA
CCTGTCTC 
GGGACCAGATGC
GGGAAC 
56°C 109bp 
Olig2 
(Oligodendrocyte 
transcription factor 2) 
CACAGGAGGGACT
GTGTCCT 
GGTGCTGGAGGA
AGATGACT 
56°C 144bp 
Id2                   
(DNA-binding protein 
inhibitor 2) 
TTTCCTCCTACGAG
CAGCAT 
CCAGTTCCTTGA
GCTTGGAG 
56°C 160bp 
G6PDH            
(Glucose-6-Phosphat-
Dehydrogenase) 
CCAGCCTCCACAA
GCACCTCAAC 
AATTAGCCCCCA
CGACCCTCAGTA 
58°C  
Material and Methods 
  50 
 
3.1.5. Consumables 
 
Materials Source 
Coverslips and slides VWR; Mendite 
Cell-culture ware Peske, Aindlingen-Arnhofen, Germany; Corning 
Costar, Bodenheim, Germany; Sarstedt, 
Nümbrecht, Germany; 
Cell-Culture media PAN Biotech, Aidenbach, Germany                             
Invitrogen / Gibco, Karlsruhe, Germany 
Growth factors R&D Systems, Germany 
 
3.1.6. Software 
Program Software producer 
Adobe Illustrator CS3 Adobe, San Jose, CA, USA 
Adobe Photoshop Adobe, San Jose, CA, USA 
EndNote X3 Thomson Reuters, CA, USA 
Mircosoft Office for MacOS X 
(10.5.8) 
Redmond, WA, USA 
OsiriX for MacOS X Los Angeles, CA, USA 
Prism 4, Version 4.0a for Macintosh GraphPad Software, San Diego, CA, 
USA  
Spot 3.5.9. for Mac OS Diagnostic Instruments, Sterling 
Heights, MI, USA 
Leica confocal software Leica, Wetzlar, Germany 
MxPro-Mx3005P software Stratagene, La Jolla, CA, USA 
 
3.1.7. Equipment and Instruments 
Apparatus Source 
Hera Cell incubator Heraeus, Germany 
Hera Safe cell culture hood Heraeus, Germany 
Inverse fluorescence microscope for 
cell culture 
Olympus, Germany 
Leica confocal fluorescence 
microscope (TCS-NT)  
Leica, Wetzlar, Germany 
Leica fluorescent microscope 
equipped with a Spot CCD camera 
model 2.2.1  
Leica, Wetzlar, Germany;                      
Diagnostic Instruments, Inc., Sterling 
Heights, MI, USA 
refrigerated table centrifuge Eppendorf, Hamburg, Germany 
table centrifuge mini spin plus Eppendorf, Hamburg, Germany 
 Mx3005P Real-Time PCR System Stratagene, La Jolla, CA, USA 
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3.2. Methods 
3.2.1. Animal subjects 
Adult female Fischer 344 rats (Charles River Deutschland GmbH, Sulzfeld, 
Germany) weighing 160-180g (3-4 months old) were used as donors for the 
isolation of NPC, MSC and fibroblasts and for all transplantation experiments. 
Nineteen to 21 days postnatal Wistar rats were used as donors for the 
hippocampal slice cultures. 
All experiments were carried out in accordance with the European 
Communities Council Directive (86/609/EEC) and institutional guidelines. 
Animals had ad libidium access to food and water throughout the study. All 
efforts were made to minimize the number of used animals and their suffering.  
 
3.2.2. Preparation and cell culture 
3.2.2.1. Preparation of neural progenitor cells (NPC) 
For the different cell isolation procedures, adult female Fischer-344 rats or 
transgenic rats expressing ubiquitously the green fluorescent protein (GFP) 
reporter (Lois et al. 2002) were deeply anesthetized using a cocktail of 
ketamine (62.5mg/kg; WDT, Garbsen, Germany), xylazine (3.175mg/kg; 
WDT, Garbsen, Germany) and acepromazine (0.625mg/kg, Sanofi-Ceva, 
Düsseldorf, Germany) in 0.9% sterile saline solution and killed by 
decapitation. Brains and spinal cords were removed and put in 4° C 
Dulbecco’s phosphate buffered saline (DPBS) (PAA Laboratories, Linz, 
Austria). Overlying meninges and blood vessels were removed. The 
hippocampus (HC) and ependymal zones, including subependymal and 
subventricular zones from the lateral wall of the lateral ventricle (SVZ), were 
aseptically removed. The dissected tissue was transferred to fresh DPBS, 
washed once, transferred to Petri dishes, and dissociated mechanically. The 
cell suspension was washed in DPBS to rinse off excess of blood and further 
digested in PPD solution containing papain (0.01%, Worthington 
Biochemicals, Lakewood, USA), 0.1% dispase II (Boehringer, Germany), 
DNase I (0.01%, Worthington Biochemicals) and 12.4 mM MgSO4, dissolved 
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in Hank’s balanced salt solution (HBSS, PAA Laboratories) for 30 min at 
37°C. The cell suspension was triturated every 10 min until the tissue was 
digested completely. The tissue was centrifuged at 120 x g for 5 min at 4°C 
and washed three times in Neurobasal (NB) medium (Gibco BRL, Germany) 
supplemented with B27 (Gibco BRL, Germany), 2 mM L-glutamine (PAN, 
Germany), 100 U/ml penicillin / 0.1 mg/l streptomycin (PAN, Germany). Cells 
were resuspended in NB medium supplemented additionally with 2µg/ml 
heparin (Sigma, Germany), 20 ng/ml FGF-2 (R&D Systems, Germany) and 20 
ng/ml EGF (R&D Systems, Germany). Cultures were maintained as 
neurospheres in uncoated culture flasks at 37°C in a humidified incubator with 
5% CO2.  Half of the cell culture medium was changed twice a week, by 
centrifuging the medium containing the neurospheres at 120 x g for 5 min at 4 
°C and then removing the supernatant and resuspending the cells in fresh 
growth medium (Wachs et al. 2003, Hofstetter et al. 2002). Cultures were 
maintained at 37° C in an incubator with 5% CO2. Single cells began to form 
spheres within 5 to 7 days of suspension culture and continued to grow in 
mass and number during the next weeks. Half of the medium was changed 
every 3 days. Cell cultures were passaged in weekly intervals. Passaging of 
the neurospheres was performed as follows: the medium containing the 
neurospheres was collected in a 15ml centrifuge tube and centrifuged at 120 
x g for 5 min at 4°C. The pellet was resuspended in 200µl of AccutaseTM (PAA 
Laboratories, Linz, Austria) and incubated at 37°C for 10 min. The 
neuropheres were resuspended in growth medium and triturated. Viable cells 
were counted by trypan blue exclusion assay in a Neubauer hemocytometer, 
a total number of 5 x 104 cells/ml was seeded in T75 culture flasks in fresh 
growth medium. 
Neurosphere cultures from passage number 2 to 6 were uses throughout this 
study and termed NPC.  
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3.2.2.2. Preparation of fibroblasts 
Primary cultures of adult Fischer 344 fibroblasts or transgenic rats expressing 
ubiquitously the GFP reporter (Lois et al. 2002) were generated from skin 
biopsies and cultivated under standard culture conditions as previously 
described (Pfeifer et al. 2004, Tuszynski et al. 1994). Briefly, a small skin 
biopsy from the abdominal region was taken. The biopsy was put into 70% 
ethanol for a few seconds, washed in HBSS and all fat-tissue was removed. 
The biopsy was then cut into small pieces (1 x 1 mm) and transferred in 
culture wells containing Dulbecco’s minimal essential medium (DMEM) 
supplemented with 2 mM L-glutamine (PAN, Germany), 100 U/ml penicillin / 
0.1 mg/l streptomycin (PAN, Germany), 3.5 mg/ml Glucose (Merck, 
Darmstadt, Germany) and 10% fetal calf serum. The medium was changed 
twice a week. When the cells reached 90% confluence, they were passaged 
by trypsinization. After counting an aliquot of the resulting single cell 
suspension in a Neubauer hemocytometer 5 x 104 cells/ml were plated in 
fresh medium. 
 
3.2.2.3. Preparation of mesenchymal stem cells (MSC) 
For isolation of MSC, bone marrow plugs were harvested from femurs and 
tibias of 2-4 month-old female Fisher-344 rats (Charles River Deutschland 
GmbH, Germany). Plugs were mechanically dissociated in Minimum Essential 
Medium alpha Medium (α-MEM) (Gibco Cell Culture, Invitrogen GmbH, 
Germany) and recovered by centrifugation. Cell pellets were resuspended in 
α-MEM containing 10% Fetal Bovine Serum (αMEM-10% FBS) (PAN Biotech 
GmbH, Germany) and seeded at 1x106 cells/cm2 in a humidified incubator at 
37°C with 5% CO2. After 3 days, the media was changed non-adherent cells 
were removed. Adherent cells were incubated in fresh αMEM-10%FBS until a 
confluent layer of cells was reached. These cells were trypsinized using 
0.25% Trypsin (Gibco Cell Culture, Invitrogen GmbH, Germany), seeded in α-
MEM-10%FBS at 8,000 cells/cm2. After 3-5 days of culture, the resulting 
monolayer of cells, hereafter named rat bone marrow-derived MSC, was 
trypsinized and frozen or further cultured for experiments. As demonstrated in 
our previous work, this cell culture preparation is highly enriched in 
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multipotent MSC with virtually no hematopoietic contamination (Rivera et al. 
2006).  
 
3.2.2.4. Preparation and use of Conditioned Media (MSC-CM) 
For preparation of MSC-CM, MSC were plated at 12,000 cells/cm2 and 
incubated in α-MEM-10%FBS. After 3 days, MSC-CM was collected and 
filtered using a 0.22µm pore filter. NPC were plated on polyornithine 
(100µg/ml) and laminin (5µg/ml)-coated glass coverslips at a density of 
10,000 cells per cm2 in α-MEM-10% FBS for 12-24 hours. Thereafter, the 
medium was replaced with MSC-CM or, the cells were kept in control αMEM-
10% FBS media. After 7 days, cells were fixed for 30 minutes with phosphate-
buffered 4% (wt/vol) paraformaldehyde (37°C, pH 7,4) and then processed for 
immunofluorescence staining. 
 
3.2.2.5. Cell labeling 
3.2.2.5.1. Labeling of NPC with BrdU 
NPC were incubated with 1 µM 5-bromo-2´-deoxyuridine (BrdU, Sigma, 
Germany) in growth medium for 48 h before transplantation. BrdU-
incorporation could be demonstrated in more than 95% of NPC by 
immunohistochemistry (data not shown).  
 
3.2.2.5.2. Labeling of MSC through lentiviral transfection 
EGFP-labeled MSC were used in transplantation experiments. We used an 
HIV-based lentiviral eGFP vector pseudotyped with VSV-G, where eGFP is 
encoded under the control of the human ubiquitin C promotor (Costa et al. 
2008). A total of 107 MSC were transduced in 0.5 ml of medium with 107 
infectious viral particles for 1,5 hours at 37°C, washed and seeded. Two days 
later, the eGFP expressing cells are enriched to approximately 90% by FACS 
sorting using a FACSAria (Becton Dickinson) (Rivera et al. 2006). 
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3.2.2.6. Co-cultures of NPC and MSC 
Co-cultures of BrdU-labeled NSC and MSC were cultured as described 
(Rivera et al. 2006). Briefly, MSC (passage 2 to 6) were plated on 
polyornithine and laminin coated dishes at a density of 2,500-5,000 cells per 
cm2. Twelve to 24 hours later NPC isolated from the SVZ of adult transgenic 
rats ubiquitously expressing GFP (Lois et al. 2002), were plated over the MSC 
layer at a density of 10.000 cells per cm2.in (αMEM)-10% fetal bovine serum 
(FBS) and co-cultured for 7 days. Medium was refreshed on the third day. 
Cells were fixed for 30 minutes with phosphate-buffered 4% (wt/vol) 
paraformaldehyde (37°C, pH 7,4) and then processed for 
immunofluorescence staining. 
 
3.2.2.7. NPC pre-differentiation for grafting into the intact spinal 
cord 
NPC derived from the SVZ were pre-differentiated by co-cultivation with MSC. 
Co-cultures of BrdU-labeled NSC and MSC were cultured as described. 
Briefly, MSC (passage 2 to 6) were plated on polyornithine and laminin coated 
dishes at a density of 2,500-5,000 cells per cm2. After 16hrs BrdU-labeled 
NPC were plated over the MSC at a density of 65,000 cells per cm2. Cells 
were incubated in aMEM-10% FBS for 3 days. After this period, co-culture 
was treated with 0.25% trypsin (Gibco BRL, Germany) and cells were 
collected for transplantation. 
 
3.2.2.8. NPC pre-differentiation for seeding onto hippocampal 
slice cultures 
NPC (derived from the HC) were pre-differentiated by culturing in MSC-CM. 
MSC-CM was prepared as described above. Briefly, MSC were plated at 
12,000 cells/cm2 and incubated in MEM-10% FBS. After 3 days, the 
conditioned medium was collected and filtered using a 0.22 m-pore filter. 
BrdU-labeled NPC were plated on polyornithine (100µg/ml) and laminin 
(5µg/ml)-coated dishes and incubated for 2 days with MSC-CM. After this 
period, cells were treated with 0.25% trypsin (Gibco BRL, Germany) and 
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collected for transplantation. Based on our previous studies, this time frame is 
sufficient to trigger an oligodendrogenic program in NPC, since i) the 
presence of MSC-CM for two to three days was sufficient to increase the 
expression level of pro-oligodendrogenic transcription factors (olig 1/2) and to 
decrease expression level of the anti- oligodendrogenic factor Id2 (Rivera et 
al. 2006), and ii) a two day incubation with MSC-CM was sufficient to induce 
and promote the expression of the oligodendroglial markers 
Galactocerebroside C (GalC) and myelin basic protein (MBP) and to inhibit 
expression of the astroglial marker GFAP (Rivera et al. 2008).  
 
3.2.2.9. Preparation of respective cell types for transplantation  
A sample of single cell suspension of the NPC was stained with Trypan Blue 
(Sigma, Germany) and counted in a Neubauer hemocytometer. The 
remaining single cell suspension was washed twice and resuspended in PBS 
to yield the desired final concentration. Fibroblasts and MSC were trypsinized 
and counted in a Neubauer hemocytometer. Cells were washed twice and 
resuspended in PBS. NPC and MSC/FF suspension were mixed immediate 
before transplantation. 
 
3.2.3. Immunocytochemistry 
Fixed cells were washed in Tris-buffered saline (TBS) (0.15 M NaCl, 0.1 M 
Tris-HCl, pH 7.5), then blocked with a solution composed of TBS, 0.2% fish 
skin gelatin (Sigma-Aldrich, Germany), 1% bovine serum albumin (BSA, 
Biomol, Hamburg, Germany) and 0.1% Triton X-100 (Sigma-Aldrich, Germany 
– only for intracellular antigens (fish gelatin buffer [FGB], AbDSerotec, UK) for 
2 h. The same solution was used for the incubation steps with antibodies. 
Primary antibodies were applied overnight at 4°C. Fluorochrome-conjugated 
species-specific secondary antibodies were used for immunodetection. 
The following antibodies and final concentrations were used: rabbit anti-glial 
fibrillary acidic protein (GFAP) for astroglia (1:1000; Dako, Denmark A/S, 
Glostrup, Denmark), rabbit anti-GalC (1:250; Chemicon International, 
Temecula, CA) and mouse anti-MBP (1:750; SMI-94; Covance, Emeryville, 
CA) for oligodendrocytes, mouse anti-Microtubule Associated Protein 2ab 
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(Map2ab) for neurons (1:250; Sigma-Aldrich) and Goat anti-GFP (1:500; 
Rockland Immunochemicals, Inc., Gilbertsville, PA) was used to detect GFP-
positive NPC.  
Secondary antibodies: donkey anti-mouse, -rabbit or –goat conjugated with 
Alexa Fluor 488 (1:1000; Molecular Probes) or rhodamine X (RHOX) (1:500; 
Dianova, Germany). In case of detergent-sensitive antigens (i.e.,GalC), Triton 
X-100 was omitted from FGB. Nuclear counterstaining was performed with 4’, 
6’-diamidino-2-phenylindole dihydrochloride hydrate (DAPI) at 0.25µg/µl 
(Sigma-Aldrich). The coverslips were mounted onto glass slides using 
Prolong-antifade (Invitrogen GmbH, Germany). Epifluorescence observation 
and photo-documentation were realized using a Leica fluorescent microscope 
(Leica, Wetzlar, Germany) equipped with a Spot CCD camera model 2.2.1 
(Diagnostic Instruments, Inc., Sterling Heights, MI, USA). 
For each culture condition, 10 randomly selected observation fields, 
containing a total of 500-1,000 cells, were photographed for cell fate analysis. 
The expression frequency of selected cell type markers was determined for 
every condition in three independent experiments. 
 
3.2.4. Quantitative RT-PCR  
NPC were plated on polyornithine (100 g/ml) and laminin (5µg/ml)-coated 
dishes at a density of 30.000 cells per cm2 in α-MEM-10% FBS for 12-24 
hours. Then, NPC were incubated in either in 1.) MSC-CM, 2.) MSC-CM + 
10ng/ml Bone Morphogenic Protein 2 and 4 (BMP 2/4; R & D Systems), 3.) α-
MEM-10% FBS + BMP 2 or 4.) α-MEM-10% FBS (as control). Medium 
change defines day 0. RNA was extracted at day 0, 3, or 7 with the RNeasy 
kit (QIAGEN GmbH, Hilden, Germany), and cDNA was synthesized using the 
Reverse Transcription System (Promega). Expression analysis was 
performed by real-time quantitative PCR with the Mx3005P (Stratagene, La 
Jolla, CA, USA) with the SYBRGreen JumpStartTM Taq Ready MixTM (Sigma-
Aldrich, Germany) using specific primers (supplemental online Table 1). As an 
internal reference, the primer pair for Glucose-6-phosphate dehydrogenase 
(G6PDH) was used. For quantification, a standard curve was established by 
amplification of serial dilutions of a mixture of all cDNAs obtained from NPC 
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cultured under the different conditions. The following temperature profile was 
used: activation of polymerase: 95°C, 10 minutes; denaturing: 95°C, 30 
seconds (40 cycles); annealing: 56°C, 60 seconds; and elongation: 72°C, 60 
seconds. The quality of the products was controlled by a Melt curve. Three 
replicates were run for each cDNA sample with the test and control primers in 
separate wells of a 96-well plate. The relative quantity of 
targetgene/referencegene was calculated for each primer. From these results, 
the ratio of Olig1/Id2 or Olig2/Id2 was calculated. 
In parallel, cells were NPC were plated on polyornithine and laminin coated 
glass coverslips at a density of 10,000 cells per cm2 in αMEM-10% FBS for 
12-24 hours. Thereafter, the medium was replaced with 1.) MSC-CM, 2.) 
MSC-CM + BMP 2/4, 3.) α-MEM-10% FBS + BMP 2/4 or 4.) control (α-MEM-
10% FBS) media. After 7 days, cells were fixed for 30 minutes with 
phosphate-buffered 4% (wt/vol) paraformaldehyde (37°C, pH 7,4) and then 
processed for immunofluorescence staining. 
 
3.2.5. Surgical procedures 
For all surgical procedures animals were anesthetized using a cocktail of 
ketamine, xylazine and acepromazine as described above.  
 
3.2.5.1. Organotypic hippocampal slice cultures and cell 
transplantation  
Preparation and maintenance of organotypic hippocampal slice cultures and 
cell transplantation were performed as described (Eyupoglu et al. 2005). 
Briefly, postnatal day 19-21 Wistar rats were decapitated, the brains removed 
and placed into ice-cold preparation medium. Horizontal 350 µm sections 
were prepared on a Leica VT-1000 vibratome (Leica Microsystems, 
Bensheim, Germany), placed in transwell cell-culture inserts in 6 well plates 
(Greiner Bioscience, Germany) and cultured as interface cultures (Stoppini, 
Buchs and Muller 1991) in slice culture medium (Holsken et al. 2006). The 
slices were cultured in a humidified atmosphere at 35°C. Medium was 
changed on the first day and every other day thereafter. For stem cell 
transplantation, a total of 5,000 cells (MSC, NPC or a 1:1 mix of both) were 
grafted one day after slice culture preparation into different hippocampal 
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regions (CA region and dentate gyrus) in 0.05 µl of medium using a Hamilton 
syringe. Alternatively, 5,000 MSC-CM pre-conditioned (pre-differentiated) 
BrdU-labeled NPC were transplanted. After 7 days, slices were fixed in 4 % 
paraformaldehyde for 24 hours and placed in 30% sucrose. 
 
3.2.5.2. Cervical dorsal column transection  
Lesions of the dorsal columns were performed using a tungsten wire knife 
(Kopf Instruments, Tujunga, CA) to transect the dorsal columns bilaterally, 
thereby interrupting the dorsal component of the corticospinal projection and a 
portion of the rostrally projecting proprioceptive dorsal sensory pathway. Rats 
were fixed in a spinal stereotactic unit (Kopf Instruments, Tujunga, CA), skin 
and muscle were incised, and a laminectomy was performed at C3. A small 
dura incision was made. For C3 lesions, the tungsten wire knife was 
stereotaxically positioned 0.6 mm to the left of midline and lowered to a depth 
of 1.1 mm (for illustration see Fig.1.6.). The tip of the wire knife was extruded 
from the device, forming a 2.25-mm-wide wire, that was then raised 2 mm to 
lesion the CST bilaterally. To ensure complete interruption (rather than 
stretching) of corticospinal axons, a 500-µm-wide glass pipette was then 
tightly compressed against the wire loop under microscopic guidance. A large 
proportion of the overlying dorsal funicular dorsal sensory ascending 
projection was also lesioned by this procedure. The wire arc was retracted 
back into the knife device, and the instrument was removed from the cord. 
This lesion is highly localized and reproducible, permitting precise 
characterization of local responses to injury and associations of defined 
axonal populations to the injury milieu (Vroemen et al. 2003, Weidner et al. 
1999b, Weidner et al. 2001). 
 
3.2.5.3. Spinal Cord contusion injury 
 A total of 8 rats received a spinal cord contusion injury at thoracic vertebra 
(T10) by using the Infinite Horizon (IH) Impactor spinal cord injury device 
(Precision Systems & instrumentation, Lexington, Ky, USA). This device 
creates a reliable contusion injury to the exposed spinal cord by rapidly 
applying a force-defined impact with a stainless steel-tipped impounder. The 
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instrument does this by employing a stepping motor to apply a controlled 
impact defined in terms of force. A laminectomy was performed at T10 to 
expose the dorsal portion of the spinal cord. The exposed vertebral column 
was stabilized by attaching Adson forceps to the rostral T9 and caudal T11 
vertebral bodies. Particular care was taken to align the exposed spinal cord 
perpendicular to the axis of the Impactor. The 2.5-mm stainless steel 
impounder tip was lowered to approximately 3–4 mm above the surface of the 
exposed spinal cord. The contusion injury was finally induced, by applying an 
impact force of 2 Newton (equal to 200 kilodyne) to the exposed spinal cord at 
a velocity of 130 mm/s. Overlying muscle layers were sutured and the skin 
was closed (Weber et al. 2006, Scheff et al. 2003). Postoperatively, animals 
were kept warm, placed on beds of sawdust, and given manual bladder 
evacuation twice a day for a period of 10 days as necessary and received 
intramuscular injections of 10 mg Cotrimoxazol (Ratiopharm, Ulm, Germany) 
once daily for a period of 10 days. Animals regained automatic neurogenic 
bladder function after 5-10 days.  
 
3.2.5.4. Cell transplantation into the intact spinal cord 
For injection of respective cell types into the intact spinal cord, animals 
received a partial laminectomy at cervical level C3. Then a total volume of 2µl 
cell suspension containing a) 1.2 x 105 NPC/µl (NPC n= 6), b) 1.2 x 105 
NPC/µl + 0.3 x 105 MSC/µl (NPC/MSC; n=6) or c) 1.2 x 105 NPC/µl + 1 x 
105 MSC/µl, which were co-cultured 3 days prior to transplantation (prediff-
NPC/MSC , n=7), was injected stereotactically guided (medio-lateral midline, 
dorso-ventral 0.8mm), using 15-nl per pulse into the spinal cord through a 
pulled glass micropipette (100µm internal diameter) using a pneumatically 
driven device (Picospritzer Π, General Valve, Fairfield, USA). The 
micropipette tip remained in place for 25 s before withdrawal. The 
implantation site was covered with gelfoam (Gelita Tampon; Braun, Germany) 
before readapting muscular layers and stapling the skin above the lesion. 
    
Material and Methods 
  61 
 
3.2.5.5. Cell transplantation into the injured spinal cord 
Spinal cord lesions were performed as described above. After stereotactically 
guided transection of the dorsal CST with a tungsten wire knife (David Kopf 
Instruments, USA) at cervical level C3, a total volume of 2µl cells suspension 
containing a) 0.6 x 105 MSC/µl (MSC; n=5), b) 1.8 x 105 NPC/µl (NPC n=5), 
c) 1.2 x 105 NPC/µl + 0.3 x 105 MSC/µl (NPC/MSC , n=6) or 1.2 x 105 NPC/µl 
+ 0.3 x 105 FF/µl (NPC/FF n=8) was injected directly into the lesion site 
through a pulled glass micropipette (100 µm internal diameter) using a 
Picospritzer Π (General Valve, Fairfield, USA). Animals receiving spinal cord 
lesions without cell transplantation served as controls (LESION n=6). For 
this experiment NPC derived from the SVZ were used.  
To investigate the differentiation and survival of endogenous NPC, a total 
volume of 2 µl cell suspension containing a) 0,6x105 MSC/µl (MSC ; n=6), b) 
0,6x105 fibroblasts/µl (FF ; n=6) was injected directly into the lesion site. 
Animals receiving spinal cord lesions without cell transplantation (Lesion 
only, n=6) served as controls. The lesion/implantation site was covered with 
gelfoam before readapting muscular layers and stapling the skin above the 
lesion. 
 
3.2.5.6. BrdU-Injection 
A short course of BrdU-injection (50 mg/kg) was done intraperitoneally (i.p.) 
starting right after the surgery until day 3 post-op. Animals were perfused on 
day 3 to study endogenous cell proliferation (early time-point). For 
investigations on survival of newborn cells derived from endogenous NPC, 
BrdU (50mg/kg) was administered i.p. from day 3-10 before the animals were 
sacrificed on day 28 (late time-point) (for illustration see Fig.4.10.). 
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3.2.6. Histology  
Animals were transcardially perfused with 0.9% saline solution followed by 4% 
paraformaldehyde in 0.1 M phosphate buffer. The spinal cords were 
dissected, post fixed overnight and cyroprotected in 30% sucrose. Cervical 
spinal cords of unlesioned animals or a half of the animals, which received a 
contusion injury, were cut into sagittal 35µm thick cyrostat sections (CM 3000, 
Leica, Bensheim) and processed for immunohistochemistry. Every seventh 
section was taken for Nissl staining to determine the injection site. A 3mm 
long part of the cervical spinal cords containing the lesioned area from 
animals, which underwent dorsal column transection or spinal cord contusion 
injury, were cut into coronal 40 µm thick cryostat sections. Three sections 
(lesion center [LC], rostral and caudal) with a distance of 1120µm between 
each other were processed for immunohistochemistry. Every seventh section 
was taken for Nissl staining to determine the lesion/injection site and to 
assess the overall neuropathological changes (tissue loss, hemorrhage, cyst 
formation). (Fig.3.1.). Prussian blue staining was employed to identify 
hemosiderin deposits for the animals, which received a contusion injury. 
A 9 mm long part of the cervical spinal cords containing the lesioned area 
from animals for the endogenous study, was cut into coronal 40 µm thick 
cryostat sections. Three sections (lesion center [LC], rostral [RO] and caudal 
[CA]) with a distance of 3 mm between each other were processed for BrdU-
DAB staining and immunohistochemistry. Every seventh section was collected 
for Nissl staining to exactly determine the lesion/injection site. Sections were 
stored in 25% glycerol, 25% ethylene glycol and 50% 0,1 M sodium 
phosphate solution at 4°C. (Fig.3.2.) 
 
3.2.6.1. Nissl Staining 
The Nissl staining is used in particular to display important structural features 
of neurons. This is achieved by various basic dyes (e.g. thionine, or cresyl 
violet) which bind to basophile (negatively charged) compounds like RNA and 
DNA and therefore stain the nucleus and ribosomes blue or violet. Because 
cell organells of nerve tissue exist only in their soma and dendrites of 
neurons, but not in the axon, only the cell bodies will be stained. The cryostat 
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cut sections were put on gelatin-coated coverslips. The coverslips were then 
hydrated in a downward ethanol series starting with a 1:2 chloroform/ethanol 
mixture. The coverlips were incubated in each case for 2 min in 100%, 95%, 
70% and 40% ethanol and then for 5 min in H2Odest. The staining was done by 
incubation the coverslips into a thionine-solution for 30 sec or longer, 
depending on the sections. Afterwards, the coverslips were dipped into 
H2Odest several times before they were incubated for 2 min each time in an 
ascending ethanol series (40%, 70%, 80%, 95%) in order to dehydrate the 
sections again. After incubating the coverslips for about 5 min in NeoClear, 
the sections were mounted wet in NeoMount. 
 
3.2.6.2. Prussian Blue Staining to detect iron 
The cryostat cut sections were put on gelatin-coated coverslips. The 
coverslips were incubated for 15 min in a solution composed of 4% potassium 
ferrocyanide (K4Fe(CN)6) and 4% HCl. After rinsing the sections several times 
in H2Odest, they were counterstained with Nuclear Fast red solution (Linaris, 
Wertheim) for 5 min. After 5x washing with H2Odest, the sections were 
dehydrated through a isopropanol series. After incubating the coverslips for 
about 5 min in NeoClear, the sections were mounted wet in NeoMount. 
 
3.2.7. Immunohistochemistry 
3.2.7.1. DAB Staining 
Diaminobenzidine (DAB) labelings were obtained as followes: Free-floating 
sections were treated with 0.6% H2O2 in Tris-buffered saline (TBS: 0.15 M 
NaCl, 0.1 M Tris–HCl, pH 7.5) for 30 min. For immunohistological detection of 
the incorporated BrdU, pre-treatment of tissues was performed as followed: 
after rinsing in TBS, sections were incubated for 30 min in 0.6% H2O2 ad 
rinsed again in TBS. Afterwards, the sections were incubated for 1h in 50% 
formamide/2xSSC (0.3M NaCl, 0.03M sodium citrate) at 65°C. Sections were 
rinsed in 2xSSC, incubated for 30 min in 2M HCl at 37°C and rinsed for 10 
min on 0.1M boric acid (pH 8.5). Following extensive washes in TBS, sections 
were blocked with a solution composed of TBS, 0.2% fish skin gelatin (Sigma-
Aldrich, Germany), 1% bovine serum albumin (BSA, Biomol, Hamburg, 
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Germany) and 0.1% Triton X-100 (Sigma-Aldrich, Germany – only for 
intracellular antigens) (fish gelatin buffer (FGB)) for 1 h. This buffer was also 
used during the incubation with the antibody rat anti-BrdU (1:500). The 
primary antibody was applied overnight at 4°C. For chromogenic immuno-
detection, sections were washed extensively and further incubated with a 
biotin-conjugated species-specific secondary antibody, donkey anti-rat biotin 
conjugated (1:500; Dianova, Germany), followed by a peroxidase–avidin 
complex solution from the Vectastain Elite ABC kit (Vector Laboratories, 
Burlingame, USA). Sections were developed in TBS containing 0.25mg/ml 3, 
3′-diaminobenzidine (DAB) (Vector Laboratories, Burlingame, USA), 0.01% 
(v/v) H2O2, and 0.04% (w/v) NiCl2. Sections were mounted on gelatin-coated 
slides and coverslipped with Neo-Mount (Merck, Darmstadt, Germany).  
Sections were photographed using a Leica DMR microscope (Leica, Wetzlar, 
Germany) equipped with a Spot™ CCD digital camera model 2.2.1 
(Diagnostic Instrument Inc, Sterling Heights, USA) and epifluorescence 
observation was performed on a confocal scanning laser microscope (Leica 
TCS-NT, Wetzlar, Germany).  
 
3.2.7.2. Immunfluorescence Labeling 
Double/triple labeling immunofluorescence techniques were performed with 
free-floating sections to assess the NPC differentiation pattern in vivo. 
Sections were washed in TBS, then blocked with a solution composed of TBS 
+ 3% donkey serum + 0.1% Triton-X100 (only for intracellular antigens) for 1h, 
and incubated with primary antibodies in the same solution overnight at 4°C 
on a rotating platform. 
The following primary antibodies were used: rat anti-BrdU (1:500) for grafted 
NPC, rabbit anti- GFAP for astroglia (1:1000), mouse anti- Adenomatous 
polyposis coli for oligodendrocytes (APC; 1:500, Calbiochem, Darmstadt, 
Germany). For detection of BrdU-prelabeled nuclei of adult NPC the following 
DNA denaturation steps preceded the incubation with rat anti-BrdU antibody: 
after rinsing in TBS, sections were incubated for 1h in 50% formamide/2xSSC 
(0.3M NaCl, 0.03M sodium citrate) at 65°C. Sections were rinsed in 2xSSC, 
incubated for 30 min in 2M HCl at 37°C and rinsed for 10 min in 0.1M boric 
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acid (pH 8.5). After rinsing in TBS, in rat anti-BrdU in TBS / 3% donkey serum 
/ 0.1% Triton-X100 as described above. The following day, sections were 
rinsed and incubated with fluorophor rhodamine-X (1:1000; Dianova, 
Germany), fluorescein (1:1000; Molecular Probes), or Cy5 (1:1000; Dianova, 
Germany) conjugated donkey secondary antibodies for 2h. After a final rinsing 
step in TBS, sections were mounted onto glass slides and coverslipped with 
Prolong Antifade (Invitrogen GmbH, Karlsruhe, Germany).  
 
3.2.8. Immunhistochemical analysis  
3.2.8.1. Immunhistochemical analysis of DAB stained sections 
Quantitative analysis of BrdU-DAB labeled cells was performed using a 40× 
objective lens of a light microscope (Leica, Wetzlar, Germany). 
For the study in the intact animal, all BrdU-poitive cells were counted within 
the section containing the most cells. Graphs are expressed as the total 
number of cells detected. 
For the endogenous study, the number of BrdU-DAB positive cells was 
counted in three sections from different levels of spinal cord: one in the lesion 
center (LC), one 3 mm rostral (RO) and another one 3 mm caudal (CA) to the 
lesion center. Within each section one field of view was quantified in up to 
seven different regions (for illustration see Fig.3.2.): 1.) central canal (CC), 2.) 
grey matter / white matter transition zone (GM/WM), 3.) corticospinal tract 
(CST), 4.) ascending tract (AT), 5.) grey matter (GM), 6.) lateral column white 
matter (LCWM) and 7.) dorsal root entry zone (DREZ). Graphs are expressed 
as the total number of cells detected in all seven regions and in all 3 sections. 
 
3.2.8.2. Immunhistochemical analysis of immunofluorescence-
labeled sections  
Analysis of immunofluorescence-labeled sections was performed using 
confocal fluorescence microscopy (Leica TCS-NT) equipped with a 40x PL 
APO oil objective (1.25 numeric aperture). Co-localization of BrdU pre-labeled 
NPC with the individual differentiation marker was determined by analyzing 
between 30-35 adjacent optical sections through the z-axis of a 40 µm thick 
coronal sections. Co-localization was confirmed, once the differentiation 
marker was spatially associated with BrdU nuclear labeling through 
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subsequent optical sections in the z-axis. The in vivo differentiation pattern for 
the animals that underwent dorsal column transection, was quantified in one 
section rostral and one caudal to the lesion by analyzing two different regions 
(for illustration see Fig.3.1.): 1. dorsal column white matter (DCWM) and 2. 
dorsal horn grey matter (GM), or directly in the lesion center/graft (LC) for 
each differentiation marker.  
In unlesioned animals, one sagittal section per differentiation marker was 
quantified by analyzing one field of view in three different regions: 1.) directly 
at the injection site in the dorsal column white matter (ISWM), 2.) caudal to 
the injection site in the dorsa column white matter (WM) and 3.) in the grey 
matter (GM) just ventral to the injection site.  
 
Figure 3.1. Schematic representation of the morphological analysis of grafted NPC the 
injured spinal cord 
A 3 mm long piece of the spinal cord was cut into 40 µm thick coronal sections. For 
quantification for each differentiation marker, one section rostral and one caudal to the lesion 
center (LC) was analyzed in two different regions: 1. dorsal column white matter (DCWM) and 
2. dorsal horn grey matter (GM), or directly in the lesion center (LC). Each of the analyzed 
sections had a space of 1120µm from each other. Red arrow indicates the lesion site. 
 
The in vivo differentiation pattern of endogenous spinal cord NPC was 
quantified in three sections from different levels of spinal cord: one in the 
lesion center (LC), one 3 mm rostral (RO) and another one 3 mm caudal (CA) 
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to the lesion center. Each section (LC, RO, CA) was quantified by analyzing 
the differentiation markers in one field of view in four different regions (for 
illustration see Fig. 3.2.; 1.) central canal (CC), 2.) grey matter / dorsal column 
white matter transition zone (GM/WM), 3.) corticospinal tract (CST) and 4.) 
ascending tract (AT).  
The total number of BrdU positive cells within each section was counted and 
correlated to the number of BrdU positive cells co-localizing with the 
respective differentiation marker (GFAP, APC). Because APC immunostaining 
is not restricted to oligodendrocytes, and a subset of astrocytes becomes also 
labeled with APC (McTigue, Wei and Stokes 2001, Bhat et al. 1996), cells 
showing the markers BrdU and APC in absence of a GFAP-signal were 
counted as oligodendroglia, cells expressing BrdU and GFAP in parallel were 
counted as astroglia.  
 
 
Figure 3.2. Schematic representation of the morphological analysis of endogenous 
NPC in the injured spinal cord 
A 9 mm long piece of the spinal cord was cut into 40 µm thick coronal sections. Three 
sections (lesion center [LC], rostral [RO] and caudal [CA]) with a distance of 3 mm between 
each other were quantified. Within each section one field of view was quantified in up to 
seven different regions: 1.) central canal (CC), 2.) grey matter / white matter transition zone 
(GM/WM), 3.) corticospinal tract (CST), 4.) ascending tract (AT), 5.) grey matter (GM), 6.) 
lateral column white matter (LCWM) and 7.) dorsal root entry zone (DREZ). For quantification 
of the BrdU-DAB staining, all seven regions were analyzed, and for the fluorescence staining, 
only the first four regions (CC, GM/WM, CST and AT) were analyzed. Red arrow indicates the 
lesion site. 
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3.2.9. MR scanner 
All MR imaging experiments were conducted on a 3T clinical dedicated head 
MR scanner, Siemens Magnetom Allegra (Siemens Medical Solutions, 
Germany). The Magnetom Allegra system was equipped with four 
independent receiver channels and gradients achieving peak gradient 
amplitudes of 40mT/m per axis and a minimum slew rate of 400 T/m/s. Only 
standard Siemens product sequences were used with modifications of the 
imaging protocols to adapt to small animal imaging. Besides the standard 
hardware of the MR scanner a dedicated four-channel rat spine phased array 
coil (RAPID Biomedical GmbH, Germany) was used. The operating frequency 
of the spine array is 123.2 MHz. It consists of four equivalent rectangular 
surface coil elements with a size of 20 mm x 30 mm each. They are orientated 
along z-direction for best coverage of the spinal cord. The array elements are 
fixed tuned and matched to 50 Ω for loading an average sized rat. An active 
decoupling mechanism switches the array coil off-resonant during RF 
transmission. The body coil of the MR system is used for sample excitation. In 
addition low noise preamplifiers assure the same high signal to noise ratio for 
a wide range of load variations. 
 
3.2.9.1. MR imaging 
Anesthesia was induced by using an inhalation mixture of 5% isoflurane in 30 
% O2 and air mixture and then maintained by using 1.5% of isoflurane. A total 
of eight spinal cord contused rats underwent MR imaging on day one post 
injury (MR imaging on day 1; n=4). Out of these, four animals received follow-
up MR imaging on day 43 post injury (MR imaging on day 1 and 43; n=4). 
Normal spine gray and white matter has been characterized on intact female 
Fischer 344 rats (n=4). The rats were placed in supine position over the 
rectangular surface of the coil housing. No corrections for motion artifacts 
arising out of spontaneous respiration or from blood flow were applied. 2D 
coronal and sagittal images of the spine were acquired using the T2 weighted 
turbo spin echo (TSE) sequences with repetition time (TR) of 2340 ms, echo 
time (TE) of 113 ms, echo train length of 6, image matrix 128 x 128 and field 
of view (FOV) 2.5 cm. The acquired images had an in-plane resolution of 200 
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µm with a section thickness of 400 µm and no gap between sections. The 
total acquisition time with 3 averages and 11 slices in 2 concatenations was 5 
minutes and 35 seconds. T1 weighted spin-echo (SE) were acquired with the 
following sequence parameters; TR of 400 ms, TE of 19 ms, image matrix 64 
x 128, and a FOV of 1.25 cm x 2.5 cm. The acquired images had an in plane 
resolution of 200 µm with a section thickness of 1 mm. The total acquisition 
time with 6 averages and 15 slices in 2 concatenations was 10 minutes and 6 
seconds.  
Proton density (PD)- weighted TSE images were acquired with a TR of 2500 
msec, TE of 16 msec, image matrix 128 x 128, and an FOV of 2.5 x 2.5 cm. 
The images had an in-plane resolution of 200 µm with a section thickness of 1 
mm. The total acquisition time with four averages and 15 slices was 6 minutes 
and 14 seconds. OsiriX software (Version v.2.6fc1 32-bit) was used for image 
processing and 3D rendering. 
 
3.2.10. Statistical analysis 
Statistical analysis was performed using parametric two-tailed t test or for the 
slice culture experiments one-tailed Mann Whitney t test, two–way ANOVA for 
the RT-PCR data and one-way analysis of variances (ANOVA) followed by 
Tukey’s Multiple Comparison test for multiple group comparisons (*, p < .05; 
**, p < .01; *** < .001). Averages are expressed with their standard error of the 
mean (SEM) and or for the slice culture experiments with their standard 
deviations (SD). Statistical analysis were performed using PRISM4 software 
(GrapPad, San Diego, CA, USA). 
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4. Results 
4.1. MSC promote oligodendroglial differentiation in SVZ 
derived NPC in vitro 
A recently published study by our group focusing on the oligodendroglial 
determination and differentiation demonstrated that MSC secrete one or more 
yet unidentified factors, which strongly promote oligodendroglial differentiation 
of hippocampal adult NPC in co-culture conditions in vitro, whereas the 
astrogenic commitment of NPC is inhibited (Rivera et al. 2006). To confirm 
that the MSC derived oligodendrogenic effect is not restricted to hippocampal 
derived NPC and therefore is not region specific, SVZ derived NPC were co-
cultured with MSC for 7 days. SVZ derived NPC grown in α-MEM-10%FBS 
served as control. 
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Figure 4.1. Cocultures of MSC and NPC promote oligodendrogenesis of SVZ derived 
NPC in vitro  
MSC and NPC (derived from GFP-expressing rats) were co-cultured for 7 days. NPC display 
immunoreactivity for (C) the astroglial marker GFAP and (G) the oligodendroglial marker 
GalC. Differentiation markers are shown in red, GFP in green, DAPI nuclear counterstain is 
shown in blue; merged pictures are on the right. Note that expression of the neural markers is 
restricted to NPC-derived cells. (I) Quantitative analysis of the expression of the differentiation 
pattern of adult NPC in control and in co-cultures (NPC + MSC) conditions. The percentage of 
GFP-positive cells expressing GFAP, GalC or Map2ab was determined. Five hundred to 
1,000 GFP-positive cells were analyzed in randomly chosen fields. Experiments were done in 
triplicate. Data represent standard error of the mean (SEM). Non-parametrical one-tailed 
Mann Whitney t test was used for statistical analysis.  ** p < 0.01;  *** p < 0.001.  Scale bar: 
25 µm.  
 
As expected, SVZ derived NPC co-cultured with MSC expressed all three 
mature neural lineages, MAP2ab (neurons), GFAP (astroglia) and GalC 
(oligodendroglia). Consistent with previous experiments, the number of NPC 
expressing GalC was significantly increased in co-cultures with MSC (GalC: 
48.6% ± 5.7) compared to NPC alone (GalC: 7.5% ± 2.7). As a consequence, 
the proportion of GFAP-expressing NPC declined in co-culture conditions 
(39.1% ± 6.3) compared to NPC cultured alone (69.5% ± 5.4) (Fig.4.1.). In 
contrast, the percentage of cell expressing the neuronal marker Map2ab did 
not significantly differ between both culture conditions (co-culture: 2.8% ± 0.8; 
control: 1.9% ± 1.0).  
 
4.2. MSC-CM promotes oligodendroglial differentiation 
of SVZ derived NPC in vitro 
Incubation of NPC with MSC-derived supernatants yielded similar results: a 
significantly higher proportion of GalC and MBP expressing cells compared to 
control cultures (GalC: 39.2 ± 0.5 % versus 3.1 ± 0.6%; MBP: 31 ± 3% versus 
1.7 ± 0.3%), a decrease in the number of GFAP-expressing cells (26.8 ± 2.8% 
versus 41.9 ± 4.8%) and no significant changes in Map2ab expression (0.8 ± 
0.4% versus 1.1 ± 0.5%) (Fig.4.2.). Taken together, oligodendrogenic effects 
of MSC co-cultivation and MSC-CM on SVZ derived NPC is comparable to 
previously described effects on hippocampal NPC. 
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Figure 4.2. MSC soluble factors induce the expression of oligodendrocyte markers in 
SVZ-derived NPC in vitro 
NPC were incubated for 7 days in control medium (α-MEM-10% FBS) and in MSC-CM. 
Quantitative analysis of the expression of neural differentiation markers in control conditions 
and with MSC-CM (NPC + MSC-CM). The percentage of cells expressing GFAP, MBP, GalC 
or Map2ab was determined. Five hundred to 1,000 GFP-positive cells were analyzed in 
randomly chosen fields. Experiments were done in triplicate. Data represent standard error of 
the mean (SEM). Non-parametrical one-tailed Mann Whitney t test was used for statistical 
analysis; ** p < 0.01; *** p < 0.001. Abbreviations: MBP: Myelin basic protein. 
 
 
4.3. Oligodendrogenic effect of MSC-CM and FF-CM on 
NPC cultures derived from different regions 
To test whether this pro-oligodendrogliogenic effect is specific for NPC 
derived from a particular region of the CNS, NPC derived from subventricular 
zone (SVZ), hippocampus (HC) and spinal cord (SC) were cultured in MSC-
CM for one week and subsequently analyzed for the differentiation markers 
GFAP, MBP and Map2ab. NPC grown in α-MEM-10%FBS served as control. 
Furthermore, based on previous findings that fibroblasts promote a rather glial 
differentiation in co-cultured NPC and that the co-grafting of NPC with 
fibroblasts following spinal cord injury not only replaces the cystic lesion 
defect but also leads to an enhanced axonal regeneration (Pfeifer et al. 2004), 
two more groups were added to this experimental approach: NPC cultured 
with conditioned medium derived from fibroblasts (FF-CM) and NPC cultured 
with a mixture of conditioned medium of MSC and fibroblasts (MSC-CM +FF-
CM).  
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Figure 4.3. The origin of the NPC does not influence their differentiation potential in 
vitro 
NPC were incubated for 7 days in MSC-CM, FF-CM and in MSC-CM+FF-CM or in control 
medium (α-MEM-10% FBS). Quantitative analysis of the expression of neural differentiation 
markers under the different culture conditions analyzed. The percentage of cells expressing 
(A) MBP or (B) GFAP was determined. Five hundred to 1,000 GFP-positive cells were 
analyzed in randomly chosen fields. Experiments were done in triplicate. Data represent 
standard error of the mean (SEM). One-Way ANOVA was used for was used for statistical 
analysis.  
 
By comparing the different culture conditions in relation to the distinct origins 
of the NPC, no significant alterations could be detected for any of the tested 
markers under the four culture conditions (MSC-CM, MSC-CM+FF-CM, FF-
CM, α-MEM-10%FBS) (Fig. 4.3.).  
On the other hand, the comparison of the different culture conditions for the 
glial markers GFAP and MBP within the three NPC-groups (SVZ, HC, SC) 
revealed significant differences. Significantly less cells expressed the 
astroglial marker GFAP in SVZ derived NPC incubated with MSC-CM (MSC-
CM: 44.6% ± 7.4; MSC-CM+FF-CM: 20.7% ± 3.3) compared to control 
conditions (80.6% ± 1.8). Moreover, this reduction was even stronger in NPC 
incubated with FF-CM (6.5% ± 0.1). In contrast, the amount of MBP positive 
NPC was significantly increased FF-CM cultures (FF-CM: 74.2% ± 4.0; MSC-
CM+FF-CM: 55.7% ± 3.2) compared to NPC treated with MSC-CM (27.9% ± 
8.6) or α-MEM-10%FBS (2.9% ± 2.5). The proportion of Map2ab (for neurons) 
expressing cells was in all condition very low or not detectable (data not 
shown). 
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Similar results were obtained for NPC derived from the hippocampus. A 
significantly higher proportion of NPC expressed the marker MBP in all 
cultures treated with conditioned media (MSC-CM: 43.6% ± 12.8; FF-CM: 
76.6% ± 0.5; MSC-CM+FF-CM: 55.8% ± 1.3) compared to the control (4.5% ± 
1.4). Whereas significantly fewer NPC were GFAP positive after the 
incubation with FF-CM (FF-CM: 7.8% ± 3.2; MSC-CM+FF-CM: 25.2% ± 5.4) 
compared to MSC-CM (58.1% ± 8.1) and control conditions (80.1% ± 7.2). 
By comparing the expression of GFAP and MBP under different culture 
conditions for SC-derived NPC, the just described results were even more 
prominent. The proportion of MBP positive cells was again significantly 
increased in all culture conditions (MSC-CM: 50.1% ± 0.9; FF-CM: 73.4% ± 
3.4; MSC-CM+FF-CM: 54.5% ± 10.4) compared to the control (2.4% ± 0.9). 
Furthermore, differences between the groups incubated with either MSC-CM 
or FF-CM were also significant. The percentage of GFAP positive NPC was 
significantly decreased in all conditions (MSC-CM: 27.5% ± 2.0; FF-CM: 
10.7% ± 0.9; MSC-CM+FF-CM: 12.8% ± 1.6) compared to control conditions 
(78.0% ± 2.0). Under FF-CM containing conditions the number of GFAP 
positive cells was reduced significantly compared to cells incubated with 
MSC-CM. 
Overall the highest percentage of MBP positive cells, as well as the lowest 
percentage of GFAP positive cells was always found in the group treated with 
FF-CM, independent of the region NPC were derived from (SVZ, HC or SC). 
Furthermore, no additive effect in terms of MBP- or GFAP-expression could 
be detected in cultures incubated with both, MSC-CM and FF-CM.  
In summary, these data show that the incubation of NPC with MSC-CM 
promotes their differentiation into MBP expressing oligodendrocytes in 
expense of astroglial differentiation, independent of the origin of the NPC. 
Moerover, this pro-oligodendrogenic effect is not specific to MSC-CM. FF-CM 
exerts an even stronger pro-oligodendrogenic effect on NPC (Fig.4.3.). 
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4.4. Oligodendrogenic effect of MSC on NPC seeded on 
organotypic hippocampal slice cultures 
Previous studies demonstrated that MSC as well as MSC-derived soluble 
factors induce oligodendrogenesis in expense of astrogenesis and promote 
oligodendroglial differentiation/maturation in adult rat HC-derived NPC in vitro 
(Rivera et al. 2006, Rivera et al. 2008). As mentioned above, the same results 
were observed for adult rat NPC derived from the SVZ and the SC. To see if 
this pro-oligodendrogenic activity is maintained after co-seeding of NPC with 
MSC into a CNS-organotypic environment, hippocampal slice cultures were 
used as a target tissue. Organotypic hippocampal slice cultures have the 
advantage that they are easy to obtain and retain the three-dimensional cyto-
architecture of the tissue of origin. They therefore preserve most of the 
synaptic and anatomical organization of the neuronal circuitry and show 
functional characteristics similar to those found in vivo (Gahwiler et al. 1997, 
Costa et al. 2008, Miyata et al. 2001, Laskowski et al. 2005, Stoppini et al. 
1991).  
 
4.5. Limited survival of NPC pre-differentiated towards 
oligodendroglia after seeding onto hippocampal slice 
cultures 
The first question was whether adult NPC pre-differentiated towards an 
oligodendroglial lineage by MSC-CM could survive, integrate and generate 
oligodendrocytes after seeding onto hippocampal slice cultures. In order to 
identify NPC, cells were incubated with BrdU prior to seeding (Rivera et al. 
2006). Pre-labeled NPC were incubated with MSC-CM for two days prior to 
seeding on hippocampal slices (Fig. 4.4.A). However, 7 days after seeding, no 
BrdU-labeled pre-differentiated NPC could be detected, suggesting that pre-
differentiation dramatically reduced the survival of seeded pre-differentiated 
NPC.  
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Figure 4.4. Schematic representation of the seeding paradigm 
(A) Seeding of pre-differentiated NPC. NPC were labeled as neurospheres with BrdU under 
proliferative conditions for 48 hours. Then, these cells were plated on dishes and incubated 
with MSC-derived conditioned medium (MSC-CM) for 48 hours. After this period, BrdU-
labeled NPC were seeded (TX) onto a hippocampal slice. (B) Co-seeding of MSC and NPC. 
BrdU-labeled NPC were mixed 1:1 with MSC or with eGFP-expressing MSC (MIX) and 
seeded onto a hippocampal slice. As a control, BrdU-labeled NPC were seeded alone (NPC). 
After 7 days, slices were analyzed for cell survival and differentiation.  
 
4.6. Good survival of NPC after seeding onto 
hippocampal slices 
In the next step, NPC were seeded together with MSC or alone onto 
hippocampal slice cultures. For this approach, the NPC were again pre-
labeled with BrdU and mixed with the MSC immediately prior to the seeding 
procedure (Fig.4.4.B). After one week, slices were examined for the survival 
and differentiation of grafted NPC. Quantitative analysis of BrdU-labeled cells 
revealed that more than 40% of the seeded NPC survived either seeded 
alone or in combination with MSC (Fig.4.5.). 
 
Figure 4.5. Survival of NPC and MSC seeded on hippocampal slice cultures 
GFP-expressing MSC were co-seeded with NPC and incubated for 7 days. Quantitative 
analysis of survival of BrdU-labeled NPC expressed as the number of transplanted cells 
detected with respect to the total number of seeded cells. NPC were co-seeded with MSC (+ 
MSC) or alone (control). Data represent means ± SD (standard deviation). Non-parametrical 
one-tailed Mann Whitney t test was used for statistical analysis (Rivera et al. 2009). 
Results 
  77 
 
4.7. MSC promote oligodendroglial differentiation of co-
seeded NPC on hippocampal slices 
Cell fate determination of grafted NPC by confocal analysis indicated that 
most of the NPC co-seeded with MSC differentiated towards an 
oligodendroglial lineage, indicated by the oligodendroglia markers MBP and 
GST-π. In contrast, NPC seeded alone preferentially differentiated into GFAP 
positive astrocytes. In both groups, DCX expression could not be detected in 
the NPC grafts, indicating the absence of neuronal differentiation (Fig.4.6.).  
Taken together, these date demonstrate that the pro-oligodendrogenic effect 
of MSC is maintained after co-seeding with NPC onto hippocampal slice 
cultures, confirming the previous in vitro results. Thus, co-transplantation of 
MSC with NPC might represent a promising strategy to replace lost 
oligodendroglia and to enhance remyelination after spinal cord injury. 
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Figure 4.6. MSC promote oligodendroglial differentiation of NPC seeded on 
hippocampal slices  
Seven days after cell seeding onto hippocampal slice cultures, the differentiation pattern of 
the grafted NPC was assessed, by co-localizing BrdU as a marker for seeded NPC (shown in 
red) with glial markers (shown in green). (A-I) Confocal images of grafted NPC alone (A, D, G, 
H) or together with MSC (B, C, E, F, I). NPC display immunoreactivity for MBP (green, A-C) 
and GST- π (green, D-F) for oligodendrocytes and GFAP (green, G-I) for astrocytes. Middle 
column (B, E, H) shows a higher magnification image including the Z-axis (C, F and G, 
respectively). Scale bar: 50 µm. (J-L) Quantitative analysis of the expression of neural 
differentiation markers of the seeded NPC, graphs show the percentage of MBP- (J), GST-π- 
(K) and GFAP- (L) expressing cells. MSC enhance the percentage of MBP- and GST-π- 
expressing cells (oligodendrocytes) at the expense of GFAP-expressing astroglial cells. 
Experiments were done in triplicate. Data represent means ± SD. Non-parametrical one-tailed 
Mann Whitney t test was used for statistical analysis; * p < 0.05 (Rivera et al. 2009). 
 
4.8 . Pre-differentiated NPC co-grafted with MSC 
promote oligodendroglial differentiation in the intact 
spinal cord 
In the first set of experiments, NPC were grafted into the intact spinal cord. In 
order to detect the NPC after the transplantation, cells were pre-labeled with 
BrdU. NPC co-cultured with MSC for 3 days (prediff-NPC/MSC) were 
compared with NPC and MSC mixed just prior to transplantation (see above; 
NPC/MSC) into the intact dorsal column at cervical level C3. Pure NPC 
grafts (NPC) served as control. 10 days post-injection many BrdU-positive 
NPC were identified at and around the injection site in the dorsal column of 
the cervical spinal cord. Interestingly, NPC within NPC/MSC grafts were much 
more confined to the injection site, whereas NPC as pure grafts migrated 
widely distributed along the rostro-caudal axis of the spinal cord (Fig.4.7.A-C).  
The absolute number of BrdU-prelabeled grafted NPC varied significantly 
within the different groups. NPC/MSC grafts yielded 2768 ± 241.9 surviving 
NPC, whereas their number was reduced to 1407 ± 253 and 210 ± 37 NPC in 
the NPC and prediff-NPC/MSC group, respectively (Fig.4.7.D). 
The fate of grafted NPC was investigated by confocal analysis of the 
oligodendroglia marker APC and the astroglial marker GFAP. The percentage 
of BrdU-positive cells expressing APC (GFAP negative) or GFAP is shown as 
total of the three analyzed regions, ISWM, WM and GM. Indeed, in the prediff-
NPC/MSC group significantly more BrdU-positive cells expressed APC 
(18.4% ± 2.4) as a marker for oligodendroglial differentiation compared to the 
NPC and the NPC/MSC group (3.0% ± 1.5 and 5.6% ± 1.6, respectively). 
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GFAP expression was reduced in the prediff-NPC/MSC group (16.5% ± 0.8) 
compared to NPC and the NPC/MSC grafts (48.8% ± 3.0 and 39.7% ± 4.2, 
respectively) (Fig.4.7.E, F).  
 
 
 
Figure 4.7. MSC promote an oligodendroglial fate of co-grafted pre-differentiated NPC 
in the intact spinal cord  
NPC survival and differentiation was analyzed 10 days following transplantation into the intact 
spinal cord. (A-C) Brightfield images of sagittal BrdU-DAB stained sections; dorsal top; scale 
bar: 100µm. Immunodetection of BrdU prelabeled NPC reveals only few cells in prediff-
NPC/MSC-gafts (A). Most of the BrdU-positive NPC were detected around the injection site in 
the dorsal column of the cervical spinal cord in NPC/MSC co-grafts (B). NPC were widely 
distributed along the rostro-caudal axis of the spinal cord in NPC only grafts (C). (D) 
Quantitative analysis of survival of BrdU-labeled NPC is expressed as the total number of 
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cells detected within the section containing the most cells. Significantly more NPC survived  
after co-grafting with MSC. (E, F) Quantitative analysis of the expression of neural 
differentiation markers of the grafted NPC was assessed by co-localizing BrdU as a marker 
for grafted NPC with glial the markers GFAP (astrocytes) and APC (oligodendrocytes). 
Graphs show the percentage of APC- (E) and GFAP- (F) expressing cells. Averages are 
expressed with their standard error of the mean (SEM). Parametric one-way ANOVA was 
used for statistical analysis; *** p < 0.001. 
 
4.9. MSC co-grafted with NPC fill the lesion site 
The next experiments were done to investigate whether the pro-
oligodendrogenic effect of the MSC seen in vitro is also present after co-
transplantation of NPC with MSC into the injured spinal cord. Because the 
survival of pre-differentiated NPC was very limited after co-grafting with MSC 
into the intact spinal cord, NPC were not pre-differentiated for grafting into the 
injured spinal cord. 
Previous studies have shown that fibroblasts sustain co-grafted NPC within 
the lesion center and allow complete tissue replacement (Vroemen et al. 
2003, Pfeifer et al. 2004, Pfeifer et al. 2006). In the present study co-grafts of 
MSC and NPC (NPC/MSC) were grafted into the lesion site as mixed cell 
suspensions immediately after a C3 dorsal column transection. Animals 
receiving lesions only (LESION), pure NPC grafts (NPC), pure MSC grafts 
(MSC) or NPC/fibroblast co-grafts (NPC/FF) served as controls. Six weeks 
postoperatively, MSC containing grafts (NPC/MSC  and MSC) replaced the 
cystic lesion defect identical to NPC/FF co-grafts, whereas NPC grafts failed 
to fill the spinal cord lesion defect, typically displaying a triangular or round 
cystic lesion cavity following a cervical wire knife dorsal column transection 
(Fig.4.8.A-E). 
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Figure 4.8. Cystic lesion replacement 
(A) Six weeks following a cervical wire knife dorsal column transection a typical triangular 
shaped cystic lesion defect develops in animals with spinal cord lesion alone (B) or in 
combination with NPC grafts. (C) NPC/FF co-grafts, (D) MSC grafts as well as (E) NPC/MSC 
co-grafts replace the lesion defect completely. A-E: coronal Nissl stained sections, dorsal top; 
scale bar: 500µm. 
 
4.10. MSC fail to promote oligodendroglial 
differentiation of co-grafted NPC in the injured spinal 
cord 
The glial differentiation of NPC containing grafts (NPC, NPC/MSC, NPC/FF) 
was assessed six weeks postoperatively by co-localizing BrdU pre-labeled 
NPC with the astroglial marker GFAP and oligodendroglial marker APC (cells) 
in two different regions - dorsal column white matter (DCWM) and dorsal horn 
gray matter (GM) (Fig.3.1., Fig.4.9.A-H). Surprisingly, co-grafting with 
fibroblasts (NPC/FF), but not with MSC, significantly increased the number of 
grafted NPC expressing APC (GFAP negative) in the DCWM and GM 
(DCWM: NPC/FF: 27.1% ± 2.6; NPC/MSC: 14.7% ± 1.9; NPC: 13.6% ± 3.4; 
GM: NPC/FF: 49.7% ± 13.4; NPC/MSC: 13.9 ± 2.8; NPC: 12.7% ± 4.4) 
(Fig.4.9.I,J). There was no statistically significant differences in the number of 
of GFAP/BrdU double-labeled cells between all groups (Fig.4.9.I,J). 
The differentiation of NPC at the lesion center can only be assessed in MSC 
or fibroblast containing co-grafts (NPC/MSC, NPC/FF), which replace the 
cystic lesion defect. We observed a trend towards enhanced oligodendroglial 
Results 
  82 
and astroglial differentiation within NPC/FF grafts compared to NPC/MSC 
grafts, which was not statistically significant (oligodendrocytes:  NPC/FF: 
33.5% ± 9.9; NPC/MSC: 20.7% ± 3.0; astrocytes: NPC/FF 60.3% ± 13.5; 
NPC/MSC: 35.1% ± 9.8) (Fig.4.9.K).  
 
 
 
Figure 4.9. Analysis of cell differentiation in NPC co-grafted with MSC or fibroblasts 
into the injured spinal cord 
(A-D) BrdU-prelabeled NPC co-localized with GFAP as an example of astroglial 
differentiation. (E-H) BrdU-positive NPC co-localized with APC (GFAP negative) as an 
example for oligodendroglial differentiation. (D, H) Respective merged micrographs; scale 
bar: 10µm. (I-K) Quantification of BrdU-prelabeled NPC co-localized with the glial markers 
GFAP or APC, in the dorsal column white matter (I), dorsal horn grey matter (J) and the lesion 
center (K). Fibroblasts enhance the percentage of APC-expressing cells in all regions 
analyzed. Averages are expressed with their standard error of the mean (SEM). Parametric 
one-way ANOVA was used for statistical analysis; * p < 0.05; ** p < 0.01. 
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4.11. Transplantation of MSC does not alter the 
proliferation of endogenous cells after spinal cord injury  
Two different experiments were performed to investigate the proliferation and 
survival of newborn cells derived from endogenous NPC after spinal cord 
injury (Fig.4.10.). In order to examine the proliferation rate of endogenous 
NPC, animals received BrdU injections intraperitoneally once a day on 4 
consecutive days, starting right after the animals received a cervical dorsal 
column transection followed by immediate cell transplantation of either GFP-
positive MSC (MSC) or GFP-positive fibroblasts (FF). Three days 
postoperatively (early time-point), the amount of BrdU positive cells was 
assed in 3 different sections (lesion center [LC], rostral [RO] and caudal [CA]) 
(for illustration see Fig.3.2). 
 
 
 
Figure 4.10. Schematic representation of the experimental design 
All animals received a cervical wire knife dorsal column transection. Early time-point: Animals 
received BrdU injections intraperitoneally once a day on 4 consecutive days, starting right 
after the surgery. Perfusion of the rats was performed on post-op day 3. Late time-point: Rats 
received BrdU injections once a day for 8 consecutive days, starting on post-op day 3. 
Animals were perfused 4 weeks postoperatively. 
 
Quantitative analysis of the BrdU-positive cells revealed that the 
transplantation of MSC seems to reduce the number of proliferating cells 3 
days post-injury, even though the MSC did not alter the proliferation of the 
endogenous cells significantly compared to control animals. However, 
significantly more BrdU-labeled cells were found in the group receiving 
fibroblast grafts compared to the MSC group (Fig.4.11.A, C, E and G). 
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Figure 4.11. MSC do not alter the proliferation or survival of endogenous cells after 
spinal cord injury 
Endogenous NPC proliferation and survival was analyzed 3 days, and 4 weeks 
postoperatively. (A-F) Brightfield images of coronal BrdU-DAB stained sections; dorsal top; 
scale bar: 100µm. Immunodetection of BrdU pre-labeled cells reveals more cells in the FF-
group at the early time-point (B). At the late time-point, only few BrdU positive cells could be 
detected in the FF-group (E). Survival in the LESION (D) and MSC (F) group. (G, H) 
Quantitative analysis of BrdU-positive cells. The amount of BrdU positive cells is expressed 
as total of the three analyzed sections (lesion center [LC], rostral [RO] and caudal [CA]), 
whereas 4 regions each were analyzed in the rostral and caudal section. (G) The proliferation 
rate of the endogenous NPC was significantly reduced after grafting of MSC. (H) The survival 
of endogenous cells was significantly diminished after MSC-transplantation in comparison to 
the FF and LESION group. Averages are expressed with their standard error of the mean 
(SEM). Parametric one-way ANOVA was used for statistical analysis; * p < 0.05; ** p < 0.01. 
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In order to investigate the survival of the newborn endogenous NPC, animals 
received intraperitoneal BrdU injections once a day starting at day 3 until day 
10 after the lesion/transplantation. The animals received MSC (MSC) or 
fibroblast (FF) grafts, whereas animals receiving only a lesion served as 
control (LESION). Four weeks postoperatively (late time-point), the 
number of BrdU positive cells was analyzed. Just like at the early time-point, 
the survival of the group which received MSC grafts was not altered 
compared to the control group. However, the survival of endogenous cells 
was significantly reduced in the FF-group compared to the two other groups. 
This effect was seen in all sections analyzed as well as in the total of the three 
sections. (Fig.4.11.B, D, F and H). 
In summary these data suggest that transplantation of MSC does not alter the 
proliferation or survival of newborn cells directly after spinal cord injury 
compared to non-transplanted animals, while the transplantation of fibroblasts 
enhances the proliferation and decreases the survival of those cells. 
 
4.12. MSC enhance endogenous oligodendroglial 
differentiation already within 3 days after SCI 
Next, the glial differentiation of the newly generated endogenous NPC in the 
injured spinal cord was investigated with laser confocal microscopy. For this 
purpose, BrdU positive cells  were co-localized with the glial markers APC (for 
oligodendroglia) and GFAP (for astroglia). The percentage of BrdU positive 
oligodendrocytes or astrocytes is shown as total of all analyzed 
regions/sections. 
The expression of the oligodendroglial marker APC (GFAP negative) was 
already significantly increased three days postoperatively (early time-point) 
in the group receiving MSC-grafts (5.2 ± 0.9) compared to the FF-group (0.9 ± 
0.2) or the control group (1.2 ± 0.2). Regarding the astroglial differentiation, a 
significant reduction of cells expressing GFAP in the MSC-group (51.6 ± 1.2) 
compared to the FF-group (59.9 ± 2.1) was found, whereas no alterations 
could be detected compared to the control group (56.7 ± 0.6) (Fig.4.11.A, B). 
Results 
  86 
 
4.13. MSC grafts shift the differentiation pattern of 
endogenous NPC towards oligodendroglia four weeks 
after SCI 
An enhanced oligodendroglial differentiation of the endogenous NPC could 
also be detected four weeks postoperatively (late time-point) in the group 
receiving MSC-grafts (7.1 ± 0.5) compared to the two other groups (FF: 0.8 ± 
0.2; LESION: 1.5 ± 0.2). Moreover, significantly fewer cells expressed the 
astroglial GFAP in the MSC group (47.3 ± 1.0) compared to group receiving 
fibroblasts (58.1 ± 1.0) or to the control group (56.7 ± 1.1) (Fig.4.11.C, D). 
These data indicate that MSC grafts enhance the oligodendroglial 
differentiation of endogenous NPC in expense of the astroglial differentiation 
after spinal cord injury (at the early and late time-point), recapitulating in vitro 
findings in cell culture (Rivera et al. 2006) as well as in hippocampal slice 
cultures (Rivera et al. 2009). However, fibroblast grafts failed to recapitulate 
the pro-oligodendrogenic effect observed in vitro and after co-transplantation 
with NPC into the injured spinal cord.  
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Figure 4.12. Oligodendrogenic effect of MSC on endogenous NPC 
Quantitative analysis of the expression of neural differentiation markers of the enodenous 
NPC was assessed by co-localizing BrdU as a marker of newborn cells with the glial markers 
APC (oligodendrocytes) and GFAP (astrocytes), three days and four weeks after cell grafting. 
Graphs show the percentage of APC- (A, C) and GFAP- (B, D) expressing cells. MSC 
significantly enhance the percentage of APC-expressing cells (oligodendrocytes). Averages 
are expressed with their standard error of the mean (SEM). Parametric one-way ANOVA was 
used for statistical analysis; * p < 0.05; ** p < 0.01. 
 
As shown above, MSC did not promote oligodendroglial differentiation in NPC 
after co-grafting into the injured spinal cord. We hypothesized that this could 
be caused by factor released in the acute spinal cord injury , which might 
counteract MSC derived soluble factors.  
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4.14. BMP2/4 block the effect of MSC-CM on cultured 
NPC 
BMP2 and BMP4, which are highly up-regulated following spinal cord injury, 
are known as potent promotors of astroglial differentiation at the expense of 
oligodendroglial differentiation (Bonaguidi et al. 2005, Gross et al. 1996, 
Nakashima et al. 2001, Samanta and Kessler 2004). To test whether pro-
oligodendrogenic effects of MSC-derived soluble factors could be inhibited by 
BMPs, NPC were cultured with MSC-CM alone or with MSC-CM + BMP-2/4. 
Additional controls were incubated with α-MEM-10% FBS + BMP-2/4 or α-
MEM-10% FBS (Fig.4.13.A).  
As suspected BMP 2/4 block the MSC-CM oligodendrogenic effect. The 
percentage of MBP expressing cells was drastically reduced when BMP2/4 
were added to MSC-CM (MSC-CM+BMP 2/4: 9.0% ± 3.4). Consistent with 
previous findings, MSC-CM alone promoted MBP expression in NPC cultures 
(56.6% ± 9.5; control conditions with α-MEM-10% FBS only: 6.1% ± 2.3). 
Conversely, the percentage of GFAP-expressing astrocytes was significantly 
increased after adding BMP2/4 to MSC-CM treated NPC cultures compared 
to cells treated only with MSC-CM (MSC-CM + BMP 2/4: 83.8% ± 5.4; MSC-
CM: 20.8% ± 6.5; control condition: 81.9% ± 2.4). The quantification of 
Map2ab-expressing cells indicating neuronal differentiation was very low 
without significant differences between all conditions (data not shown). 
To identify the molecular mechanism underlying the effects of BMPs to 
override MSC-derived oligodendrogenic effects, the expression of 
determinants known to participate in the oligodendrocyte/astrocyte fate 
decision of NPC was analyzed. The expression of the oligodendrogenic 
transcriptional factors Olig1 and Olig2 (Olig1/2) and the inhibitor of 
differentiation 2 (Id2), which has an anti-oligodendrogenic activity, was 
determined. It has been shown that Id2 can sequester Olig1/2 in the 
cytoplasm preventing their entry into the nucleus and DNA binding, therefore 
inhibiting the oligodendrogenesis and enhancing astrogenesis (Samanta and 
Kessler 2004) Moreover, the balance of Olig1/2 and Id2 determines 
oligodendrocyte/astrocyte fate decision.  
NPC were incubated up to 7 days with MSC-CM in the presence or absence 
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of BMP2/4. The expression level of Olig1, Olig2 and Id2 and Olig1/Id2 and 
Olig2/Id2 ratios were analyzed after 0, 3 and 7 days of incubation by 
quantitative RT-PCR. The Olig1/Id2 and Olig2/Id2 ratios were determined for 
the different conditions. Results showed that there is a significant change in 
both, Olig1/Id2 and the Olig2/Id2, ratios over time (p < 0.001, two-way-
ANOVA). MSC-CM increased Olig1/Id2 and Olig2/Id2 ratios in NPC after 7 
days (p < 0.001) of incubation. BMP 2/4 blocked this effect (p < 0.001) 
decreasing both ratios toward control condition levels (Fig.4.13.B+C). In 
summary, BMPs strongly inhibit the MSC derived oligodendrogenic activity by 
a mechanism that involves the balance of olig1/2 and Id2. 
 
Figure 4.13. Anti-oligodendrogenic effect of BMP2/4 on cultured NPC 
(A) NPC were incubated for 7 days in MSC-CM, MSC-CM+BMP2/4, α-MEM-10% 
FBS+BMP2/4 or in control medium (α-MEM-10% FBS). Quantitative analysis of the 
expression of neural differentiation markers (GFAP for astroglia; MBP for oligodendroglia). 
MSC-CM significantly enhanced the oligodendroglial differentiation, whereas the addition of 
BMP2/4 blocked this effect. Five hundred to 1,000 GFP-positive cells were analyzed in 
randomly chosen fields. Experiments were done in triplicate. Data represent standard error of 
the mean (SEM). Parametric one-way ANOVA was used for statistical analysis; *** p < 0.001. 
(B, C) NPC were incubated in MSC-CM, MSC-CM+BMP2/4, α-MEM-10% FBS+BMP2/4 or in 
control medium (α-MEM-10% FBS) for 0, 3 and 7 days. mRNA was prepared and quantitative 
RT-PCR was performed. Experiments were done in triplicate. Relative RNA concentrations 
with respect to a standard dilution curve versus time for Olig1, Olig2 and Id2 was calculated. 
Data express the Olig1/Id2 and Olig2/Id2 ratio over time. MSC-CM significantly enhanced the 
both ratios in NPC over time. Averages are expressed with their standard error of the mean 
(SEM). Two-way ANOVA was used for statistical analysis; *** p < 0.001.  
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4.15. Magnetic resonance (MR) imaging to analyze 
spinal cord injury in small animals non-invasively 
Magnetic resonance imaging (MRI) represents the only noninvasive method 
to study the pathomorphologic changes in the injured human spinal cord 
parenchyma (Hadley and Teasdale 1988, Manelfe 1991). MRI is able to 
identify pathologic changes after spinal cord injury such as hemorrhage, 
edema, and secondary degenerative changes including cystic degeneration 
and fibroglial scar formation. In addition, MRI can be used to locate grafted 
cells, which have been labeled with special markers (e.g. iron oxide 
nanoparticles or gadolinium based probes). Various studies used dedicated 
experimental imaging systems with high-field strength to study morphological 
changes after spinal cord injury (Bilgen et al. 2000, Fraidakis et al. 1998, Ohta 
et al. 1999, Weber et al. 2006, Metz et al. 2000). However, the availability of 
high-field animal-dedicated systems is restricted. Unlike experimental imaging 
systems, clinical systems give access to a larger number of pulse sequences 
and allow directly comparing results between humans and rodents, since 
signal changes observed with experimental high-field MRI systems do not 
directly translate into findings obtained with clinical routine systems in 
humans. Overall, clinical systems are equipped with a more user-friendly 
interface, which helps to reduce setup time.  
Therefore, the purpose of this study was to investigate the capacity of a 
broadly available routine clinical 3T MRI system equipped with a commercially 
available dedicated phased array spine surface coil to detect 
pathomorphological changes occurring in the adult rat spinal cord following 
contusion injury at the thoracic level or mechanical dorsal column transections 
at the cervical level. 
 
4.16. MRI of the intact rat spinal cord  
T1-weighted SE (spin-echo), T2-weighted TSE (turbo spin echo), and PD- 
(proton density) weighted TSE imaging with the 3T clinical MR scanner 
equipped with a dedicated four-channel rat spine phased array coil setup 
generated good-quality images of the uninjured spinal cord in vivo (Fig.4.14.) 
with an acquisition time between 6 and 10 minutes. The cerebrospinal fluid 
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appeared as a small hyperintense rim surrounding the spinal cord in T2-
weighted TSE images (Fig.4.14.C). Only PD-weighted axial scans allowed a 
clear gray/white matter differentiation with the typical butterfly-shaped gray 
matter in axial scans (Fig.4.14.D).  
 
 
Figure 4.14. 3T MRI of the intact rat thoracic spinal cord in vivo  
Shown is the intact thoracic rat spinal cord in T2- (A) and PD-weighted (B) sagittal scans. T2- 
(C) and PD-weighted (D) axial scans. In-plane resolution 200 x 200 µm. Scale bars: (A) 2.5 
mm, (B) 3.2 mm, (C) 0.42 mm, and (D) 0.44 mm (Sandner et al. 2009). 
 
 
4.17. MRI of the contused rat spinal cord  
One day after spinal cord contusion injury, a total of eight injured rats 
underwent MRI. From these, four animals were perfused one day later. 
Another four animals were subjected to MRI again 43 days post injury. At day 
one post-injury, typical sequels of spinal cord trauma such as hemorrhage, 
tissue loss and beginning cyst formation in the center of the lesion could be 
detected consistently (Fig.4.15.A-C). 
Most of the hemorrhage was confined to the gray matter. These findings were 
confirmed by correlating MR scans with corresponding Nissl stained sections 
(Fig. 4.15.D-F). At this early time point, hemorrhage-derived iron is not yet 
oxidized, which explains why the Prussian blue staining was consistently 
negative. 
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Figure 4.15. Axial images of the injured rat spinal cord in vivo one day post injury 
(A-C) Axial T2 weighted MR images from the lesion center acquired on day one post injury. 
In-plane resolution 200 x 200 µm. (D-F) Corresponding Nissl stained coronal sections. 
Hypointense areas (arrowheads in A-C) in MR scans correspond to red appearing regions in 
Nissl stained sections (arrowheads in D, F) indicating trauma induced hemorrhage mostly 
confined to the spinal cord gray matter. In contrast, hyperintense signal changes (arrow in C) 
represent areas of cell debris, necrosis and cystic demarcation (arrow in F). Edema is 
represented by the faint hyperintense signal change surrounding the gray matter (A), which 
corresponds to the less intense Nissl-stained area of the spinal cord white matter (D) Scale 
bar (A-C) 0.86 mm, (D-F) 0.5 mm (Sandner et al. 2009). 
 
 
 
At day 43 post injury, Prussian blue staining (Fig.4.16.B, 17C) specifically 
identified iron containing hemosiderin deposits, which could also be correlated 
with MR imaging, both in axial (Fig.4.16.A) and sagittal scans (Fig.4.17.A, B).  
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Figure 4.16. Axial images of the injured rat spinal cord in vivo 43 days post injury  
(A) Axial T2 weighted MR image from the lesion center acquired on day 43 post injury. TSE, 
TR 2340 ms, TE 113 ms, section thickness 400 µm, FOV 2.5 cm, in-plane resolution 200 x 
200 µm. (B) Corresponding Prussian blue stained coronal section. Areas with hyperintense 
signal changes (arrowheads in A) representing cystic degeneration (arrowheads in B) 
become more pronounced at the later time point investigated. The hypointense region 
(asterisk in a) corresponds to the Prussian blue positive location in the respective histological 
section (asterisk in B) indicating a previous hemorrhage. Scale bar (A) 0.78 mm, (B) 0.5 mm 
(Sandner et al. 2009). 
 
Furthermore, due to the clearance of cell debris at the lesion site over time 
and consecutive cyst formation, areas with hyperintense signal changes were 
more pronounced and became more extensive corresponding to histological 
findings. At the late time point (day 43), spinal cord atrophy was detectable in 
axial and sagittal MR scans (Fig.16A, 20B).  
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Figure 4.17. 3T MRI of the injured rat spinal cord in vivo 43 days post injury  
(A, B) Sagittal T2 weighted MR images from the lesion center acquired on day 43 post injury 
from the same animal. TSE, TR 2340 ms, TE 113 ms, section thickness 400 µm, FOV 2.5 cm, 
in-plane resolution 200 x 200 µm. (C) Corresponding Prussian blue stained sagittal section. 
As seen in axial scans, hypointense signal changes representing hemorrhage (arrowheads in 
A, B) can be correlated with Prussian blue positive regions in sagittal sections (arrowheads in 
C). Regions of hyerintensity both within and around the spinal cord appear to enlarge over 
time, indicating the cystic degeneration at the injury site and the resulting spinal cord atrophy 
respectively. Scale bar (A) 1.77 mm, (B) 1.4 mm, (C) 1.0 mm (Sandner et al. 2009). 
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4.18. MRI of the rat spinal cord after cervical dorsal 
column transection 
Representative T2- and PD-TSE images in both coronal and sagittal planes of 
cervical lesion 30 days post-injury and their histology are provided (Fig.4.18.). 
T2-TSE images clearly characterize cyst formation as confirmed by histological 
sections (Fig.4.18.A, C, E) whereas PD-TSE images portrayed injury along 
with a clear delineation of the gray-white matter structure confirmed by Nissl 
stained histology section (Fig.4.18.B, D, F). 
 
 
Figure 4.18. Tungsten wire knife induced cervical spinal lesion at 30-days post-injury 
(A, C) Sagittal and axial T2-TSE images. Arrows indicate fluid filled cyst as confirmed by (E, 
F) Prussian blue and Nissl stained histological sections. (B, D) Arrows highlight the detectable 
gray matter in sagittal and axial PD-TSE sections. Scale bar (C,D) 0.47; (E,F) 0.5mm. 
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5. Discussion 
 
The results of the present study demonstrate, that mesenchymal stem cells 
(MSC) promote the differentiation and maturation of adult rat neural progenitor 
cells (NPC) towards an oligodendroglial fate (Rivera et al. 2006, Rivera et al. 
2008). Co-transplantation of MSC together with NPC onto hippocampal slice 
cultures promoted oligodendrogenesis of the transplanted NPC. Moreover, 
co-transplantation of NPC, which have been pre-differentiated in vitro, 
together with MSC into the intact spinal cord also revealed an increased 
oligodendroglial differentiation of the grafted NPC. Similar results were 
obtained after transplantation of MSC into the injured spinal cord. MSC 
enhanced the differentiation of endogenous NPC towards an oligodendroglial 
fate at the expense of astroglial differentiation. The differentiation towards an 
oligodendroglial phenotype was not enhanced after NPC/MSC co-grafting into 
the injured spinal cord. As a likely underlying mechanism, BMP2 and BMP4, 
which are up-regulated after spinal cord injury, block the oligodendrogenic 
effect of MSC. 
  
5.1. Determinants of graft differentiation in the injured 
spinal cord  
Apparently an injury-induced differential expression of molecular factors yields 
different neural phenotypes. It is already known that the host environment 
rather than the intrinsic properties of the transplanted NPC determine the 
differentiation of grafted NPC (Shihabuddin et al. 2000, Gage et al. 1995a, 
Suhonen et al. 1996). For example, adult spinal cord derived NPC 
transplanted into the spinal cord differentiate exclusively into glial cells (Cao et 
al. 2002b, Cao et al. 2001, Enzmann et al. 2005, Pfeifer et al. 2004, 
Shihabuddin et al. 2000, Vroemen et al. 2003). In contrast, transplantation of 
the same type of NPC into a neurogenic region such as the hippocampus, 
induces predominantly neuronal differentiation (Shihabuddin et al. 2000). The 
question rises, which factor(s) might be responsible for the injury-associated 
determination of cell differentiation.  
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Potential candidates are bone-morphogenetic-proteins (BMPs) - in particular 
BMP2 and BMP4, which are strong promotors of astroglial differentiation at 
the expense of oligodendroglial and neuronal differentiation (Bonaguidi et al. 
2005, Gross et al. 1996, Nakashima et al. 2001, Samanta and Kessler 2004). 
Moreover, BMPs are up-regulated in oligodendrocytes and astrocytes around 
the injury site (Matsuura et al. 2008) and have shown to promote glial scar 
formation (Setoguchi et al. 2004, Setoguchi et al. 2001, Fuller et al. 2007). 
Furthermore, in vitro experiments demonstrated that BMP2 and BMP4 inhibit 
the oligodendroglial and neuronal differentiation in cultured NPC and promote 
their astroglial differentiation (Bonaguidi et al. 2005, Gross et al. 1996, 
Nakashima et al. 2001, Samanta and Kessler 2004).  
Strikingly, BMP2 and BMP4 block the MSC-CM derived effect. By adding 
BMP2/4 to the MSC conditioned media or to the control media, almost 90% of 
the cells differentiated into astrocytes and just about 2-8% obtained an 
oligodendroglial fate. Therefore, BMP2/4 are likely candidates to prevent MSC 
derived oligodendrogenic effect in the injury environment.  
On the transcriptional level, BMPs are known to up-regulate the transcriptional 
regulator Id2, resulting in the inhibition of the pro-oligodendrogenic 
transcription factors Olig1 and Olig2 (Samanta and Kessler, 2004), which are 
required to induce oligodendroglial differentiation. Since Id2 and Id4 must 
reach a critical level in the cytoplasm to inhibit oligodendrogenesis through the 
binding of Olig1 and Olig2 to the DNA (Samanta and Kessler 2004), the 
Olig1/Id2- and Olig2/Id2-ratio was determined. A significant increase along 
time in the Olig1/Id2-ratio as well as in the Olig2/Id2-ratio in cells cultured in 
MSC-CM was detected. However, after incubation with BMP2/4 the Olig1/Id2-
and the Olig2/Id2-ratio remained at the level of control conditions indicating 
that the BMPs block the pro-oligodendrogenic effect of MSC-CM. These 
findings strongly suggest that BMPs act also on the transcriptional level to 
neutralize MSC-CM induced effects.  
This indicates, that the milieu at the injury site, were BMPs are up-regulated, 
might be at least in part, responsible for the lack of co-grafted NPC with MSC 
to differentiate into oligodendrocytes. It has been demonstrated, that the 
lesion site is mainly infiltrated by fibronectin-positive cells, whereas GFAP-
positive cells up-regulate among others BMP4, in the tissue adjacent to the 
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lesion center (Chen, Leong and Schachner 2005). This is in accordance with 
preliminary data from our group, also indicating that BMP2/4 are 
predominately up-regulated in the tissue adjacent to the graft/lesion center. 
NPC, which have been grafted directly into the lesion site, are close to cells 
expressing BMPs. Hence, the effect of BMPs might be stronger than the 
effect of the grafted MSC, therefore inhibiting the oligodendroglial 
differentiation of the grafted NPC, just as my in vitro date indicate. 
The fact that grafted MSC still have a strong pro-oligodendrogenic effect on 
endogenous NPC, might be due to the location of the endogenous NPC. 
Endogenous NPC are not located in the lesion site like the grafted NPC, but 
rather get attracted from the adjacent host parenchyma. Therefore, it might be 
possible that these cells do not get affected as strong as the grafted NPC by 
the locally increased BMPs. Since MSC release a soluble factor, it might be 
possible that this factor is still be able to reach the endogenous NPC, inducing 
an oligodendroglial differentiation. 
MSC could not induce the oligodendroglial differentiation of co-grafted NPC 
into the intact spinal cord most likely due to the fact, that even though the 
animals did not underwent a spinal cord transection, the cell injection itself 
causes some inflammation and the up-regulation of BMPs. Therefore, the 
presence of BMPs in close relation to the grafted cells might again inhibit the 
pro-oligodendrogenic effect of the MSC. Since pre-differentiated NPC showed 
an enhanced oligodendroglial differentiation, this further indicates that once 
the NPC are committed towards an oligodendroglial fate, they are not affected 
by BMPs anymore. However, further studies need to be done to confirm these 
explanations.  
Both, MSC and FF grafts filled the cystic defect developing after SCI and 
provided a supporting scaffold to maintain adult NPC within the lesion cavity 
in line with previous studies (Lu et al. 2005, Pfeifer et al. 2004, Vroemen et al. 
2007). Surprisingly FF, introduced as a control condition, significantly 
increased the expression of oligodendroglial marker (>30% of co-grafted 
NPC) in co-grafted NPC. In a previous study employing NPC/FF co-grafts 
only 18% of the co-grafted NPC differentiated into oligodendrocytes (Pfeifer et 
al. 2004). There, post-transplantation survival time was only 3 weeks 
compared to 6 weeks in the present study, which might explain the 
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differences. It is conceivable, since both, FF and MSC belong to the 
mesenchymal lineage (Haniffa et al. 2008, Cappellesso-Fleury et al. 2010) 
that the same factor is responsible for promoting oligodendroglial 
differentiation. Fibroblasts may express this yet unknown factor at higher level 
or express additional factors, which facilitate oligodendroglial differentiation in 
addition. So far, a number of growth factors, cytokines, and hormones have 
been excluded as potential oligodendrogenic factors in the MSC-CM: insulin-
like growth factor-1 (IGF-1), thyroid hormone (TH), fibroblast growth factor-2 
(FGF-2), vascular endothelial growth factor (VEGF), interleukin-6 (IL-6), brain-
derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), nerve 
growth factor (NGF), transforming growth factor β-1 (TGFβ1), neurotrophin-3 
(NT-3), Shh, PDGF-AA, UDP-glucose, and Noggin (Rivera et al. 2006, Rivera 
et al. 2008). 
My in vitro experiments demonstrated that the pro-oligodendrogenic effect of 
MSC-CM on NPC was even more pronounced in FF-CM. The combination of 
MSC-CM with FF-CM did not lead to an additive or over-additive effect in 
terms of astroglial or oligodendroglial differentiation, therefore it might be 
possible that factors secreted by MSC or fibroblasts stimulate at least in part 
the same signaling pathway. Another possibility might be that either more 
than one FF-CM derived factor is inducing this pro-oligodendrogenic/anti-
astrogenic effect or fibroblasts express the yet unknown factor in higher 
concentrations.  
Another study focusing on wound healing demonstrated that paracrine factors 
released by MSC and fibroblasts or by their conditioned medium revealed 
different expression levels in response to injury. The factors released by MSC 
have shown to recruit significantly more macrophages and endothelial lineage 
cells into the wound, thereby enhancing wound healing, compared to 
fibroblast-derived factors (Chen et al. 2008). These results demonstrate, that 
even though MSC and fibroblasts release the same factors, it might be that 
these factors act differently on the differentiation of NPC. 
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The analysis of endogenous NPC differentiation after SCI revealed that the 
fibroblast grafts did not enhance the differentiation of endogenous NPC 
towards oligodendrocytes. However, MSC grafts enhanced the number of 
APC-expressing oligodendroglia. Although APC-positive oligodendrocytes 
have been shown to represent a mature phenotype (Bhat et al. 1996, Fuss et 
al. 2000, Tripathi and McTigue 2007) (Fig.5.1.), which can promote 
remyelination (Cai et al. 2010, Mela and Goldman 2009, Cao et al. 2010, 
Chambers and Perrone-Bizzozero 2004), it needs to be assessed whether 
APC-positive oligodendrocytes remyelinate axons in the described 
experiments.  
 
 
Figure 5.1. Oligodendrocyte maturation markers  
During development, a progressive differentiation from oligodendrocyte precursor to mature 
oligodendrocytes is observed. Stage specific expression of markers are listed. (Figure 
adopted from (McDonald and Belegu 2006, de Castro and Bribian 2005, Nishiyama 2007) 
 
The fact, that fibroblasts did not promote oligodendroglial differentiation in 
endogenous NPC might be due to the fact that endogenous NPC do not 
respond in the same way to soluble factor(s) derived from fibroblasts than 
transplanted NPC.  
In animals receiving fibroblast grafts cell proliferation was increased 3 days 
postoperatively compared to MSC grafted animals. However, the number of 
surviving newborn cells (determined by quantification of BrdU at 4 weeks 
survival time-points) was significantly reduced in FF grafted spinal cords 
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compared to MSC grafted animals. Syngenic FF grafts could induce a strong 
inflammatory response early on (reflected by an increased number of 
proliferating cells). Over time, the early inflammatory response may create an 
unfavorable milieu for newborn cells. As a consequence, an increased 
number of endogenous NPC undergoes cell death. The situation is different in 
MSC grafts. Known immunomodulatory effects of MSC (Caplan 2007, Uccelli 
et al. 2008, Uccelli et al. 2007, Uccelli et al. 2006) diminish the recruitment of 
inflammatory cells in the beginning (3 day survival time-point), resulting in less 
proliferating cells, which leads in the long term to better survival of 
endogenous NPC indistinguishable from animals with lesions only. Further 
studies need to confirm these explanations.  
 
5.2. Graft survival excludes proper cell differentiation 
and vice versa 
Previous studies demonstrated that the stimulation of NPC with MSC-CM for 
2-3 days sufficiently induces oligodendrogenic commitment in NPC (Rivera et 
al. 2006, Rivera et al. 2008). Therefore, NPC were incubated with MSC-CM 
for 3 days prior to transplantation into the intact spinal cord. Indeed, 
significantly more pre-differentiated NPC expressed oligodendroglial marker 
after transplantation into the intact spinal cord compared to NPC, which were 
not pre-differentiated. Apparently the pre-differentiation of NPC is mandatory 
to maintain oligodendroglial differentiation after transplantation, however, at 
the expense of NPC graft survival. These results – favorable cell survival 
prohibits the desired cell differentiation and vice versa - once again illustrate 
the dilemma of stem/progenitor cell transplantation. This is in agreement with 
previous studies, in which cells transplanted at early stages of the 
oligodendroglial lineage, like oligodendrocyte progenitors, showed a better 
survival and a greater capacity for migration in rodent models of focal 
demyelination, compared to cells, which are already more differentiated 
towards the oligodendroglial lineage (Archer et al. 1997, Warrington, 
Barbarese and Pfeiffer 1993, Windrem et al. 2004). The same applies for 
human neural precursor cells, which have been pre-differentiated before 
transplantation into the intact adult rat hippocampus – the undifferentiated 
cells showed a better survival then the pre-differentiated ones (Le Belle, 
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Caldwell and Svendsen 2004). One solution to overcome this problem could 
be NPC grafts, which have been genetically modified to introduce regulatable 
transgenes in a temporally controlled manner (e.g. with tetracycline-regulated 
expression systems), which express pro-oligodendrogenic transcription 
factors such as Olig1 and Olig2. Undifferentiated NPC are allowed to survive 
and integrate into the host parenchyma before Olig1/2 expression is turned on 
to promote oligodendroglial differentiation.  
Previously, adult NPC have been genetically modified to express neurogenin-
2 (Ngn2) before transplantation into the injured spinal cord (Hofstetter et al. 
2005). Ngn2 is a pro-neural transcription factor that promotes neuronal and 
inhibits astroglial differentiation (Nieto et al. 2001). However, Ngn2 expressing 
NPC grafts showed enhanced oligodendroglial differentiation compared to 
naive NPC. In this case, pre-differentiation did not negatively influence graft 
survival. Grafted Ngn2 expressing NPC adopted a more immature 
oligodendroglial phenotype, which might explain the favorable cell survival. 
Over time, grafted Ngn2 expressing NPC prevented dysmyelination and 
increased remyelination (Hofstetter et al. 2005).  
 
5.3. Responsivity of different neuroantomical regions to 
pro-oligodendrogenic cues 
At first, an increased oligodendroglial differentiation was observed after 
adding MSC-CM to rat hippocampus-derived NPC (Rivera et al. 2006). Here it 
is shown that rat NPC from different regions of the CNS are equally 
responsive to MSC-CM to differentiate into oligodendroglia. Both, SVZ and 
spinal cord derived NPC strongly increase oligodendroglial marker expression 
after co-cultivation with MSC or incubation with MSC-CM. This is supported 
by recent findings showing that adult rat SVZ derived NPC do not differ from 
spinal cord derived NPC in terms of the percentage of neuronal, astroglial and 
oligodendroglial differentiation (Kulbatski and Tator 2009). Considering 
autologous NPC transplantation as a potential clinical application this is good 
news. The SVZ and the spinal cord represent a much more accessible region 
to obtain tissue for NPC isolation compared to the hippocampus. 
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Several studies described an increased proliferation of endogenous neural 
progenitor cells following spinal cord injury (Yamamoto et al. 2001, Xu et al. 
2006, Zai and Wrathall 2005, Horky et al. 2006, McTigue et al. 2001). 
Therefore, the recruitment and modulation of endogenous NPC towards an 
oligodendroglial fate as shown here with the transplantation of MSC might 
represent an alternative strategy in order to promote functional outcome 
following spinal cord injury.  
Here enhanced oligodendroglial differentiation with MSC and FF grafting has 
been described. However, this does not yet say anything about remyelination 
and restoration of nerve conduction with this approach. Several studies 
emphasized that the presence of endogenous oligodendrocyte precursor cells 
within the injured or demyelinated spinal cord does not automatically mean 
remyelination (Karimi-Abdolrezaee et al. 2006, Sher et al. 2008). A clear 
demonstration that the generated cells are able to differentiate into mature, 
myelin-producing oligodendrocytes is missing (Levine and Reynolds 1999). In 
the present study the analysis of toluidine blue stained semi-thin sections did 
not provide evidence of enhanced remyelination after MSC grafting. However, 
the dorsal column transection model is most likely not an appropriate model to 
study demyelination following spinal cord injury. Studies comparing spinal 
cord contusion and transection demonstrated that that the extent of myelin 
pathology differs following contusion and transection injury. A hemisection 
injury resulted in focal only demyelination, whereas a contusion injury resulted 
in a more widespread demyelination at greater distances from the lesion 
center (Siegenthaler, Tu and Keirstead 2007). Therefore, the next step is to 
investigate remyelination in a contusion model. A contusion injury leads in 
addition to the mechanical damage to the spinal cord also to displacement of 
tissue at a distance from the site of injury, which results in more severe and 
longer lasting locomotor deficits than in a transection model. Hence, contusion 
injuries reproduce more closely anatomical and behavioral outcomes 
occurring in patients suffering from spinal cord injury (Basso et al. 1996, 
Hamers et al. 2001, Siegenthaler et al. 2007).   
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5.4. Feasibility of a clinical 3T MRI scanner to study 
pathological changes occurring after spinal cord injury 
in the rat 
Results from the MRI study demonstrate that a clinical 3T MR imaging system 
with a dedicated phased array spine surface coil allows the visualization of 
neuropathological sequels of spinal cord contusion injury in the living rat. So 
far, this is the first time that a 3.0T MR scanner designed for routine clinical 
studies has been employed to obtain high quality images from the rat spinal 
cord. 
The employed clinical 3T imaging system achieves a spatial resolution that is 
roughly 8 times lower compared to the 17.6T MRI (Weber et al. 2006). Until 
now, the 17.6T MRI system yielded the best resolution for MRI of the rat 
spinal cord. However, compared to experimental imaging systems that 
operate in a similar range of field strength (1.5– 4.7T), the spatial resolution of 
the clinical 3T scanner is almost equivalent to systems with a field strength up 
to 4.7T (Metz et al. 2000, Ohta et al. 1999, Fukuoka et al. 1998b, Guizar-
Sahagun et al. 1994, Fraidakis et al. 1998). Even compared to previous 
studies using implantable coils (Narayana et al. 2004, Bilgen et al. 2000, Ford 
et al. 1994) requiring additional invasive surgery the difference in spatial 
resolution is rather small.  
The spatial resolution in PD-weighted images is very important in the spinal 
cord as it is the only one sequence that can clearly delineate the gray and 
white matter tracts of the intact rat spinal cord in vivo. The loss of gray-white 
matter contrast is the hallmark of spinal contusion injuries, which is invariably 
associated with lower body paralysis. The return of gray-white matter contrast 
in images acquired by PD-TSE sequences therefore serves as a surrogate 
marker for clinical improvement (Narayana et al. 2004). With T2-weighted 
images, which are known to detect hemorrhage and edema in the acute stage 
as well as cystic degeneration in the subacute/chronic stage (Flanders et al. 
1990, Hackney et al. 1986, Kulkarni et al. 1987), we could clearly identify 
these sequels of spinal cord injury with 3T MRI. The MRI findings were 
confirmed by analysis of corresponding histological sections. Of course, the 
spatial allocation of respective signal changes is not as precise as observed 
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with 17.6T MRI; however, it is sufficient to serve as a morphological outcome 
parameter or to help find the optimal transplantation site in the context of cell- 
or biomaterial-based spinal cord repair strategies (Pfeifer et al. 2004, Prang et 
al. 2006). 
In general, high field strength MRI systems are superior to the 3T clinical 
scanner in terms of spatial resolution. Pathomorphological changes following 
experimental spinal cord injury in small animals can be detected more 
precisely. However, not all systems are suitable for imaging of the adult rat 
spinal cord in vivo. For example, with 17.6T MRI the mortality rate was high 
due to the small bore size and insufficient air/anesthetic circulation, which 
makes studies over time with identical animals not really feasible. In the 
present study with the 3T MR scanner, there was not a single animal lost 
resulting from the imaging procedure. With this system, rats weighing up to 
400 g can be analyzed. Of course, high-field animal-dedicated scanners in the 
range from 4.7 up to 11.7T with larger bore diameters can also be applied for 
adult rats without major restrictions in animal size. Unfortunately, these 
experimental high-field imaging systems are only available in dedicated 
imaging centers.  
In conclusion, the employed routine clinical 3T MR scanner in combination 
with a dedicated phased array spine surface coil allows the noninvasive 
visualization of morphological changes occurring in the injured rat spinal cord 
in vivo at a spatial resolution that thus far could only be achieved with 
experimental MRI systems at higher field strength.  
 
5.5. Summary and Conclusion 
As shown here, MSC represent promising cellular candidates to promote 
oligodendroglial differentiation in endogenous glial progenitor cells 
proliferating after spinal cord injury. The functional relevance in terms of 
remyelination and restoration of nerve conduction has yet to be determined in 
a relevant spinal cord injury model. Further efforts need to identify the soluble 
factor(s) responsible for the observed oligodendrogenic effects. Besides, the 
creation of cellular bridges and reduction of the glial scar through MSC, by 
having anti-inflammatory effects, e.g. through inhibiting the proliferation of T 
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and B lymphocytes (Uccelli et al. 2007), MSC have some axon-regenerative 
aspects (Cho et al. 2009) and show positive effects on the vasculature (Parr, 
Tator and Keating 2007), which would be important for a possible clinical 
application. Moreover, MSC can be easily genetically modified to over-
express certain growth factors and are therefore suitable cell types for ex vivo 
gene delivery (Lu et al. 2005, Lu et al. 2004). Others have demonstrated that 
MSC grafts establish a cellular matrix that supports host axonal growth into 
but not beyond spinal cord lesion sites (Lu et al. 2005, Lu, Jones and 
Tuszynski 2007, Ankeny et al. 2004, Hofstetter et al. 2002, Neuhuber et al. 
2005). Therefore, combinatorial approaches will be necessary to achieve 
axonal growth beyond the lesion site and functional recovery (Lu and 
Tuszynski 2008, Lu et al. 2004, Pearse et al. 2004). Taylor et al. 
demonstrated that grafts of MSC in combination with a gradient of NT-3 
rostral to the lesion site allows sensory axons to bridge for short distances 
beyond the lesion site (Taylor et al. 2006). Subsequent studies demonstrated 
that the distance of sensory axon regeneration is increased when a gradient 
of NT-3 is combined with the stimulation of regenerative responses at the cell 
soma (Alto et al. 2009). Other approaches demonstrated that the combined 
stimulation of neural cells bodies with cAMP and the stimulation of injures 
axons with NT-3 promotes axonal regeneration (Lu et al. 2004). Taken 
together, these unique properties of MSC make them a favorable cell type to 
be developed further towards clinical translation. 
Finally, a clinical 3T MRI scanner was successfully employed to non-
invasively visualize morphological changes occurring after spinal cord injury in 
the rat, which is a prerequisite for translating cell-based therapies into the 
clinic. 
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6. List of Abbreviations 
 
α-MEM    Alpha Modified Eagle Media 
ANOVA   Analysis of Variance 
APC    Adenomatous polyposis coli 
ASIA    American Spinal Injury Association 
AT    Ascending Tract 
ATP    Adenosine Triphosphate 
BBB    Blood-Brain Barrier 
BDNF    Brain Derived Neurotrophic Factor 
bFGF    basic Fibroblast Growth Factor 
BMP 2/4   Bone Morphogenetic Protein 2/4 
BrdU    5-Bromo-2’-Deoxyuridine 
BSA    Bovine Serum Albumin 
CA    Caudal 
GalC    Galactocerebroside 
CAP    Cortical Cytoskeleton-associated Protein 
CC    Central Canal 
cDNA    Complementary DNA 
ChABC   Chrondroitinase ABC 
CNPase   2',3'-Cyclic Nucleotide 3'-Phosphodiesterase 
CNS    Central Nervous System 
CPS    Cyro Protect Solution 
CSF    Cerebrospinal Fluid 
CSPG    Chondroitin Sulfate Proteoglycan 
CST    Corticospinal Tract 
Cy5    Cyanine 5 
DAB    3,3'-Diaminobenzidine 
DAPI    4’,6-Diamidino-2-phenylindole 
DCWM   Dorsal Column White Matter 
Dk    Donkey 
DMEM    Dulbecco’s Modified Eagle Media 
DMSO    Dimethyl Sulfoxide 
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DNA    Deoxyribonucleic Acid 
DPBS    Dulbecco’s Phosphate Buffered Saline 
DREZ    Dorsal Root Entry Zone 
ECM    Extracellular Matrix 
EGF    Epidermal Growth Factor 
eGFP    enhanced Green Fluorescent Protein 
EPHB2   Ephrin-B2 
EPO    Erythropoetin 
FACS    Fluorescence Activated Cell Sorting 
FBS     Fetal Bovine Serum 
FF    Fibroblast 
FF-CM   Fibroblast-Conditioned Media 
FOV    Field Of View 
FSBG    Fish Skin Gelatin Buffer 
G6PDH   Glucose-6-Phosphat-Dehydrogenase 
Galc     Galactosylceramidas 
GAG    Glycosaminoglycan 
GFAP    Glial Fibrillary Acidic Protein 
GFP    Green Fluorescent Protein 
GM    Grey Matter 
GM/WM   Grey matter / White Matter transition zone 
GPI    Glycosylphosphatidyl 
GAP    Growth Associated Protein-π  
GST-π   Glutathione S-transferase 
GTP    Guanosintriphosphat 
HC    Hippocampus 
HIV    Human immunodeficiency virus 
Id2/4    DNA-binding protein inhibitor 2/4 
IgG    Immunoglobulin, isoform G 
iNOS    inducible Nitric Oxide Synthase 
i.p.    intraperitoneally 
ISWM    Injection Site in the White Matter 
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LC    Lesion Center 
LCWM   Lateral Column White Matter 
Map2ab                              Microtubule-associated Protein 2 Isoform a+b 
MAG    Myelin-Associated Glycoprotein 
MBP     Myelin Basic Protein 
MOG    Myelin Oligodendrocyte Glycoprotein 
MR    Magnetic Resonance 
MRI    Magnetic Resonance Imaging 
mRNA   messenger Ribonucleic Acid 
Ms    Mouse 
MSC    Mesenchymal Stem Cell 
MSC-CM          Mesenchymal Stem Cell-Conditioned Media 
NB    Neuro Blasal 
NCAM   Neural Cell Adhesion Molecule 
NG2    Chondroitin Sulfate Proteoglycan 
NGF    Nerve Growth Factor 
NgR    Nogo Receptor 
NMDA   N-Methyl-D-Aspartate 
NO    Nitric Oxide 
NPC     Neural Progenitor Cell 
N.S.    Not Significant 
NSCISC   National Spinal Cord Injury Statistical Center 
NSPC    Neural Stem / Progenitor Cell 
NT    Neurotrophin 
O4    Oligodendrocyte antigen O4 
OEC    Olfactory Ensheathing Cell 
Olig 1/2   Oligodendrocyte Transcription Factor 1/2 
OMgp    Oligodendrocyte Myelin Glycoprotein 
OPC    Oligodendrocyte Precursor 
PBS    Phosphate Buffered Saline 
PD    Proton-Density 
PDGF-AA   Platelet Derived Growth Factor-AA 
PFA    Paraformaldehyde 
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PLP    proteolipid protein 
PNS    Peripheral Nervous System 
Prediff.   Predifferentiated 
PSA-NCAM   Poly-Sialated Neural Cell Adhesion Molecule 
RAG    Regeneration Associated Gene 
Rb    Rabbit 
RF    Radio Frequency 
RhoA    Ras homolog gene family, member A 
Rhox    Rhodamine X 
RIP    Receptor Interacting Protein 
RO    Rostral  
Rt    Rat 
RT-PCR   Real-Time Polymerase Chain Reaction 
SC    Spinal Cord 
SCI    Spinal Cord Injury 
SD    Standard Deviation 
SE    Spine Echo 
SEM    Standard Error of the Mean 
Sema     Semaphorin  
SNR    Signal-to-Noise 
SPRR    Small Proline-rich Repeat Protein 
SVZ    Subventricular Zone 
T    Tesla 
TBS    Tris-Buffered Saline 
TE    Echo Time 
TGF-β   Transforming Growth Factor beta 
TNF-alpha   Tumor Necrosis Factor-alpha 
TR    Repetition Time 
TSE    Turbo Spin Echo 
VEGF    Vascular Endothelial Growth Factor 
VSVG    Vesicular Stomatitis Virus G 
WM    White Matter 
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